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SUMMARY 
Besides oxygen, carbon and hydrogen, nitrogen is an essential element that constitutes 
life. It is generally consumed as nitrate (NOs") or nitrite (N02~). Changes in patterns 
of agricultural practice, food processing and industrialization have impacted 
accumulation of nitrates/nitrites in the environment. Nitrate-is abundantly present in 
the soil and water [Hill, 1991]. It is a valuable fertilizer and is used extensively in the 
farming practice. Livestock and poultry as well as urban sewage treatment also 
contribute nitrogenous wastes to the soil. Bacteria present in the soil, water, feed and 
foods are capable of utilizing these nitrogenous compounds to synthesize nitrates (and 
nitrites) de novo via heterotrophic nitrification (and nitrate reduction) [Tannenbaum et 
al. 1978]. Nitrates and nitrites, used in combination with salt, serve as important 
antimicrobial agents in meat to inhibit the growth of bacterial spores that cause 
botulism, a deadly food-borne illness. Nitrites are also use as preservatives and for 
tlavoring and fixing color in a number of red meat, poultry, and fish products. 
Additionally, nitrites have been employed as a vasodilator, or a circulatory depressant 
to relieve smooth muscle spasm, and an antidote for cyanide poisoning [Nickerson, 
1970]. and potassium nitrate has been usedttierapeutically as a diuretic agent. Other 
precursors or sources of nitrite include N-co'fft^ining foods, nitrogen containing 
drugs/chemicals (e.g. nitroglycerin, an anti-micro|ial agent and coronary dilator; 
sodium nitroprusside, Na2[Fe(CN)6NO], an anti-hypertensive agent and nitric oxide 
(NO) [Chow and Hong, 2002]. Nitric oxide (NO), which is synthesized in vivo from 
L-arginine (ARG), can be oxidized to nitrite or nitrate. NO is also a component of 
cigarette smoke and automobile exhaust. Thus, man and animals are subjected to 
significant nitrate and nitrite levels in foods, feed, soil and water as well as those 
formed in vivo. Nitrites and nitrates formed from nitrogenous sources from 
microorganisms in saliva, intestine, however, are the major source of human exposure 
under normal conditions [White, 1975; Tannenbaum et al.. 1978]. 
Nitrates are generally not toxic however, ingestion of large amounts of nitrates was 
found to be associated with methemoglobinemia, anemia, severe gastroenteritis and 
nephritis [Dollahite and Rowe, 1974]. Any toxicity linked with nitrate was foimd to 
be due to its bioconversion to nitrite by the bacteria in the soil, mouth or stomach 
[Duncan el al., 1995; Lundberg and Govoni, 2004]. The major health concerns with 
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nitrite are the risk of methemoglobinaemia and its potential carcinogenic, mutagenic 
and cytotoxic effects [Get at ai, 1996, Magee and Barnes, 1956; Spencer et al, 2000; 
Sun el ai. 2006]. A high dietary intake of nitrite has been implicated as a risk factor 
for human cancer, and formation of nitroso-compounds in the stomach during 
inflammation is correlated with nitrate in food and water [Ames, 1983; Mirvish. 
1995|. A number of biochemical changes, functional impairments and 
histipathological lesions have been observed in nitrite-treated rats [Abuharfeil et ai, 
2001]. It has now been documented that reactions of H2O2 with nitrite and of 
superoxide with NO have a common intermediate-peroxynitrite (ONOO") 
[Carmichael et al, 1993], which is responsible for nitration of proteins, DNA strand 
breaks and mutations, and with interference of protein functions [Sampson et ai, 
1998]. Moreover in acidic conditions, nitrite is spontaneously decomposed to NO that 
can be reconverted back to nitrite [Lundberg et ai, 2008]. Sodium nitroprusside 
(SNP) is widely used as an anti-hypertensive agent in clinical practice. SNP has been 
documented to induce genotoxicity [Andreassi et ai, 2001], mutagenictiy [Asaka et 
ai, 1997; Lin et al, 1998] and apopotosis [Feldman et al, 1997]. Recent studies have 
shown that SNP alters the mitochondrial energy generation processes. It has been 
shown to irreversibly inhibit the respiratory chain [Brown and Borutaite, 2002] but 
stimulates glycolysis [Maletic et al, 2000] thereby decreasing total energy 
production. L-Arginine (ARG) is the substrate for the different nitric oxide synthase 
(NOS) isoforms which are responsible for the production of NO n vivo. ARG itself 
has very moderate toxicity, whatever harmful effects it manifests is mainly due to the 
overproduction of NO. An excessive dose of ARG was linked with pancreatitis along 
with multi-organ failure [Mizinimia et al, 1984]. It has been reported that high doses 
of ARG causes widespread morphological changes in the liver, kidney and adipose 
tissues [Kishino, 1984; Hegyi et al, 2001]. Nitric oxide is a double-edged sword as it 
can be both cytoprotective and cytotoxic. Produced by mammalian cells at an 
appropriate magnitude and tempo, it serves as a key signaling molecule in 
physiological processes as diverse as host-defense, neuronal communication, and 
vascular regulation [9-11]. On the other hand, excessive and unregulated NO 
synthesis has been implicated as causal or contributing to pathophysiological 
conditions including many lethal and debilitating human disorders: arthritis, 
atherosclerosis, cancer, diabetes, numerous degenerative neuronal diseases, stroke, 
and myocardial infarction to name a few [Culotta and Koshland, 1992, Gross and 
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Wolin, 1995]. Recently both nitrates and nitrites are recognized as key oxidation 
products of NO, which can be generated in the tissues by a number of enzymatic and 
non-enzymatic reactions [Lundberg et al, 2008 review]. Therefore, they should now 
be viewed as storage pools for NO-like bioactivity, thereby complementing the NO 
synthase (NOS)-dependent pathway. The recognition of this mammalian nitrogen 
cycle (nitrate-nitrite-NO) has led researchers to explore the role of nitrate and nitrite 
in physiological and pathophysiological processes where NO is known to play a key 
role. 
The last two decades have witnessed a major drift in the interests of the scientific 
community towards providing better means to containing the health risks of the 
human race. The century old chemotherapies against various disorders have never 
been a success, albeit not a total failure. Such therapies have a major drawback of side 
effects that give rise to unseen disorders that emerge as a new challenge. From ancient 
times, the physicians and scholars in Asia have understood that food has both 
preventive and therapeutic value and is an integral part of human health. The concept 
of chemo-prevention of certain diseases using naturally occurring substances that can 
be included in the diet consumed by human populations is gaining attention. Of late, 
renewed interest and vigor has been showered on the role of omega fatty acids. Fish 
oil enriched in co-3 PUFA (EPA and DHA) provide one such dietary source of 
biologically active components that has been shown to be co-preventative and co-
therapeutic in a wide variety of ailments [Doughman el ai, 2007]. Early clues to the 
possible importance of unsaturated fatty acids especially polyunsatiirated fatty acids 
(PUFA) came from studies showing that young humans and experimental animals 
experienced impaired growth when all fatty acids were removed from the diet. Small 
amounts of co-3 (a-linolenic acid) or co-6 (linoleic acid) fatty acids prevented that 
impaired growth and thus were termed as "essential" [Burr and Burr, 1930]. Highly 
unsaturatedypolyunsaturated FA (HUFA/PUFA) were relatively found to be several-
fold more effective [Turpeinen, 1937]. 
Further studies have revealed that both a>-3 and co-6 PUFA have numerous health 
benefits. However, co-3 PUFA especially from fish/marine foods were found to be 
more effective in lowering incidence of various pathologies compared to co-6 PUFA 
rich diets [Simopoulos, 2001]. This stems from the observations of the different 
prevalence of coronary heart disease and other chronic diseases (including psoriasis, 
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bronchial asthma, diabetes mellitus and thyrotoxicosis) in the Greenland Inuit 
(Eskimo) population relative to Western populations [Kromann and Green, 1980]. co-3 
PUFA (e.g. EPA and DHA) from marine fish and mammals were indicated as the 
main dietary factor responsible for such differences [Dyerberg et al, 1975; Bang et 
al.. 1976]. The consumption offish has now been linked with the rate of depression 
among various populations. In countries where people eat the least fish the rate of 
depression is highest, and vice versa [Hibbeln, 1998; Small, 2002]. This correlation 
holds true across the world. The most dramatic change in what we eat has happened in 
the past century, with industrialization and development of the food industry, the 
intake of saturated fat, trans fat and especially a)-6 enriched refined oils have 
enormously increased whereas the consumption of co-3 PUFA has considerably 
declined. These dietary imbalances in fat intake, in fact, are prime cause of modem 
sufferings like cancer, hypertension, diabetes, depression, cardiovascular and renal 
disorders. 
Role of fish oil/co-3 PUFA has been extensively investigated and has received a great 
deal of attention in recent times as therapeutic options in a variety of clinical 
situations ranging from CVD to hyperlipidemia, cancer, inflammatory and immime 
disorders, respiratory diseases, depression and diabetes [De Caterina et al., 1994; 
Kakar el al., 2008]. Lately, (o-3 PUFA from certain plants/seeds e.g. walnut, canola 
and most notably from flaxseed (linseed) showed many similar health benefits as 
demonstrated by co-3 PUFA from fish/fish oil [Nannicini et al., 2006; Vijaimohan et 
al.. 2006]. 
Although (0-3 PUFA have been shown as deterrents for environmental pollutants, 
studies on their possible beneficial effects against drug/chemical induced 
nephrotoxicity and gastrointestinal toxicity are very limited [Watkins et al, 2007; 
Priyamvada et al., 2008, 2010]. Considering profound beneficial health effects of co-3 
PUFA from marine or plant foods against various pathologies the present work 
embodied in this thesis was undertaken to study the detailed mechanisms of NO 
donors/metabolites induced nephrotoxic alterations and possible mechanism of 
protection/prevention of 00-3 fatty acids enriched fish oil (FO) and/or flaxseed oil 
(FXO) in the diets against NO donors/metabolites induced nephropathies. Useful 
sources of NO for study in animal models are its essential amino acid substrate L-
arginine and pharmacological donors like sodium nitroprusside (SNP). To study the 
role of NO metabolites, sodium nitrite (SNT) was used. In extension, the effects of 
NO donors/metabolites and FO/FXO were also studied in small intestine and liver, 
which are primary targets of toxic insult. In view of numerous beneficial health 
effects of co-3 PUFA "we hypothesized that: dietary FO and FXO enriched in co-3 
PUFA would be able to prevent/reduce NO donors/metabolites induced nephrotoxic 
and other adverse effects in the rat kidney, intestine and liver." 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of NO donors/metabolites induced 
nephrotoxic and other adverse effects in rat kidney, intestine and liver. The effects of 
dietary (o-3 PUFA was also determined to observe any protection provided by them 
against NO donors/metabolites nephrotoxicity. The following parameters were 
determined: 
(a) Certain biochemical parameters in serum/urine. 
(b) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis and HMP-shunt pathway in renal cortex 
and medulla, small intestine and liver. 
(c) The activities of BBM and lysosomal marker enzymes in renal cortical and 
mucosal homogenates and BBM marker enzymes in isolated BBM preparations 
from renal cortex and intestinal mucosa. 
(d) The transport of •'^ Pi in renal cortical BBM. 
(e) The enzymatic and non-enzymatic parameters of antioxidant defense system in 
renal cortex and medulla, small intestine and liver. 
# THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS; 
O PART I: EFFECT OF FISH OIL (FO) AND FLAXSEED OIL (FXO) ON 
SODIUM NITRITE (SNT) INDUCED NEPHROTOXIC AND OTHER 
ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
SNT treatment to control rats resulted in significant increase in serum creatinine (Scr) 
and blood urea nitrogen (BUN), but decrease in cholesterol, glucose, phospholipids 
and inorganic phosphate (Pi) as compared to control rats. These changes where 
associated with profound phosphaturia, proteinuria and glucosuria, accompanied by 
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decrease in creatinine clearance. Feeding of FO or FXO diet to SNT administered rats 
resulted in significant reversal of various SNT elicited deleterious effects on serum 
and urine parameters. 
(b) Enzymes of carbohydrate metabolism: 
(i) SN r treatment to rats significantly increased the activity of lactate dehydrogenase 
(LDH) but decreased malate dehydrogenase (MDH), hexokinase (HK); glucose-6-
phosphatase (G6Pase) and fructose-1, 6-bisphosphatase (FBPase) activities in the 
renal cortex. When SNT treatment was extended to FO and FXO-fed rats, SNT-
induced alterations in metabolic enzyme activities were not only prevented by FO and 
FXO diets, but G6Pase remained significantly higher in FOSNT and FXOSNT 
compared to control as well as SNT rats in the renal cortex. 
SNT treatment to control rats significantly increased G6PDH but decreased ME 
activity. SNT elicited increase of G6PDH activity was normalized to near control 
values by both FO and FXO diets. SNT induced ME activity decrease was arrested by 
both FO and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by SNT treatment (Table 3a) as in the cortical homogenates. 
Feeding of FO and FXO to SNT treated rats prevented SNT induced alterations in 
various enzyme activities. Similar to cortex, G6PDH activity increased whereas ME 
activity decreased by SNT in the medulla (Table 3b). FO and FXO diet to SNT treated 
rats decreased G6PDH activity and increased ME activity. 
(iii) The effect of SNT and dietary oils was also determined on the enzymes of 
carbohydrate metabolism in mucosal homogenates from different experimental rats. 
SNT treatment to rats caused significant increase in LDH (+40%) and hexokinase 
(HK) but decrease in MDH activities. SNT caused significant decrease in 
gluconeogenic enzymes, G6Pase and FBPase in the intestine. The activities of LDH, 
G6Pase and to some extent FBPase remained significantly higher after SNT treatment 
to FO and FXO-fed rats compared to control rats reversing the SNT-induced decrease 
in G6Pase and FBPase activities. SNT-induced decline in MDH activity was also 
restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+34%) but that of ME decreased (-21%) by SNT treatment compared to control rats. 
However, when SNT treatment was given to FO/FXO diet fed rats, SNT induced 
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increased in G6PDH and decrease in ME activities were not observed indicating that 
both FO and FXO diet significantly prevented the alterations caused by SNT. 
(iv) SNT treatment significantly increased the activities of LDH (+62%), HK (+43%) 
and G6PDH (+30%) whereas decreased G6Pase, FBPase and ME activities in the 
liver. When SNT treatment was extended to FO-fed rats, SNT-induced decrease of 
metabolic enzyme activities was prevented by FO and FXO alike except HK and 
MDH. whose activities remained significantly higher than control by FXO. 
(c) Marker enzymes ofBBM and lysosomes: 
(i) The activites of alkaline phosphatase (AlkPase), y-glutamyl transpeptidase 
(GGTase) and leucine aminopeptidase (LAP) and acid phosphatase were determined 
under different experimental conditions in the homogenates of renal cortex and 
medulla. SNT treatment to control rats caused significant reduction in the specific 
activities of AlkPase (-35%), GGTase (-57%) and LAP (-52%) in cortical 
homogenate. The prior feeding of FO or FXO diet with SNT treatment prevented SNT 
elicited decrease in BBM enzyme activities. The activity of acid phosphatase 
(ACPase) was also decreased (-45%) by SNT in cortical homogenates and FO/FXO 
diet was able to prevent the decrease in enzyme activity in a similar manner. The 
consumption of FO/FXO in combination with SNT treatment resulted in the reversal 
of SNT induced decrease in AlkPase (-19%), GGTase (-33%) and LAP (-42%) in the 
medulla. The activity of ACPase was not affected by SNT and SNT+FO. However it 
was found to be lower in SNT+FXO rats (-18%) compared with the control rats. 
(ii) The effect of SNT, FO and FXO on BBM marker enzymes was further analyzed 
in BBMV preparations isolated from the renal cortex. The data shows a similar 
activity pattern of BBM enzymes as observed in cortical homogenates. However the 
magnitude of the effects was much more pronounced in BBMV than in cortical 
homogenates. Activities of AlkPase (-67%). GGTase (-53%) and LAP (-51%) 
profoundly declined by SNT treatment as compared to control rats. Fish oil (FO) and 
flaxseed oil (FXO) dietary supplementation similar to the effect in the homogenates 
appeared to lower the severity of the SNT treatment. SNT-induced decrease in BBM 
enzyme activities was significantly prevented by dietary FO and to greater extent by 
FXO diet. 
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(iii) SNT treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. SNT treatment also resulted in the decrease of 
ACPase activity. When SNT treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. 
The effect of SNT, FO and FXO diets was also observed on BBM marker enzymes in 
isolated BBMV preparations. The results showed a similar activity pattern of various 
enzymes in the BBMV as observed in mucosal homogenates. SNT treatment 
profoundly decreased the activities of all BBM enzymes but sucrase which was 
elevated, FO/FXO caused marked increase in AlkPase and GGTase whereas LAP and 
sucrase activities were significantly normalized by both FO/FXO diets. SNT induced 
decrease in the BBMV and lysosomal marker enzymes was not only preserved by 
FO/FXO diets but the activities were restored to near control values. 
(iv) The effect of SNT and FO/FXO diet was also determined on marker enzymes of 
BBM and lysosomes in liver homogenates. SNT treatment to rats resulted in extensive 
reduction in the specific activity of alkaline phosphatase (AlkPase) whereas other 
enzymes were not altered significantly in the liver homogenates. The feeding of FO 
and FXO-diet to SNT treated (FOSNT/FXOSNT) rats not only prevented SNT 
elicited changes, but the activities of GGTase, AlkPase and LAP were even increased 
by FO/FXO diet. 
(d) Enzymatic and non-enzvmatic antioxidant defense parameters: 
(i) SNT enhanced lipid peroxidation (LPO) and significantly altered antioxidant 
enzymes both in cortex and medulla, albeit differently. LPO measured in terms of 
maiodiaidehyde (MDA levels) significantly enhanced in the cortex (+46%) and 
medulla (+40%) to similar extent whereas total-SH declined in these tissue (-29% to -
37%). SNT treatment caused marked increase in superoxide dismutase (SOD, +58%) 
and Glutathione peroxidase (GSH-Px, +30%) activities but decrease in catalase (-
16%)) activity in the renal cortex. In medulla however the activity of SOD (-58%) and 
catalase (-28%)) significantly decresed but in the activitiy of GSH-Px (+45%)) was 
significantly increased by SNT administration alone. FO and FXO dietary 
supplementation was able to ameliorate the SNT induced oxidative damage in both 
renal cortex and medulla. 
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(ii) The effect of SNT, FO and FXO were determined on various antioxidant 
parameters in mucosal homogenates. SNT treatment caused marked increase in SOD 
(+160%), catalase (+55%) and GSH-Px (+28%). These changes were associated with 
significant increase in lipid peroxidation (+87%) measured in terms of MDA levels 
and decrease in total-SH (-21%). Both FO and FXO-diet partially prevented SNT-
induced increase in SOD, catalase and GSH-Px activities. SNT induced increase in 
LPO and decreased SH-content were prevented by FO/FXO diet. 
(iii) The effect of SNT, FO and FXO-diet was determined on various antioxidant 
parameters in liver homogenates. SNT treatment to control rats caused marked 
increase in SOD (+34%) and GSH-Px (+55%)) activities but decrease in catalase (-
20%)). These changes were associated with significant increase in lipid peroxidation 
(+30%) and decrease in total-SH content (-37%). Both FO/FXO-diets prevented SNT-
induced increase in SOD and GSH-Px activities whereas catalase was significantly 
lowered by FO and FXO diet were given in combination with SNT treatment. Total-
SH and LPO were also normalized to near control values. 
(e) Na'^- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by SNT treatment. However, the uptake of 
'"Pi at the equilibrium phase (120min) when Na^ ^^ Nai was not significantly different 
between the two groups. Also Na-independent uptake (in the absence of a Na 
gradient, when NaCl in the medium was replaced by KCl where Ko> Kj) of Pi at 30s 
and 120min was also not affected by SNT treatment indicating specific alterations 
only when Na-gradient was present. When SNT treatment was extended to FO and 
FXO feeding rats, SNT induced decrease in "'^ Pi transport was not observed. 
(f) Tissue concentration of nitrite: 
Exposure of SNT to rats increased the tissue concentrations of nitrite in all tissues, the 
accumulation of nitrite being greater in renal cortex (+78%)) and intestine (+52%)), 
When FO/FXO was given in combination with SNT, both FO and FXO partially 
improved the values to near control in renal cortex, medulla and intestine, whereas in 
the liver complete amelioration was observed (Table 14). 
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ftf Interpretation: In general, SNT caused severe adverse effects on various 
serum/urine parameters and on the enzymes of carbohydrate metabolism, BBM and 
antioxidant defense system in rat kidney and intestine. FO and/or FXO diet similarly 
protected against GM-induced nephrotoxic and other adverse effects most likely due 
to their intrinsic biochemical and antioxidant properties. 
O PART II: EFFECT OF FISH OIL (FO) AND FLAXSEED OIL (FXO) ON 
SODIUM NITROPRUSSIDE (SNP) INDUCED NEPHROTOXIC AND OTHER 
ADVERSE EFFECTS 
(a) Serum/urine parameters: 
SNP treatment to control rats resulted in significant increase in serum creatinine (Scr), 
blood urea nitrogen (BUN), cholesterol, glucose and phospholipids but decrease in 
inorganic phosphate (Pi) compared to control rats. These changes where associated 
with profound phosphaturia, proteinuria and glucosuria accompanied by decrease in 
creatinine clearance (Table 2). Feeding of FO or FXO diet to SNP administered 
(FOSNP and FXOSNP) rats resulted in significant reversal of various SNP elicited 
deleterious effects on serum and urine parameters. 
(b) Enzymes of carbohydrate metabolism: 
(i) SNP increased the activity of lactate dehydrogenase (LDH) and hexokinase (HK) 
but decreased malate dehydrogenase (MDH), glucose-6-phosphatase (G6Pase) and 
fructose-1. 6-bisphosphatase (FBPase) activities in the renal cortex. When SNP 
treatment was extended to FO and FXO-fed rats. SNP-induced alterations in 
metabolic enzyme activities were prevented by FO and FXO diets alike. SNP 
treatment to control rats significantly increased G6PDH but decreased ME activity. 
SNP elicited increase of G6PDH activity was normalized to near control values by 
both FO and FXO diets. SNP induced ME activity decrease was arrested by both FO 
and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by SNP treatment as in the cortical homogenates. Feeding of 
FO and FXO to SNP treated rats prevented SNP induced alterations in various 
enzyme activities. Similar to cortex, G6PDH activity increased whereas ME activity 
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decreased by SNP in the medulla (Table 4). FO and FXO diet to SNP treated rats 
decreased G6PDH activity and increased ME activity. 
(iii) SNP treatment to control rats caused significant increase in LDH (+29%) and 
hexokinase (HK) but decrease in MDH activities. SNP caused significant decrease in 
gluconeogenic enzymes, G6Pase and FBPase in the intestine. The activities of LDH, 
G6Pase and to some extent FBPase remained significantly higher after SNP treatment 
to FO and FXO-fed rats compared to control rats reversing the SNP-induced decrease 
in G6Pase and FBPase activities. SNP-induced decline in MDH activity was also 
restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+29%) but that of ME decreased (-19%) by SNP treatment compared to control rats. 
However, when SNP treatment was given to FO/FXO diet fed rats, SNP induced 
increased in G6PDH and decrease in ME activities were not observed indicating that 
both FO and FXO diet significantly prevented the alterations caused by SNP. 
(iv) SNP treatment significantly increased the activities of LDH (+35%) and HK 
(+59%) whereas decreased G6Pase, FBPase, ME and G6PDH activities in the liver. 
When SNP treatment was extended to FO-fed rats, SNP-induced decrease of 
metabolic enzyme activities was prevented by FO and FXO alike except HK and 
MDH. whose activities remained significantly higher than control by FXO. 
(c) Marker enzymes of BBM and lysosomes'. 
(i) SNP treatment to control rats caused significant reduction in the specific activities 
of GGTase {-1A%) and LAP (-56%») in cortical homogenates. The prior feeding of FO 
or FXO diet with SNP treatment prevented SNP elicited decrease in BBM enzyme 
activities. The activity of acid phosphatase (ACPase) was increased (+31%) by SNP 
in cortical homogenates and FO/FXO diet was able to restore the enzyme activity in a 
similar manner. The activites of BBM enzymes similar to the cortex were also 
lowered in the medulla by SNP administration although to a lower extent. The 
consumption of FO/FXO in combination with SNP treatment resulted in the reversal 
of SNP induced decrease in GGTase (-29%) and LAP (-48%) in the medulla. The 
activity of ACPase was increased (+46%) by SNP. 
(ii) Activities of AlkPase (-25%), GGTase (-13%) and LAP (-43%) profoundly 
declined by SNP treatment as compared to control rats in renal BBM. Fish oil (FO) 
and flaxseed oil (FXO) dietary supplementation similar to the effect in the 
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homogenates appeared to lower the severity of the SNP treatment. SNP-induced 
decrease in BBM enzyme activities was significantly prevented by dietary FO and to 
greater extent by FXO diet. 
(iii) SNP treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. SNP treatment also resulted in the decrease of 
ACPase activity. When SNP treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. SNP treatment profoundly decreased the activities of all 
BBM enzymes, FO/FXO caused significant normalization in the values of AlkPase, 
GGTase and sucrase. SNP induced decrease in the BBMV and lysosomal marker 
enzymes was not only preserved by FO/FXO diets but the activities were restored to 
near control values. 
(iv) SNP treatment to rats resulted in extensive reduction in the specific activity of 
GGTase and LAP whereas AlkPase and ACPase where increased in the liver 
homogenates. The feeding of FO and FXO-diet to SNP treated (FOSNP/FXOSNP) 
rats prevented SNP elicited changes. 
(d) Enzymatic and non-enzymatic antioxidant defense parameters: 
(i) SNP enhanced lipid peroxidation (LPO) and significantly altered antioxidant 
enzymes both in cortex and medulla, albeit differently. LPO measured in terms of 
malodialdehyde (MDA levels) significantly enhanced in the cortex (+42%) and 
medulla (+75%) to similar extent whereas total-SH declined in these tissue (-22% to 
-37%). SNP treatment caused marked increase in superoxide dismutase (SOD, +40%) 
but decrease in Glutathione peroxidase (GSH-Px. -29%)) and catalase (-18%)) activities 
in the renal cortex. In medulla however the activity of SOD (-87%)), catalase (-35%)) 
and GSH-Px (-42%) significantly decreased by SNP administration alone. SNP 
induced increase in LPO and decrease in total-SH was not observed by feeding FO or 
FXO diet to SNP-treated rats. The activity of catalase and GSH-Px in the cortex and 
medulla remained significantly higher in FO/FXO + SNP rats compared to SNP rats. 
(ii) SNP treatment caused marked increase in SOD (+46%)) but decrease in catalase 
(-36%) and GSH-Px (-39%o). These changes were associated with significant increase 
in lipid peroxidation (+60%)) measured in terms of MDA levels and decrease in total-
SH (-23%). Both FO and FXO-diet partially prevented SNP-induced alteration in 
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SOD. catalase and GSH-Px activities. SNP induced increase in LPO and decreased 
SH-content were prevented by FO/FXO diet. 
(iii) SNP treatment to control rats caused marked decrease in SOD (-21%) and GSH-
Px (-43%) activities. These changes were associated with significant increase in lipid 
peroxidation (+34%) and decrease in total-SH content (-40%)). Both FO/FXO-diets 
prevented SNP-induced increase in SOD and GSH-Px activities whereas catalase was 
significantly elevated by FO and FXO diet when given in combination with SNP 
treatment. Total-SH and LPO were also normalized to near control values. 
(e) Na^- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of "'^ Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by SNP treatment (Table 13). However, the 
uptake of -Pi at the equilibrium phase (120min) when Nao^Nai was not significantly 
different between the two groups. When SNP treatment was extended to FO and FXO 
feeding rats. SNP induced decrease in Pi transport was not observed. 
(f) Tissue concentration of nitrite: 
Nitrite is the predominant metabolite of nitric oxide in vivo therefore. The effect of 
SNP. FO and FXO on tissue accumulation of nitrite was determined by the Griess 
reagent assay as described in methods. SNP significantly increased nitrite 
accumulation in all tissues however the effect was maximum in renal medulla. Both 
FO and FXO reduced the amount of nitrite in rat tissues. 
<t^ Interpretation; SNP treatment caused severe damage to the kidney and intestine 
as reflected by increase in serum creatinine and BUN and decrease in biomarker 
BBM enzymes. There appeared to be a shift from aerobic to anaerobic metabolism 
most likely due to SNP induced mitochondrial damage. SNP also increased oxidative 
stress as indicated by increased LPO and decreased total-SH levels associated with 
imbalances in the activities of antioxidant enzymes. FO/FXO-diet prevented/retarded 
SNP-induced alterations in various biochemical parameters and enzyme activities 
most likely due to their incorporation in cellular membranes and antioxidant 
properties. 
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O PART III; EFFECT OF FISH OIL (FQ) AND FLAXSEED OIL (FXO) ON L-
ARGININE (ARG) INDUCED NEPHROTOXIC AND OTHER ADVERSE 
EFFECTS 
(a) Serum/Urine Parameters: 
ARG treatment to control rats resulted in significant increase in serum creatinine 
(Scr), blood urea nitrogen (BUN), glucose and phospholipids but decrease in 
inorganic phosphate (Pi) compared to control rats. These changes where associated 
with profound phosphaturia, proteinuria and glucosuria accompanied by decrease in 
creatinine clearance. Feeding of FO or FXO diet to ARG administered (FOARG and 
FXOARG) rats resulted in significant reversal of various ARG elicited deleterious 
effects on serum and urine parameters. 
(b) Enzymes of carbohydrate metabolism: 
(i) ARG treatment to control rats significantly increased the activity of lactate 
dehydrogenase (LDH) and hexokinase (HK) but decreased malate dehydrogenase 
(MDH), glucose-6-phosphatase (G6Pase) and fructose-1, 6-bisphosphatase (FBPase) 
activities in the renal cortex (Table 3, 4). When ARG treatment was extended to FO 
and FXO-fed rats, ARG-induced alterations in metabolic enzyme activities were 
prevented by FO and FXO diets. ARG treatment to control rats significantly increased 
G6PDH but decreased ME activity. ARG elicited increase of G6PDH activity was 
normalized to near control values by both FO and FXO diets. ARG induced ME 
activity decrease was arrested by both FO and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by ARG treatment as in the cortical homogenates. Feeding of 
FO and FXO to ARG treated rats prevented ARG induced alterations in various 
enzyme activities. Similar to cortex, G6PDH activity increased whereas ME activity 
decreased by ARG in the medulla. FO and FXO diet to ARG treated rats decreased 
G6PDH activity and increased ME activity 
(iii) ARG treatment to control rats caused significant increase in LDH (+26%) but 
decrease in MDH activities. ARG caused significant decrease in gluconeogenic 
enzyme, G6Pase in the intestine. The activity of G6Pase remained significantly higher 
after ARG treatment to FO and FXO-fed rats compared to control rats reversing the 
ARG-induced decrease in its activity. ARG-induced decline in MDH activity was also 
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restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+24%) but that of ME decreased (-39%) by ARG treatment compared to control rats. 
However, when ARG treatment was given to FO/FXO diet fed rats, ARG induced 
increased in G6PDH and decrease in ME activities were not observed. 
(iv) ARG treatment significantly increased the activities of LDH (+41%), HK (+35%) 
and G6PDH (+50%)) whereas decreased G6Pase, MDH and ME activities in the liver 
(Table 5, 6). When ARG treatment was extended to FO-fed rats, ARG-induced 
decrease of metabolic enzyme activities was prevented by FO and FXO. 
(c) Marker enzymes ofBBMand tysosontes: 
(i) ARG treatment to control rats caused significant reduction in the specific activities 
of AlkPase (-28%), GGTase (-27%) and LAP (-29%) in cortical homogenate. The 
prior feeding of FO or FXO diet with ARG treatment prevented ARG elicited ecrease 
in BBM enzyme activities. As can be seen from the data ARG induced decrease in 
BBM enzyme activities were similarly prevented by FO or FXO diet. The activity of 
acid phosphatase (ACPase) was also decreased (-17%) by ARG in cortical 
homogenates and FO/FXO diet was able to prevent the decrease in enzyme activity in 
a similar manner. The activities of BBM enzymes similar to the cortex were also 
lowered in the medulla by ARG administration (Table 7). The consumption of 
FO/FXO in combination with ARG treatment resulted in the reversal of ARG induced 
decrease in GGTase (-22%) and LAP (-40%) in the medulla. The activity of ACPase 
was also lowered by ARG (-16%). However it was found to be higher in ARG+FO 
rats (+19%) compared with the control rats. 
(ii) Activities of AlkPase (-47%), GGTase (-45%) and LAP (-40%) profoundly 
declined by ARG treatment as compared to control rats in renal BBM. Fish oil (FO) 
and tlaxseed oil (FXO) dietary supplementation similar to the effect in the 
homogenates appeared to lower the severity of the ARG treatment. 
(iii) ARG treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. ARG treatment also resulted in the decrease of 
ACPase activity. When ARG treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. 
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ARG treatment profoundly decreased the activities of all BBM enzymes but sucrase 
which was elevated in intestinal BBM, FO/FXO caused marked increase in AlkPase 
and GGTase whereas LAP and sucrase activities were significantly normalized by 
both FO/FXO diets. ARG induced decrease in the BBMV and lysosomal marker 
enzymes was not only preserved by FO/FXO diets but the activities were restored to 
near control values. 
(iv) ARG treatment to rats resulted in extensive reduction in the specific activity of 
alkaline phosphatase (AlkPase), GGTase LAP and ACPase in the liver homogenates. 
The feeding of FO and FXO-diet to ARG treated (FOARG/FXOARG) rats not only 
prevented ARG elicited changes, but the activities of GGTase and AlkPase were even 
increased by FO diet. 
(d) Enzymatic and non-enzvmatic antioxidant defense parameters: 
(i) To ascertain the role of antioxidant system in ARG-induced toxicity, the effect of 
ARG observed on oxidative stress parameters. ARG enhanced lipid peroxidation 
(LPO) and significantly altered antioxidant enzymes both in cortex and medulla, 
albeit differently. LPO measured in terms of malodialdehyde (MDA levels) 
significantly enhanced in the cortex (+43%) and medulla (+51%) to similar extent 
whereas total-SH declined in these tissue (-16% to -26%). ARG treatment caused 
marked increase in superoxide dismutase (SOD, +68%) but decrease in Glutathione 
peroxidase (GSH-Px, -37%) activity in the renal cortex. In medulla however the 
activity of SOD (-36%) and GSH-Px (-16%) significantly decreased by ARG 
administration alone. ARG induced increase in LPO and decrease in total-SH was not 
observed by feeding FO or FXO diet to ARG-treated rats. The activity of GSH-Px and 
catalase in the cortex and the activity of catalase and GSH-Px in the medulla 
respectively remained significantly higher in FO/FXO + ARG rats compared to ARG 
and/or control rats. 
(ii) ARG treatment caused marked increase in SOD (+35%) but decrease in catalase (-
22%). These changes were associated with significant increase in lipid peroxidation 
(+30%) measured in terms of MDA levels and decrease in total-SH (-21%). Both FO 
and FXO-diet partially prevented ARG-induced increase in SOD, catalase and GSH-
Px activities. ARG induced increase in LPO and decreased SH-content were 
prevented by FO/FXO diet. 
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(iii) ARG treatment to control rats caused marked decrease in catalase (-22%) and 
GSH-Px (-17%) activities. These changes were associated with significant increase in 
lipid peroxidation (+35%) and decrease in total-SH content (-21%). Both FO/FXO-
diets prevented ARG-induced decrease in catalase and GSH-Px activities when FO 
and FXO diets were given in combination with ARG treatment. Total-SH and LPO 
were also normalized to near control values. 
(e) Na*- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by ARG treatment. However, the uptake of 
^^ Pi at the equilibrium phase (120min) when Nao^Nai was not significantly different 
between the two groups. Also Na-independent uptake (in the absence of a Na 
gradient, when NaCl in the medium was replaced by KCl where Ko> Kj) of'^ ^Pi at 30s 
and 120min was also not affected by ARG treatment indicating specific alterations 
only when Na-gradient was present. When ARG treatment was extended to FO and 
-JO 
FXO feeding rats, ARG induced decrease in Pi transport was not observed. 
(j) Tissue concentration of nitrite: 
ARG administration to rats increased the tissue concentrations of nitrite in all tissues, 
the accumulation of nitrite being greater in renal medulla (+35%) and intestine 
(+28%). When FO/FXO was given in combination with ARG, both FO and FXO 
partially improved the values to near control in renal cortex, medulla and intestine, 
whereas in the liver complete amelioration was observed. 
^ Interpretation; In general, ARG caused severe adverse effects on various 
serum/urine parameters and on the enzymes of carbohydrate metabolism, BBM and 
antioxidant defense system in rat kidney and intestine. FO and/or FXO-diet similarly 
protected against ARG-induced nephrotoxic and other adverse effects most likely due 
to their intrinsic biochemical and antioxidant properties. 
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Z CONCLUSION: 
In conclusion the results of the present studies demonstrate that SNT/SNP/ARG 
elicited deleterious nephrotoxic effects by causing major damage to mitochondria, 
lysosomes and in particular to BBM of renal proximal tubule, intestinal mucosa and 
liver as reflected by significant decrease in the activities of their specific biomarker 
enzymes, confirming some of the previous morphologic and biochemical observations 
that showed these organelles as prime NO donors/metabolites targets. NO 
donors/metabolites seem to enhance glycolytic enzyme LDH in various tissues in 
order to increase energy dependence on glycolysis due to mitochondrial damage and 
depressed TCA cycle enzymes. Gluconeogenic enzymes also appeared to decrease 
also due to mitochondrial dysfunction as oxalate produced by MDH is not available. 
Serum Pi and renal Pi transport was also decreased suggesting a decrease in metabolic 
activity. These nephrotoxic and other adverse effects appeared to be mediated in part 
due to NO donors/metabolites elicited oxidative/nitrosative damage. In agreement 
with previous studies except for few direct effects, SNT/SNP/ARG appear to cause 
many of these deleterious effects either by conversion to NO or by its uncontrolled 
excessive production, as supported by increased tissue levels of nitrite as NO is 
rapidly converted to nitrite. Dietary co-3 PUFA enriched fish oil and flaxseed oil to a 
larger extent prevented NO donors/metabolites induced nephrotoxicity parameters by 
enhancing nutrition/energy metabolism and 'Pi transport capacity, by strengthening 
antioxidant defense mechanism and by altering membrane 
organization/fluidity/permeability, co-3 PUFA enriched FO/FXO diets leads to an 
enhancement in the metabolic processes. This enhancement leads to increase in the 
demand of Pi, which in turn leads to increased utilization, as Pi is required in the 
synthesis of membranes such as endoplasmic reticulum, mitochondria and plasma 
membrane in order to support higher metabolic activities. The results also suggest that 
co-3 PUFA strengthen the biological antioxidant defense system thereby reducing 
oxidative/nitrosative damage induced by NO donors/metabolites. 
It is apparent that co-3 PUFA is a source of wide range of nutraceuticals that are 
digested, absorbed and metabolized and that they exert their effects at the cellular 
level. Fish/flaxseed oil enriched in co-3 PUFA provide a dietary source of biologically 
active components that has been shown to be co-preventative and co-therapeutic in a 
wide variety of ailments. Based on our present observations and already known 
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numerous health benefits, we propose that co-3 PUFA enriched FO/FXO may provide 
a cushion for a prolonged therapeutic option against drug/chemical induced 
nephropathy without harmful side effects. Similar protective effects of FO and FXO 
provide a much needed relief for millions of vegetarians who do not eat fish/fish oil 
for religious or other reasons. 
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INTRODUCTIOW 
1. General; 
Besides oxygen, carbon and hydrogen, nitrogen is an essential element that constitutes 
life. It is generally consumed as nitrate (NO3") or nitrite {N02~). Changes in patterns 
of agricultural practice, food processing and industrialization have impacted 
accumulation of nitrates/nitrites in the environment. Intensive farming practice has 
resulted in an increased use of nitrogen-based fertilizers, particularly with com, 
vegetables, other row crops and forages. Livestock and poultry as well as urban 
sewage treatment also contribute nitrogenous wastes to the soil. Bacteria present in 
the soil, water, feed and foods are capable of utilizing these nitrogenous compounds 
lo synthesize nitrates (and nitrites) de novo via heterotrophic nitrification (and nitrate 
reduction) [Tannenbaum et al, 1978]. Nitrates are abundantly present in the soil and 
water [Hill, 1991] where it is taken up by plants for which it is a major source of 
utilizable nitrogen. Initially both nitrate and nitrite were considered as undesired 
residues in the food chain and as inert oxidative end products of nitric oxide (NO) 
metabolism. Nitrates and nitrites, used in combination with salt, serve as important 
antimicrobial agents in meat to inhibit the growth of bacterial spores that cause 
botulism, a deadly food-borne illness. Nitrites are also used as preservatives and for 
flavoring and fixing color in a number of red meat, poultry, and fish products. 
Additionally, nitrites have been employed as a vasodilator, or a circulatory depressant 
to relieve smooth muscle spasm, an antidote for cyanide poisoning [Nickerson, 1970], 
and potassium nitrate has been used therapeutically as a diuretic agent. Other 
precursors or sources of nitrite include N-containing foods, nitrogen containing 
drugs/chemicals (e.g. nitroglycerin, an anti-microbial agent and coronary dilator, 
sodium nitroprusside, Na2[Fe(CN)6NO], an anti-hypertensive agent and nitric oxide 
(NO) [Chow and Hong, 2002]. Nitric oxide (NO), which is synthesized in vivo from 
L-Arginine (ARG), can be oxidized to nitrite or nitrate. NO is also a component of 
cigarette smoke and automobile exhaust. Thus, man and animals are subjected to 
significant nitrate and nitrite levels in foods, feed and water as well as those formed in 
vivo. Nitrites and nitrates formed from nitrogenous sources and from microorganisms 
in saliva, intestine, however, are the major sources of human exposure under normal 
conditions [White, 1975; Tannenbaum et al, 1978]. In acidic stomach nitrite is 
spontaneously converted to NO that that can be metabolized to nitrite [Lundberg et 
ill., 2008J. 
Nitrates are not generally toxic. It is regularly administered in the form of NH4NO3 as 
a diuretic without any acute toxic side effects [Bruijns. 1982]. Ingestion of nitrates 
was linked with methemoglobinemia in infants, anemia, gastroenteritis and nephritis 
caused by prolonged exposure to small amounts of nitrates. It was later found out that 
any toxicity linked to nitrate consumption, in fact was due to its reduction to nitrite by 
bacteria in the mouth or stomach [Dollahite and Rowe, 1974]. The major health 
concerns with nitrite are the risk of methemoglobinaemia and its potential 
carcinogenic, mutagenic and cytotoxic effects [Ger et ai, 1996, Magee and Barnes, 
1956; Spencer et ai, 2000; Sun et al, 2006]. A high dietary intake of nitrite has been 
implicated as a risk factor for human cancer, and formation of nitroso-compounds in 
the stomach during inflammation is correlated with nitrate in food and water [Ames, 
1983; Mirvish, 1995]. A number of biochemical changes, functional impairments and 
histipathological lesions have been observed in nitrite-treated rats [Abuharfeil et al, 
2001], It has now been documented that reactions of H2O2 with nitrite and of 
superoxide with NO have a common intermediate - peroxynitrite (ONOO) 
[Carmichael et al, 1993], which is found to be responsible for nitration of proteins, 
DNA strand breaks and mutations, and interference in protein functions [Sampson et 
ai. 1998]. Thus nitric oxide is a double-edged sword as it can be both cytoprotective 
and cytotoxic. Produced by mammalian ceils at an appropriate magnitude and tempo, 
it serves as a key signaling molecule in physiological processes as diverse as host-
defense, neuronal communication, and vascular regulation [Ignarro, 1989; Stuethr and 
Nathan 1989; Moncada et al, 1991]. On the other hand, excessive and unregulated 
NO synthesis has been implicated as causal or contributing factor to 
pathophysiological conditions including many lethal and debilitating human 
disorders; arthritis, atherosclerosis, cancer, diabetes, numerous degenerative neuronal 
diseases, stroke, and myocardial infarction to name a few [Culotta and Koshland, 
1992; (jross and Wolin, 1995]. Recently both nitrates and nitrites are recognized as 
key oxidation products of NO, which can be generated in the tissues by a number of 
enzymatic and non-enzymatic reactions [Lundberg et al, 2008]. Therefore, they 
should now be viewed as storage pools for NO-like bioactivity, thereby 
complementing the NO synthase (NOS)-dependent pathway. NO can also be formed 
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from other nitro-compounds such as sodium nitroprusside (SNP) and L-Arginine 
(ARG). The recognition of this mammalian nitrogen cycle (nitrate-nitrite-NO) has 
led researchers to explore the role of nitrate and nitrite or other NO donors in 
physiological and pathophysiological processes where NO is known to play a key 
role. 
The last two decades have witnessed a major drift in the interests of the scientific 
community towards providing better means to containing the health risks of the 
human race. The century old chemotherapies against various disorders have never 
been a success, albeit not a total failure. Such therapies have a major drawback of side 
effects that give rise to unseen disorders that emerge as a new challenge. In this 
regard, the concept of foodstuffs as natural medicines i.e. nutraceuticals has become 
very attractive. Early clues to the possible importance of unsaturated fatty acids 
especially polyunsaturated fatty acids (PUFA) came from studies showing that young 
humans and experimental animals experienced impaired growth when all fatty acids 
were removed from the diet. Small amounts of (o-3 (a-linolenic acid) or co-6 (linoleic 
acid) tally acids prevented that impaired growth and thus were termed as "essential" 
[Burr and Burr, 1930]. Highly unsaturated/polyunsaturated fatty acids (HUFA/PUFA) 
were relatively found to be several-fold more effective [Turpeinen, 1937]. 
Further studies have revealed that both co-3 PUFA have numerous health benefits, co-3 
PUFA especially from fish/marine foods were found to be more effective in lowering 
incidence of various pathologies compared to to-6 PUFA rich diets [Simopoulos, 
2001]. This stems from the observations of the difference in prevalence of coronary 
heart di.sease and other chronic diseases (including psoriasis, bronchial asthma, 
diabetes mellitus and thyrotoxicosis) in the Greenland Inuit (Eskimo) population 
relative to Western populations [Kromann and Green, 1980]. ©-3 PUFA (e.g. EPA 
and DHA) from marine fish and mammals were indicated as the main dietary factor 
responsible for such differences [Dyerberg et ciL, 1975; Bang et al, 1976]. The 
consumption of fish has now been linked with the rate of depression among various 
populations. In countries where people eat the least fish the rate of depression is 
highest, and vice versa [Hibbeln, 1998; Small. 2002]. This correlation holds true 
across the world. The most dramatic change in what we eat has happened in the past 
century, with industrialization and development of the food industry, the intake of 
.saturated fat, trans fat and especially co-6 enriched refined oils have enormously 
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increased whereas the consumption of (o-3 PUFA has considerably declined. These 
dietary imbalances in fat intake, in fact, are prime cause of modem sufferings like 
cancer, hypertension, diabetes, depression, cardiovascular and renal disorders. 
Role ol' fish oil/co-3 PUFA has been extensively investigated and has received a great 
deal of attention in recent times as therapeutic options in a variety of clinical 
situations ranging from CVD to hyperlipidemia. cancer, inflammatory and immune 
disorders, respiratory diseases, depression and diabetes [De Caterina et al., 1994; 
Kakar ef al., 2008]. Lately, co-3 PUFA from certain plants/seeds e.g. walnut, canola 
and most notably from flaxseed (linseed) showed many similar health benefits as 
demonstrated by co-3 PUFA from fish/fish oil [Nannicini et al., 2006; Vijaimohan et 
ai. 2006]. 
Although (JO-3 PUFA have been shown as deterrents for environmental pollutants, 
studies on their possible beneficial effects against drug/chemical induced 
nephrotoxicity and gastrointestinal toxicity are very limited [Watkins et al., 2007; 
Priyamvada et ai, 2008, 2010]. Considering profound beneficial health effects of (0-3 
PUFA from marine or plant foods against various pathologies, the present work 
embodied in this thesis was undertaken to study the detailed mechanisms of NO 
donors/metabolites induced nephrotoxic and other adverse alterations and 
possible mechanism of protection/prevention of o)-3 fatty acids enriched fish oil 
(FO) and/or flaxseed oil (FXO) in the diets against NO donors/metabolites 
induced nephropathies and other alterations. NO donors used in this study were, 
l.-Arginine which is an essential amino acid substrate for nitric oxide synthase (NOS) 
and pharmacological donors like sodium nitroprusside. SNT was used as a metabolite 
of NO and also as a donor since it is converted to NO in vivo. In extension, the effects 
of NO donons/metabolites and FO/FXO were also studied in small intestine and liver, 
which are primary targets of toxic insult. The present results support our hypothesis 
and showed that indeed FO/FXO-diets enriched in co-3 PUFA are capable of 
preventing nephrotoxic and various other alterations induced by NO 
donors/metabolites. The data further supports that diet derived 
components/nutraceuticals may play an important role in reducing drug/chemical 
induced nephrotoxic and gastrotoxic effects with minimal side effects. 
IntinoductCort/ 
2« Nitrate: 
Nitrate has long been one of more emotive anions, always being talked about, whether 
with pride or horror. It is abundantly present in the soil and in water [Hill, 1991] and 
is taken up by plants, for which it is a major source of utilizable nitrogen. Nitrate is 
the end-product of the microbial breakdown of nitrogen organic material in the soil 
and in sewage. It is a valuable fertilizer. Much of the nitrate used to end up in 
drinking water, either as a result of being pumped into local rivers, or after percolating 
down through the soil to the aquifers tapped by wells but that caused little concern 
because nitrate was good. Nitrate could be derived from its deliberate addition to food 
as a preservative, from drinking water and food grown in nitrate rich soils 
[Santamaria, 2006]. In most European countries, nitrate levels in rivers and ground 
waters have been increased gradually over the last few decades mainly as a 
consequence of large scale agricultural application of manure and fertilizers, thereby 
threatening drinking water quality [Addiscot, 1996]. Consumption of drinking water 
borne nitrate considerably contributes to overall nitrate intake [Comly, 1945, 
Donahoe, 1949]. Dietary nitrate intake is considerable and many vegetables such as 
spinach, beet, radish, celery and cabbage are among the vegetables that generally 
contain very high quantities of nitrate [Vosgen, 1992]. 
Nitrate has remarkably low toxicity in adults [Hill, 1991]. It is regularly administered 
as NHjNOi (lOg/day for 4-5 days) as a diuretic without any acute toxic side effects 
[Bruijns. 1982]. Then came the first convincing report [Comly, 1945] of infant 
methemoglobinaemia (Met-Hb) associated with consumption of baby feeds prepared 
in nitrate-rich drinking water. Nitrates are reduced to nitrite by certain 
microorganisms present in the food and in the gastrointestinal tract. The 
biocon\ersion of nitrate for dietary or endogenous sources required initial reduction to 
nitrite because mammals lack specific and effective nitrate reductase enzyme, thus 
conversion is mainly carried out by commensal bacteria present in the saliva, GI tract 
and body surface [Duncan et al, 1995; Lundberg and Govoni, 2004]. Therefore, 
whatever toxicity is attributed to nitrate is due to its conversion to nitrite. In the acidic 
stomach, nitrite is spontaneously decomposed to form NO and other bioactive 
nitrogen oxides, which regulate important physiological functions. Endogenous 
nitrosation of nitrate-derived nitrite resulting in the formation of carcinogenic N-nitro 
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compounds may induce a second health risk possibly associated with increased intake 
of nitrate [SeneM/., 1969; Low, 1974]. 
3. Nitrite: 
Sodium nitrite (SNT) is a hygroscopic, white to straw-yellow crystals [National 
Foxicology Program, 2001], 
^.1 Uses; 
It is used as a color fixative and preservative during the processing of meat, cheese 
and fish [National Toxicology Program, 2001; Karlik et ai, 1995]. It is widely used to 
preserve lunchmeat, ham, sausages, hot dogs and bacon [Karlik et al, 1995]. The 
antimicrobial activity of sodium nitrite is important in controlling the bacterium 
which causes botulism [Coquette et ai, 1999]. Because of its widespread use as a 
food additive, SNT has been the subject of FDA-sponsored toxicity and 
carcinogenesis studies [National Toxicology Program, 2001]. SNT also has been used 
in human and veterinary medicine as a vasodilator, a bronchial dilator, an intestinal 
relaxant and an antidote for cyanide poisoning [Karlik et al, 1995]. Nitrites are also 
common contaminants of food commodities and water [Karlik et al, 1995]. 
^.2 Metabolism and ohysiolocacal f unctlonst 
We now know and understand that endogenous sources of nitrite in mammals are 
derived from: (1) oxidation of endogenous NO. (2) reduction of salivary nitrate by 
commensal bacteria in the mouth and gastrointestinal tract and (3) nutritional sources 
such as meat, vegetables and drinking water. The steady-state concentrations of nitrite 
in the body are tightly regulated and vary depending on each tissue or compartment 
and relative nitric oxide synthase (NOS) activity [Bryan et ai, 2004; Rodriguez et al, 
2003], However, there is usually more nitrite concentrated in the tissues than in the 
circulation [Bryan et al, 2004]. Humans, unlike prokaryotes, are thought to lack the 
enzymatic machinery to reduce nitrate back to nitrite. However, due to the commensal 
bacteria that reside within the human body it has been demonstrated that these 
bacteria can reduce nitrate, thereby supplying an alternative source of nitrite [Goaz 
and Biswell. 1961; Tannenbaum et al, 1974; Ishiwata et al, 1975]. Plasma nitrite 
increases after ingestion of large amounts of nitrate. This increase is entirely due to 
cnterosalivary circulation of nitrate (as much as 25% is actively taken up by the 
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salivar\ glands) and reduction to nitrite by commensal bacteria in the mouth 
[Lundberg and Govoni, 1996]. Therefore, dietary and enzymatic sources of nitrate are 
now a potentially large source of nitrite in the human body. Nitrate is rapidly 
absorbed in the small intestine and readily distributed throughout the body [Walker, 
1996]. Nitrite can be metabolized to nitric oxide (NO) and also be recycled back to 
NO. Nitric oxide, an important signaling molecule may be an important mediator of 
chemically induced inflammation in vivo [Garle et al, 1996] and therefore elevated 
nitrite concentrations in food commodities, water and animal feed could pose a 
seriou.s threat to human and animal health [Karlik et al, 1995]. Various studies show 
beneficial effect of SNT, while at the same time many other studies have 
demonstrated nitrite toxicity. Studies in animal models of ischemia and reperfusion 
have now revealed a central role of nitrite in hypoxic signalling. Physiological and 
therapeutic levels of nitrite exert potent cytoprotection after prolonged ischaemia and 
blood-flow reperfusion in liver [Lu et al, 2005]. heart [Webb et al, 2004; Baker et 
al, 2007], brain [Jung et al, 2006] and kidney [Tripatara et al, 2007]. 
%A Toxictyt 
Some of the specific toxicities that are directly caused by nitrite are as following: 
(_^) MetfJemogCoSinaemia: Contamination of food during manufacture and 
degradation of nitrate in vegetables appear to be important factors in the induction of 
methemoglobinaemia. In blood, nitrite is rapidly oxidized by hemoglobin to yield 
methemoglobin and nitrate. Two forms of methemoglobin—methemoglobin and 
nitrite methemoglobin, were found in native human erythrocytes in the presence of 
sodium nitrite in suspension. The interaction of intercellular oxyhemoglobin with 
nitrite ions in normal erythrocytes resulted in the formation of methemoglobin, 
whereas it led predominantly to the formation of nitrite methemoglobin in 
nietabolically exhausted erythrocytes. Nitrite methemoglobin reacts with hydrogen 
peroxide to form reactive intermediates (e.g. peroxynitrous acid) and the products of 
haemoglobin destruction [Starodubtseva e/a/., 1999] 
((B) Co-rcinogenicity: It has been shown that sodium nitrite is a precursor of N-nitroso 
compounds with strong carcinogenic potential [Mirvish, 1975] and an increased 
incidence of tumors, such as forestomach papillomas and lymphoreticular tumors, has 
been found in rat carcinogenicity studies of NaN02 [Webb et al, 2004; Mirvish et al. 
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1980|. In Japan, which possessed the highest death rate (69 deaths/100,000 males) due 
to gastric cancer in a study of 41 countries, a correlation has been reported between the 
consumption of salted fish and the incidence of gastric cancer [Haenszel et ai, 1972; 
Correa et ai, 1973; Bjelke et al, 1974]. Fish preserved by the use of crude salt may 
contain nitrate, which can be reduced to nitrite. The high level of methylguanidine in 
fish combined with the presence of nitrite may, upon ingestion, resuh in the formation 
of methylnitrosocyanamide and methylnitrosourea [Endo et al, 1974]. Both agents 
have been shown to be potent mutagens and carcinogens. Chile, which ranked second 
in death rate due to gastric cancer (58 deaths/100,000 males), possesses large nitrate 
deposits and corresponding elevated levels of nitrate in foods and drinking water 
[Zaldivar and Robinson, 1973]. Regions of Colombia have similar geological 
structure, and Correa et ai, (1975) have reported the prevalence of gastric cancer 
there. A positive correlation between nitrate levels in food and drinking water with 
incidence of gastric cancer has been established by Zaldivar and Robinson (1973) and 
by Hawksworth et al, (1974). 
(C) Mutagenicity: The mutagenicity of SNT was further demonstrated by Akin and 
Sunier (1991) using the Salmonella/microsome test system. Ohnuma et ai, (1996) 
indicated that ImM sodium nitrite can lead to chemical mutagenesis. Recently it has 
been shown that SNT can lead to modifications in cellular proliferation i.e. from 
prolil'eraiion to toxicity. SNT was reported to be toxic to human gastric carcinoma 
epithelial cell lines (AGS) [Sun et al, 2006] as characterized by the release profiles of 
a variety of proinflammatory cytokines. 
4. Sodimw NJtroprusside fSWPl; 
Sodium nitroprusside (disodium pentacyanonitrosylferrate(2-)dihydrate, 
Na2Fe(CN)5NO-2H20) is a red coloured salt, comprised of a ferrous ion center 
complexed with five cyanide moieties and a nitrosyl group. SNP is an NO donor 
compound that has been used as an anti-hypertensive agent since the 1920s [Schimdt, 
ci al. 1992]. In contrast to the organic nitrates (e.g. nitroglycerin) which require the 
presence of highly specific thiol-containing compounds to generate NO, SNP 
spontaneously generates this product, thus functioning as a prodrug [Moncada et al, 
1991]. 
8 
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4.1 Pathophysiology of SNP: 
Although the data are very limited, it has been shown that long-term use of nitrates as 
donors of nitric oxide has the potential to induce many pathophysiological conditions. 
SNP has been documented to induce genotoxicity as assessed by measurement of 
micronucleated lymphocytes [Andreassi et ai, 2001]. In previous laboratory studies, 
SNP has been shown to cause DNA strand breaks [Asaka et ai, 1997], and to cause a 
dose-dependent increase of the mutant frequency at the gpt locus in gl2 cells [Lin et 
ai. 1998] and at the HPRT locus in MN-11 cells [Sandhu et ai, 1997]. SNP generates 
reactive oxygen species (ROS) during the redox cycling of nitroprusside 
[Ramakrishna et al, 1996], and it is converted to a number of products, such as 
nitrite. NO. iron, cyanide, and oxygen-free radicals including superoxide radical and 
hydrox)! radical [Ramakrishna et al, 1996]. Peroxynitrite (ONOO) is a potent 
oxidizing agent formed from reaction of NO and superoxide radicals and reacts 
almost exclusively with dG residues [Burney et al, 1999]. In mutagenesis 
experiments using the supF system, ONOO induced mainly G-T transversions [Jeong 
et al, 1998; Juedes et al, 1996]. It has also been postulated that a product of the 
reaction between nitric oxide and intracellular glutathione, such as GSNO or some 
species derived from it, may imderlie the promutagenic activity of SNP [Bimboim et 
ai, 2000J. 
The potential of SNP to induce apoptosis directly from NO liberation has been 
established in vitro [Feldmann, 1997]. The fact that NO is capable of triggering 
apoptosis is consistent with its ability to induce DNA damage, the inhibition of DNA 
synthesis and cell cycle arrest [Wink et al, 1991: Nguyen et al, 1992]. The reaction 
product formed between NO and superoxide [i.e.. peroxynitrite (ONOO)] plays a 
critical role in the induction of inflammatory reaction and apoptosis, but is also 
associated with tumor promotion and/or progression [Radi et al, 1991]. 
Recent studies showed that the influence of SNP on the processes in mitochondria, 
particularly on the respiratory chain. SNP has many consequences on cell function, 
even cell death. Nanomolar concentrations of NO immediately, specifically and 
rcversibly inhibit cytochrome oxidase in competition with oxygen, while higher 
concentrations of NO and its derivatives (peroxynitrite, nitrogen dioxide or S-
nitrosoliiiols - R-SNO) can cause irreversible inhibition of the respiratory chain 
[Brown and Borutaite, 2002]. On the other hand, SNP induced stimulation of 
Iy\tit>ducttoy\/ 
glycolysis [Maletic ei al, 2000] and direct influence of NO on glycolytic enzymes 
was documented for glyceraldehyde 3- phosphate dehydrogenase (GAPD) [Mallozzi 
et al.. 1997, Galli et al, 1998, 2002]. SNP induced a decrease of coupled oxygen 
consumption, therefore, ATP production via oxidative phosphorylation was 
significantly diminished [Maletic and Kostic, 1999, Maletic et al, 1999 a, b]. The 
simultaneous increase of glycolytic ATP production, being a consequence of the 
Pasteur effect [Rapoport, 1986], was not sufficient to compensate for decreased ATP 
production due to inhibition of oxidative phosphorylation. Hence, total energy 
production was significantly decreased, indicating that the mitochondrial respiratory 
chain is the primary site of SNP effects. 
S. L-Arginine f ARClt 
L-Arginine is an essential amino acid for infants and growing children, and it is a 
conditionally essential amino acid for adult mammals, as it is important in situations 
which require extra production, such as pregnancy [Bronte and Zanovello, 2005]. 
L-Arginine is a substrate for at least five enzymes identified in mammals, including 
arginasc, arginine-glycine transaminase, kyotorphine synthase, nitric oxide synthase 
(NOS) and arginine decarboxylase [Nakaki and Kato, 1994]. It has a 
significant metabolic role as the product of ammonia detoxification, the urea cycle 
metabolite, the precursor of proteins, ornithine, urea, creatinine and the amino acid 
involved in the formation of active enzyme centers [Cylwik et al, 2005]. 
s.i Physiolorfc roles and health beneKts: 
I.-Arginine is the substrate for the enzyme nitric oxide synthase (NOS), which is 
responsible or the production of nitric oxide (NO), an endogenous messenger 
molecule involved in many physiological processes. Acute and chronic administration 
of ARG has been shown to improve endothelial function in animal models 
of hypercholesterolemia and atherosclerosis [Nakaki et al, 1994; Bode-Boger et al, 
2005]. 
Researchers have debated whether dietary L-Arginine supplementation can provide 
valuable health benefits as it augments NO production in man. In fact, some 
clinical studies involving healthy volunteers or patients suffering from hypertension 
and diabetes indicate that L-Arginine may also regulate vascular hemostasis. 
Futhermore, animals and in vitro studies suggest that ARG may have a complex anti-
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aggregaiory, anti-coagulatory and profibrinolytic effects [Bode-Boger et al, 2005; 
Cylwik et al, 2005]. One mechanism that explains the occurrence of endothelial 
dysfunction is the presence of elevated blood levels of asymmetric dimethylarginine 
(ADMA) - an ARG analogue that inhibits NO formation and thereby can impair 
vascular function. Supplementation with L-Arginine has been shown to increase nitric 
oxide synthesis, restore vascular function and to improve the clinical symptoms of 
various diseases associated with vascular dysfunction [Boger et al, 2005]. 
Researchers also believe that L-Arginine metabolites may have some benefits on renal 
disease. It is because administration of exogenous ARG protected some subjects in 
ischemic acute renal failure [Cherla et al, 2004]. Infusion of L-Arginine in 
experimental animals increases renal plasma flow (RPF) and glomerular filtration rate 
(GFR). Despite persistent hyperglycemia, the administration of ARG is also found to 
prevent the development of hyperfiltration and ameliorated proteinuria in diabetic rats 
[Klahr and Morrissey, 2004]. 
S.2 Harmttil egfects and toxicity of ARC: 
ARG itself has very moderate toxicity, whatever harmful effects it manifests is mainly 
due to the overproduction of NO. Generation of nitric oxide (NO) by Arginine-
dependent pathways may injure tissue due to the toxic effects of NO or its derivatives, 
such as the formation of ONOO and hydroxyl radical (OH) after interaction of NO 
with superoxide (Boger et al, 2005]. Mulligan et al, (1991) have demonstrated that 
overproduction of NO via the ARG-pathway is responsible for the development of 
immune complex-induced injury. High dose of intraperitoneal L-Arginine 
administration has been reported to cause pancreatitis [Hegyi et al, 2004]. In the 
acute piiase of colitis, intracolonic nitrite/nitrate levels were found to be significantly 
higher in rats supplemented with 100 and 500 mg supplemented L-Arginine 
suggesting increased production of NO [Mane et al. 2001]. In one study it was found 
that L-Arginine significantly increased infarct volume [Zhang et al, 1996]. Several 
factors may account for these findings: L-Arginine stimulates hormones such as 
insulin, glucagon, growth hormone and catecholamines [Barbul et al, 1990] and can 
be converted to toxic by-products such as polyamines [Morgan DM, 1994] or 
agmatine [Li et al, 1994]. Alternatively, L-Arginine may enhance the synthesis of 
potentially detrimental NO from INOS since it countered the neuroprotective effects 
of iNOS inhibitor in two studies [ladecola et al, 1995; Zhang et al, 1996]. In another 
1 1 
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finding the authors tiave suggested that L-Arginine-NO pathway is involved in the 
pathophysiology of hyperoxia - induced seizures via various mechanisms [Bitterman 
and Bitterman, 1998]. Rhoden et al, (2001) have reported that pretreatment with 
ARG (200 mg/kg) seems to increase the renal damage by increasing kidney levels of 
MDA. NO produced via this pathway has also been reported to cause intestinal and 
colonic cancers [Yerushalmi et al, 2006]. 
6. THE NITRATE-NITRITE-NITRIC OXIDE PATHWAY; 
From research performed over the past decade, it is now apparent that nitrate and 
nitrite are physiologically recycled in blood and tissues to form NO and other 
bioactive nitrogen oxides [Benjamin et al, 1994; Cosby et al, 2003]. Therefore, they 
should now be viewed as storage pools for NO-like bioactivity, thereby 
complementing the NO synthase (NOS) - dependent pathway (Figure 1). The 
bioactivation of nitrate from dietary or endogenous sources requires its initial 
reduction to nitrite, and because mammals lack specific and effective nitrate reductase 
enzymes, this conversion is mainly carried out by commensal bacteria in the 
gastrointestinal tract and on body surfaces [Lundberg and Govoni, 2004]. Nitrite is 
unique to the nitrogen oxides in its redox position between oxidative (NO2 radical) 
and reductive (NO radical) signalling and its relative stability in blood and tissue 
[Gladwin et al, 2005]. Once nitrite is formed, there are numerous pathways in the 
body for its further reduction to NO involving haemoglobin [Cosby et al, 2003], 
myoglobin [Rassaf et al, 2007], xanthine oxidoreductase [Godber et al, 2000], 
ascorbatc [Carlsson et al, 2001], polyphenols [Gago et al, 2007] and protons 
jBenjamin et al, 1994] (Table 1). The generation of NO by these pathways is greatly 
enhanced during hypoxia and acidosis, thereby ensuring NO production in situations 
for which the oxygen-dependent NOS enzyme activities are compromised 
[Oestergaad el al, 2007]. Nitrite reduction to NO and NO-modified proteins during 
physiological and pathological hypoxia appear to contribute to physiological hypoxic 
signalling, vasodilation, modulation of cellular respiration and the cellular response to 
ischemic stress [Bryan et al, 2004; Shiva et al, 2007]. 
6.1. Sources ot nitrate and nitrite: 
There are two major sources of nitrate and nitrite in the body: the endogenous L-
Arginine - NO synthase pathway and the diet. NO, generated by NOS enzymes, is 
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oxidized in the blood and tissues to form nitrate and nitrite [Moncada and Higgs, 
1993]. The reaction of NO with oxyhaemoglobin produces nitrate and 
methaemoglobin [Moncada and Higgs, 1993], whereas the oxidation of NO forms 
nitrite, a process that is catalysed in plasma by the multi-copper oxidase and NO 
oxidase ceruloplasmin [Shiva et ah, 2006]. Dietary nitrate intake is considerable and 
many vegetables are particularly rich in this anion [Lundberg et al, 2004], For 
example, a plate of green leafy vegetables such as lettuce or spinach contains more 
nitrate [Lundberg et ai, 2004] than is formed endogenously over a day by all three 
NOS isoforms combined [Wennmalm et al, 1994]. Drinking water can also contain 
considerable amounts of nitrate, although in many countries the levels are strictly 
regulated. Nitrite can be found in some food stuffs, most notably as a preservative in 
cured meat and bacon. 
6.2. NOS-independent NO generation; 
The L - Arginine-NOS pathway is oxygen dependent, whereas the nitrate-nitrite-NO 
pathwa\ is gradually activated as oxygen tensions falls. In this sense, NOS-
independent NO formation (Figure 1) can be viewed as a back-up system to ensure 
that there is sufficient NO formation when oxygen supply is limited, which is 
analogous to the complementary role of anaerobic glycolysis in energetics. It is clear 
that at very low oxygen tensions NO generation in tissues is independent of NOS 
activity and dependent on nitrite [Bryan et al.. 2004]. This principle has driven 
hypotheses that nitrite participates in hypoxic vasodilation and in the regulation of 
oxygen consumption at the mitochondrial level. It also predicts a role for nitrite in 
cytoprotective signalling in the setting of pathological ischaemia and reperfusion. 
6.a. Intra-gastric WO generation from nitrite: 
In 1994. two groups independently described intragastric NO generation from salivary 
nitrite in humans [Lundberg et al., 1994]. This process does not require NOS activity, 
but instead involves the entero-salivary circulation of inorganic nitrate (Figure 2). 
Dietary nitrate is rapidly absorbed in the upper gastrointestinal tract. In the blood, it 
mixes with the nitrate formed from the oxidation of endogenous NO produced from 
the NOS enzymes. After a meal rich in nitrate, the levels in plasma increase greatly 
and remain high for a prolonged period of time. The nitrite levels in plasma also 
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increase after nitrate ingestion [Lundberg and Govoni, 2004]. Although much of the 
nitrate is eventually 
Table I: Reactions in\olvins nitrate, nitrite and NO 
Nitrite formation Nitrite reduction 
Auio-oxidution of NO Deoxvhaemoglobin/mvoglobm 
4Nt) ^ 0: + 2H2O -^ 4 N03'+ NO2' + Fe^ * + H' -* NO + Fe''* + OH 
4H 
C 'eruloplasmm 
NO + Cu-*-^NO* + Cu^ 
NO * H2O —HNO2 + H* 
UNO, <-> H" + NO2' 
Bacierial nitrate reductase 
NO-, "-e + H ' -» N O / + H.O 
Xanthine oxidoredticlasc 
NO2' + Mo"* + H+ — NO + Mo'"^  + OH 
Protons 
NOj" + H' -* HNO2 
2HNO2 — 2 N2O., r H2O 
N2O3 -» NO + "NO, 
Ascorbate (Asc) 
NO,' + H' -* HNO: 
2HNO2 + Asc — 2N0 + dehydroAsc + 2H2O 
Polyphenols (Ph-OH) 
NO2" + H' — HNO: 
Ph-OH + HNO, — Ph "O + NO + HjO 
Nitrite oxidation 
Haemoglobin 
4 NO,' + 4HbO, -I 4H' -> 4 N O / + 4 Met-Hb + 2H2O + 0 , 
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rNitrate and nitrite from _ food H 
^ An active uptake of nitrate 
from tlie blood occurs in 
the salivary glands 
111 
ISitrate and nitrite 
in blood originate from 
tbe food and from 
systemic NO production 
In the gastric acidic 
milieu, a non-enzymatic 
reduction of nitrite to 
NO occurs J Nitrate and remaining nitriti 
is absorbed in the intesUae i 
Nitrate is excreted 
by the kidneys 
Figure 2: The systemic circulation of nitrate-nitrite and NO in humans 
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excreted in the urine, up to 25% is actively taken up by the salivary glands and is 
concentrated up to 20-fold in saliva [Spiegelhalder el al, 1976]. Once in the oral 
cavit}. commensal facultative anaerobic bacteria use nitrate as an alternative electron 
acceptor to oxygen during respiration, effectively reducing salivary nitrate to nitrite 
by the action of nitrate reductases [Duncan et al., 1995]. Human nitrate reduction 
requires the presence of these bacteria — suggesting a functional symbiotic 
relationship — as mammalian cells cannot effectively metabolize this anion. When 
saliva enters the acidic stomach, much of the nitrite is rapidly protonated to form 
nitrous acid (HNO2), which decomposes further to form NO and other nitrogen oxides 
[Benjamin et al, 1994]. Nitrite reduction to NO is greatly enhanced by reducing 
compounds such as vitamin C and polyphenols, both of which are abundant in the diet 
[Weitzberg and Lundberg, 1998]. In addition to the stomach, a reductive pathway 
from nitrate to nitrite and then NO has also been demonstrated in the oral cavity 
[Duncan et al., 1995], on the skin surface [Weller et al., 1996], in the lower 
gastrointestinal tract [Sobko et al., 2005] and in urine [Lundberg et al., 1997]. 
6»4. PathMrays tor systemic nitrite reduction: 
Reduction of nitrite to NO occurs in blood and tissues and proceeds through several 
enzymatic and non-enzymatic pathways, some of which are listed below. 
a. Acidic (Reduction 
When nitrite is acidified, it yields nitrous acid (HNO2, reaction 1), which 
spontaneously decomposes to NO and other nitrogen oxides (reactions 2 and 3): 
(UNO^' + Fr-*—•-HNO2 ( pKa 3.2 to 3.4) 
(2) 2MNO2 • N2O3 + H2O 
(3)N:03 • NO + NO2 
6. (Reduction qfXantHine Oxidase 
Recently, it has been shown that NO is formed by Xanthine oxidase (XO) catalyzed 
reduction of nitrite [Bjome et al., 2004] or by a two step reduction of nitrate to NO 
[Petersson et al., 2007]. Nitrite reduction by XO is greatly enhanced at low oxygen 
tensions and acidic conditions such as those seen during ischemia [Holm et al., 2000]. 
17 
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c. Reduction 6y (Deo:)(yfiemo0Co6in 
Recently, several authors have expanded the role of this reaction in NO physiology 
[Nagababu et al, 2003]. It is suggested that nitrite is recycled back into bioactive NO 
by this mechanism and that this ensures an auto-regulated NO generation in regions of 
poor oxygenation where deoxy-Hb predominates. 
Hb-Fe (II) + NO2" • Hb-Fe(III) + NO 
d. (Recfuction 6y MitocdondriaCenzymes 
Components of the respiratory chain in mitochondria are theoretically well suited for 
NO generation from nitrite because they could act as electron carriers when nitrite is 
reduced. Indeed, several studies have now convincingly shown that respiring 
mitochondria in mammalian cells [Nohl et ai, 2000] and in plants [Tischner et al, 
2004] can generate NO from nitrite. The high affinity of NO to the heme-iron of 
cytochrome oxidase may support a detrimental role because NO has been shown to 
impede the energy-linked respiration and to trigger mitochondrial generation of 
superoxide radicals [Kozlov et al, 2003]. 
7. PHYSIOLOGY AND PATHOPHYSIOLOGY OF NITRIC 
OXIDE fNOl; 
Nitric oxide (NO), a pluripotent gaseous free radical is involved in a myriad of 
reactions in vivo that are both beneficial and harmful (Figure 3). It exerts potent 
actions in the regulation of cell function and tissue viability [Ignarro, 1989; Moncada 
L't al, 1991; Culotta and Koshland, 1992]. These properties extend beyond the 
recognized ability of NO to mediate signal transduction via stimulation of guanylate 
cyclase - mediated cGMP synthesis. In addition, NO has been shown to be part of the 
oxidative war chest of the immune system by virtue of involvement in anti-tumor and 
anti-pathogen host response [Hibbs et al, 1987b; Stuehr and Nathan, 1989]. Though 
these functions of NO are beneficial in maintaining proper physiological homeostasis, 
NO has also been found to be involved in a number of different diseased, as well 
as intlammatory conditions that 
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Protects against TNF toxicity 
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Neurotransmission 
Bronchodilation 
Inhibits Platelet Adhesion 
Immune Surveillance Sytem 
Renal Function 
Inhibits Enzyme Function 
Induces DNA Damage 
Induces Lipid Peroxidation 
Increased Susceptibility to: 
Radiation 
Alkylating Agents 
Toxic Metals 
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Figure 3: Multifaceted biological effects of NO. 
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ultimately lead to tissue injury. NO has been shown to participate in a large number of 
pathophysiological conditions such as arthritis, atherosclerosis, cancer, diabetes, 
numerous degenerative neuronal diseases, stroke, and myocardial infarction to name a 
few [Culotta and Koshland, 1992, Gross and Wolin, 1995]. However, there is 
considerable debate as to the exact function of NO in such diverse pathophysiological 
states, though NO and NO-derived chemical species can inhibit enzyme function, 
alter DNA. and induce lipid peroxidation, NO has antioxidant properties, and the 
ability to protect cells against cytokine induced injury and apoptosis. Nitrogen oxides 
of biologic relevance include elemental nitrogen in five oxidation states 0^20, NO, 
NO2'. NO2', NO3") [Gaston et al, 1994]. NO is one of the biologically active nitrogen 
oxides. In aqueous systems and at air-liquid interfaces, NO-generation yields nitrite 
and nitrate as end products [Stamler et al., 1992]. NO reacts rapidly with the 
superoxide radical, forming highly reactive peroxynitrite anion (ONOO) [Huie and 
Padmaja, 1993]. The broader chemistry of NO involves an array of interrelated redox 
forms implicated in the biochemistry of dioxygen: nitrosonium cation (NO^) and 
nitroxyl anion (NO") [Stamler et al, 1992]. 
7»i Physioloidc roles ot NO» 
It was not until 1987 that NO was identified as the short-lived and elusive. The 
importance of endothelial NO is not limited to its role as a vasodilator. Nitric oxide 
prevents platelet adherence and aggregation [Radomski et al, 1987; Feldman et al, 
1993J and neutrophil aggregation, [Kubes et al, 1991] and it is likely to prevent the 
adhesion of these cells to a normal endothelium. Nitric oxide may also regulate 
endothelial permeability changes [Kubes and Granger, 1992]. It is also 
antiproliferative and may suppress the proliferation of the underlying smooth muscle 
(Nakakic'/a/., 1990]. 
Recent information suggests that NO produced in the brain may influence the 
synthesis of other neurotransmitters, such as glutamate and norepinephrine [Monatgue 
et al. 1994] in the central nervous system (CNS). The functions of NO in the CNS 
appear to be important for excitatory amino acid responses [Schuman and Madison, 
1991] and both developmental and synaptic plasticity. In the GI tract, NO released by 
neurons in the myenteric plexus results in relaxation of intestinal smooth muscle. A 
second important role of NO as a neurotransmitter in the periphery is penile erection. 
2 0 
Electrical stimulation of pelvic nerves results in NO release and erection [Rajfer et al., 
1992; Burnett era/., 1992]. 
Inducible NOS or iNOS expression is part of an adaptive response during 
inflammation or infection. During an infection, stimulation of iNOS by the microbe 
itself or by cytokines produced in response to the infection contributes to the 
elimination of the offending microbe. Intracellular parasites such as malaria [Nussler 
et al.. 1991] and Leishmania [Green et al., 1990] are especially sensitive to NO, but 
some viruses [Karupiah et al., 1993], fungi [Granger et al., 1987], and bacteria 
[Malavvista et al., 1992] also are likely to be killed or inhibited by NO. It has been 
shown that activated macrophages kill some tumor cells in vitro through this pathway 
[Hibbs et al., 1987 a, b]. Widespread iNOS expression is part of the host's adaptive 
response to sepsis and it is also associated with graft rejection [Hoffman et al., 1990] 
and can result in suppressed lymphocyte proliferation and cytotoxic T-lymphocyte 
development [Lancaster et al, 1992; Hoffman et al, 1994]. Other areas in which NO 
is known to play important regulatory roles are in normal renal function [Wilcox et 
al.. 1992]. as a mediator of normal endocrine secretory function [Ceccateli et al, 
1993]. and as a smooth-muscle relaxant in pregnancy [Sladek et al, 1993]. 
7'2 Role o£ NO in relevance to human pathophysiolorfcal 
conditions; 
Reactive nitrogen species (RNS) may normally be useful but can be toxic in excess. 
Nitric oxide is the prime example. Other RNS such as peroxynltrite (ONOO) are 
probably always damaging. The chemical biology of NO can be divided into two 
distinct categories: direct and indirect effects (Figure 4) [Wink et al, 1996 a, b]. 
Direct effects are those reactions in which, NO interacts directly with biological 
molecules. In contrast, indirect effects are derived from the reaction of NO with either 
superoxide or oxygen, which yields reactive nitrogen oxide species (RNOS) [Wink et 
al.. 1996 a, b]. 
(^) Cardiovascular disease: Vascular endothelial cells generate NO for a multitude of 
physiological reasons and they may also secrete superoxide [Moncada and Higgs, 
1992; O'Hara et al, 1993] hence ONOO can form in the vasculature (Figure 1). In 
atherosclerotic lesions excess production of superoxide may cause loss of the 
modulatory action of NO and at the same time yield ONOO which is pro-aggregatory 
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Figure 4: Direct and indirect effects of NO 
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and could commit platelets in this environment to thrombus formation [Moro et al., 
1994], At an early stage in the development of atherosclerosis, chemical 
transformation of low density lipoprotein (LDL) occurs in the vessel wall [Witztum 
and Steinburg, 1991]. Lipid peroxidation is one way in which LDL modification 
occurs and it results in the formation of a rancid mixture of toxic products. Probably 
in an attempt at protection, modified LDL is engulfed by macrophages; the resulting 
lipid laden foam cells may then become part of the problem because of the effect of 
their secretory products on other cells in the lesion, e.g. encouraging smooth muscle 
cell proliferation [Witztum and Steinburg, 1991]. It is not known how LDL oxidation 
begins in the artery wall. However, peroxynitrite could be involved since it efficiently 
oxidises LDL [Darley-Usmar et al, 1992] and causes rapid depletion of several 
antioxidants (ascorbate, urate, protein thiols and ubiquinol) [Van Der Vliet et al, 
1994], 
{(B) Infiammation: ROS and RNS play important roles in killing foreign organisms 
and in acute inflammation but their over-production may cause tissue damage and 
vascular leakage in septicaemia, rheumatoid arthritis and inflammatory bowel disease 
[Moncada and Higgs, 1992; Nussier and Billiar, 1993; Abrahamsson et al, 1992]. 
The precise mechanisms of these cytotoxic effects are unknown but RNS are 
implicated since nitrotyrosine has been detected in serum and synovial fluid from 
rheumatoid patients [Kaur and Halliwell, 1994] and co-localises with NOS in a guinea 
pig model of chronic gut inflammation [Miller et al, 1995]. Furthermore, intra-
colonic instillation of peroxynitrite can produce colitis in rats [Rachmilewitz et al, 
1993] and patients with active ulcerative colitis show a marked increase in NOS 
activity in the inflamed colonic mucosa [Boughton-Smith et al, 1993]. Septicaemia is 
associated with the induction of NOS in several cell types in response to mediators 
such as cytokines [Nussier and Billiar, 1993], The iNOS isoenzymes are capable of 
sustaining high rates of NO production. In addition to the well recognized effects of 
NO in causing hypotension in this syndrome, vascular damage may also arise from 
reactive nitrogen species (RNS) [Moncada and Higgs, 1992]. Acute respiratory 
distress syndrome (ARDS) which often results from severe infection, may also 
involve RNS generation in the lung as evidenced by the presence of nitrotyrosine 
[Hadddd et al, 1994]. 
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(C) Cancer: Although RNS may be used by phagocytes to kill cancer cells, it is ironic 
that, like ROS, they have many of the characteristics of carcinogens [Nguyen et al, 
1992: Wink et al, 1993]. An important target for RNOS is DNA. Chemical alteration 
of DNA can have important consequences in a variety of cytotoxic and pathological 
mechanisms. Nitric oxide associated with chronic inflammation has been postulated 
to be a likely candidate in the genotoxic events associated with the etiology of cancer 
[Ohshima and Bartsch, 1994; Liu and Hotchkiss, 1995] There are three potential 
chemical mechanisms by which NO can damage DNA. The first is direct reaction of 
RNOS with the DNA structure. The second is through inhibition of repair processes. 
The third is to increase production of genotoxic species (alkylating agents and 
hydrogen peroxide). Structural alterations in the DNA, e.g. base pair mutations, 
rearrangements, deletions, insertions and sequence amplification can be induced by 
several RNS (HN02, ONOO) [Halliwell, 1994; Nguyen et al, 1992; Halliwell and 
Dizdaroglu, 1992]. 
((D) ^Neurodegenerative (Diseases: High levels of NO have been implicated in the 
pathology of Alzheimers disease, the consequences of viral infections of the central 
nervous system (CNS) and in the excitotoxic neuronal death that is known to play a 
role in stroke and several neurodegenerative diseases [Lipton et al, 1993; Culcasi et 
uL, 1994]. Activation of the glutamate receptors triggers calcium influx into the cell, 
which stimulates the activity of calcium/ calmodulin-dependent nNOS under 
conditions where ROS formation is also enhanced. It follows that ROS/RNS 
interactions may also be important in these effects on the CNS. Microglial cells are 
essentially macrophages resident in the brain and might be expected, on activation, to 
generate RNS as well as ROS. It is possible that reversible inhibition of cytochrome c 
oxidase by NO leads to increased superoxide formation in mitochondria, ONOO 
formation and resultant damage to FeS centres [Cleeter et al, 1994; Casto et al, 
1994]. Ihis idea is consistent with a role for both RNS and ROS in the impairment of 
mitochondrial function known to be associated with Parkinson's disease and possibly 
important in Alzheimers. A cormection between the neurological disorder 
amyotrophic lateral sclerosis (ALS), ONOO and SOD has been suggested [Deng et 
al, 1993;Beckmane/a/., 1993]. 
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8. OMEGA FATTY ACIDS • *TATS OF LIFE>*: 
"We are what we eat". This adage represents the force behind research efforts in diet 
manipulation as preventive measures and treatments of various diseased states. The 
nature of the relation between diet and disease is the subject gf great controversy and 
the last fifty years have been characterized by the understanding of the impact of 
nutrition and dietary patterns on health [Caballero, 2003]. 
The dietary and body fat are essential for life. The concept of the essentiality of the 
long chain PUFA was made by Burr and Burr [1929] at the University of Minnesota 
N4edical School [Holman, 1998]. They were first to suggest that unsaturated fatty 
acids: linolenic and linoleic acids play a bioeffector role, in the growth and 
de\'elopment of yoimg humans and animals. Thus, the generic term "essential fatty 
acid" was used for them. 
8.1 Definition* classiHcation* distribution and sources of 
dietary polyunsaturated tatty acids fPUFAlt 
Unsaturated fatty acids consist of monounsaturates (MUFA) and polyunsaturates 
(PUFA). PUFAs are further divided between two classes, omega-3 and omega-6. The 
only tatt\' acids known to be essential for complete nutrition of many species of 
animals including humans are linoleic (LA) and a-linolenic acid (ALA), as mammals 
lack the ability to synthesize them de novo and must obtain them in their diet. 
Moreover, if supplied in the diet these two can be elongated and further desaturated 
by the mammals. However, certain plants and marine mammals possess the ability 
synthesize them [Simopoulos, 1991; Teitelbaum and Walker, 2001]. Marcel et al. 
[1968] pioneered the cascade for LA and Klenk and Mohrhauer [I960] for ALA. Both 
LA and ALA are metabolized by the same microsomal enzyme system, by alternating 
desaturation and elongation to make two cascades of metabolic products up to 22 or 
more carbons long (Figure 5) which occur in tissue structural lipids in animals and in 
man [Donadio 1991; Holman, 1998]. 
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Figure 5: Metabolic cascade of o-3 and to-6 fatty acids. 
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of the double bond nearest to the terminal methyl group [Willis, 1987]. This terminal 
carbon atom is often referred to as the omega (co) as it occurs at the opposite end of 
the molecule to carbon-1 which bears the carboxyl function. The use of the "omega" 
nomenclature was proposed by Holman [1964]. Alternatively, the n-x notation is used 
instead of co-x to describe the position nearest to the methyl group [Tinoco, 1982]. co-
3 fatty acids are represented by alpha-linolenic acid ( ALA, CI 8:3 cisA^'^''^) while co-
6 fatty acids by linoleic acid (LA, CI 8:2 cisA'^'''). 
The general formulas for (o-3 and co-6 fatty acids are. 
'CH.r'CH2-^CH=CH-R 'CH3-^CH2-'CH2-'*CH2-^CH2-^CH=CH-R 
(coorn carbon) (co or n carbon) 
respectively. Where 'R' represents rest of the carbon chain and the number of 
conjugated double bonds may vary. 
Distribution: LA and ALA as well as their long chain derivatives (e.g. EPA and 
DHA). are important components of animal and plant cell membranes. LA is found in 
triglycerides, cholesterol esters and in very small amounts in phospholipids. EPA is 
found in cholesterol esters, triglycerides and phospholipids. DHA is found mostly in 
phospholipids and is one of the most abundant components of the brain's structural 
lipids [leitelbaum and Walker, 2001]. Both these essential fatty acid families have 
distinctive nutritional and metabolic effects and each has a direct precursor 
relationship with specific class of eicosanoids. Thus, all eicosanoids formed in the 
human body are generated from PUFA that must be derived from the diet [Willis, 
1987], 
So wees: The omega fatty acids are found in fish and marine foods, green leafy 
vegetables and in certain plant seeds and walnut. 
(a) Gifts from the sea: omega-3 fatty acids (EPA and DHA) 
The long chain co-3 PUFA, eicosapentaenoic acid (EPA, C20:5 co-3) and 
docosahexaenoic acid (DHA, C22:6 co-3) (Figure 6) are predominantly found in 
certain fish and sea mammals (tuna, trout, herring, salmon, sardine etc.). Infact, the 
origin of EPA/DHA in aquatic systems are the plants of the sea, microalgae and 
seaweed. They produce high levels of EPA and DHA which are acquired by the 
marine fish/mammals through the food chain. Fish oils are concentrated source of 
a? 
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EPA and DHA [Simopoulos et al., 1986]. Eggs can also provide small amount of 
DHA (<50 mg/egg) [Davis and Kris-Etherton, 2008], 
(b) Gifts from the land: omega-3 fatty acids (ALA) 
a-Linolenic acid (ALA, CI8:3 (0-3) (Figure 2) is found in chloroplast of green leafy 
vegetables (purslane, spinach etc.) and in oily seeds of canola, hempseed, walnuts and 
most notably in flaxseeds (richest source) etc. [Davis and Kris-Etherton, 2003]. 
Flaxseed (Linum usitatissimum or linseed) contains 32-45% of its mass as oil of 
which 51 -55% is ALA and is the richest source [Prasad, 2000; Simopoulos, 2002b; 
Vijaimohan et al, 2006]. The oils from these seeds are the only source of co-3 PUFA 
for vegetarians who do not eat fish for religious or other reasons. 
Some of the major co-3 sources of PUFA are summarized in Table 2 [Udo Erasmus, 
1993; USDA nutrient data laboratory]. 
8.2 Beneficial health eltects ei (o-a PUFA from marine sowces 
fEPA and DHAl: **Medieinat Jatty aeid^ 
The health benefits of fish oil have been extensively studied since the observation that 
incidence of CVD was lower among population that consumed large amounts of fish 
[Kris-Etherton et al., 2002]. Fish oil contains a high proportion of co-3 PUFA e.g. 
cicosapeiuaenoic acid (EPA) and docosahexaenoic acid (DHA). Efficacy and 
potential clinical utility of these fatty acids range from CVD to hyperlipidemia, 
cancer, inflammatory disorders of renal and gastrointestinal systems, respiratory 
diseases, diabetes etc. [Connor, 2000; Kakar el al., 2008]. A number of investigations 
have demonstrated that co-3 fatty acids present in fish oil have profound beneficial 
effects on murine function including both cell and humoral mediated immunity in 
autoimmune diseases such as lupus [Grande and Donadio, 1998] and rheumatoid 
arthritis [Yusufi et al, 2003]. Recently it has been shown that FO may have a 
therapeutic potential as an adjunct therapy for human AIDS [Xi and Chen, 2000]. 
DHA has been found to be essential in normal functional development of retina and 
brain [Simopoulos, 2000]. The intake of co-3 PUFA/fish oil or consumption of fish 
was siiown to have inverse association with growth and development and rate of 
depression and other mental deficiencies [Simopoulos, 1991]. Thus dietary co-3 fatty 
acids have moved from speculation about their functions to solid evidence that they 
are not only essential nutrients but also favorably lower the incidences and 
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progression of various chronic diseases whereas co-6 PUFA are known to produce 
pro-inflammatory factors promoting inflammation, tumor growth and most 
degenerative disorders [Simopoulos, 2001; Berquin et al, 2008]. Some of the 
beneficial effects of co-3 PUFA in detail are described as follows: 
Table 2: Fats and Oil Composition 
Fatty acid 
Components 
(%) 
ALA 
ALA+LA 
EPA 
DHA 
Vegetable Based* 
Sunflower 
1 
69 
-
*The vah 
Com 
1 
59 
-
-
aes are ex 
Canola 
11 
32 
-
-
pressed as 
Walnut 
14 
72 
-
-
jercentof t 
Flax-seed 
57 
73 
-
-
Ota! fatty acic 
Marine Based* 
Herring 
0.6 
2.2 
8.6 
7.6 
S. 
Menhaden 
-
1.2 
11.0 
16.0 
(A) cBfoocf Cipids and carcfiovascuCar effects: The potential role of FO in CVD risk 
reduction first came from the observation involving Inuits in Greenland [Mouratoff e/ 
al.. 1967]. Epidemiological data also indicate a very low incidence of ischemic heart 
disease in Eskimos and Japanese population that consume a diet rich in seafood [Bang 
ct al.. 1976; Dyerberg and Bang, 1982]. Burr el al. [1989] showed that patients who 
had myocardial infarcts had reduction in mortality over 2 years by eating fish meals a 
week. It has been reported that fish consumption reduce the incidence of deaths from 
coronary artery disease via effects on blood pressure, atherosclerosis and 
thrombogenesis [Kinsella et al., 1990; Connor, 1994; Leaf, 2008]. One of the most 
remarkable and consistent effects of (o-3 fatty acid supplementafion in humans is their 
ability to decrease plasma concentration of triglycerides and VLDL [Harris, 1997; 
Foulon e( al., 1999]. PUFA have been shown to reduce total plasma cholesterol and 
improves LDL to HDL ratio [Dupont et al., 1990; Rui2-Gutierrez et al., 1999]. 
Numerous epidemiological studies suggest that people who subsist on PUFA rich 
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diets have lower blood pressure than people whose diets have high content of 
saturated fatty acids [Smith-Barbaro and Pucak, 1983; lacono et al, 1984]. Dietary co-
3 FA retards the development of hypertension and related proteinuria [Rayner and 
Howe. 1995]. Beneficial effects of co-3 fatty acids from both plant (flaxseed oil) and 
marine sources have been demonstrated on all coronary artery disease, fatal and non 
fatal myocardial infarction, stroke, sudden cardiac death and all cause mortality 
(Naniiicini et al, 2006; Posta et al, 2006;]. Thus co-3 fatty acids are ''Heart healthy". 
(B) ^Dietary Cipids and cancer: During the past several decades, research surveys and 
animal studies have indicated that high-fat diets are associated with increased 
incidence and accelerated development of certain tumors [Fernandis and 
Venkatraman, 1993]. However, unsaturated dietary fats are inversely related to the 
development and progression of various forms of cancers. Although dietary lipid itself 
is not usually considered a true carcinogen, it is postulated to enhance or promote 
development of tumor cells. Results from experiments with carcinogen-induced and 
transplant tumor models showed that diet containing higher levels of marine oil-
derived ci)-3 PUFA affects tumorigenesis in a different manner from equivalent 
vegetable oil-derived (o-6 PUFA diets. In animal models atleast, ©-6 PUFA diets have 
stimulated development of four types of solid tumors (breast, colon, pancreas and 
prostrate), whereas (o-3 PUFA diets have diminished them [Cave, 1991]. It has been 
found that w-3 acids prevent the worsening of colon cancer while (o-6 fatty acids 
promote the growth of colon tumors [Anti et al, 1994]. ©-3 fatty acids in 
combination with other nutrients (namely vit C. vit E, beta-carotene, selenium) may 
prove to be of particular value for preventing and treating breast cancer [Zhu et al, 
1995]. DHA and EPA can inhibit the growth of prostate cancer [Aronson et al, 2001]. 
It has also been shown that changes in the lipid composition of the diet, readily induce 
fatty acid alteration in both the neoplastic and non-neoplastic cell membranes, hence 
the cell's subsequent physiological and pathological behaviour. EPA and DHA have 
been shown to inhibit carcinogenesis by several molecular mechanisms including 
decreased/increased production of free radicals and ROS; suppression of arachidonic 
acid derived eicosanoid biosynthesis, gene expression (decreasing the expression of 
AP-1) and cell cycle regulation [Siddiqui et al, 2003], influences on transcription 
factor activity, signal transduction pathway and alteration of estrogen metabolism 
[Hardman, 2002; Larsson et al, 2004]. 
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(A) g-linolenic acid (ALA) CfiemicaCformu(a: C18:3A .1\9,U,iS 
(B) Eicosapentaenoic acid (EPA) CdemicaCformula: C20:5A .ffA5,8,Il,14,17 
m 
^ 
^ ^ - , _ 
1^ to 3 1 
HOT 1 
a 
8 ^ 1 1 ^ 1 4 ^ 1 7 ^ 2 0 
(C) Docosahexaenoic acid (DHA) CdemicaCformula: C22:6A' .^A4,'J,iO,U,U,l9 
Wl 
H 
1 
7 10 13 16 19 
Figure 6: The structure? i^f ©-3 fatty acids 
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(C) (Depression and otfier mentaC disorders: There are several lines of evidence 
relating diet with depression and other mental conditions. After all, brain is all fat 
and fats in the brain could easily be altered by diet. At present in the western societies 
the diets contain 15-20 times as much co-6 as co-3 PUFA and this imbalance was 
considered to be responsible for altered mental health. According to Hibbeln [1998] 
lack of co-3 PUFA early in life may forever alter the way the brain develops and 
operates. Low levels of DHA are linked to suboptimal visual acuity and reduced brain 
development in infants, for this reason DHA is now added to infant formula milk 
[Uauy et ciL, 2001]. Diminished levels of co-3 PUFA, especially DHA have been 
associated with several neurological and behavioral disorders, such as depression, 
schizophrenia, Alzheimer's disease and attention deficit hyperactivity disorder 
[Zamaria, 2004; Bourre, 2005]. Depressed patients showed significant progress within 
two weeks of taking fish oil. Most remarkably cross culture studies demonstrate a 
strong relationship between native's consumption of a)-3 PUFA and its level of 
depression. In countries where people eat the least fish the rate of depression is 
highest, and vice versa. The average New Zealander, for example, eats only 18 kg of 
fish a year and 6% of the population suffers from depression. In Japan, where they eat 
64 kg of fish a year, depression accounts <1% of population. This correlation holds 
true across the world. Growing evidence support the essential role of PUFA in the 
development, growth and overall ftinctions of neuronal cells, as 20% of neuronal cell 
membranes are essential fatty acids. DHA and other co-3 PUFA boost serotonin and 
affect mood [Small, 2002]. In animal models, co-3 deficiency caused memory deficit 
[Gamoh et ai, 1999], learning disability [Carrie et ai, 1999] and visual acuity 
[Neuringer, 2000]. Thus, while these long- chain fatty acids are not technically 
'"essential" nutrients, it is important to ensure that they should be sufficiently present 
in the diet for ''''happy and healthy brain ". 
(D)Ome^a fatty acids and nnaC diseases: Recent studies have demonstrated that 
dietary supplementation with co-3 PUFA retards disease progression in human and 
experimental renal disease [Donadio et al, 1994; Grande and Donadio, 2001]. Fish oil 
enriched in EPA and DHA has been shown to reduce blood pressure, serum lipid 
levels, decrease eicosanoid and cytokine production and reduce proteinuria in human 
and experimental renal disease [Goldstein et ai, 1995; Engler and Engler, 2000], In 
IgA nephropathy, the most common glomerulonephritis worldwide [D'Amico, 1987], 
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the rate of renal disease progression was significantly reduced in patients given a fish 
oil supplement [Donadio et al, 2001]. Dietary co-3 competes for arachidonic acid 
oxygenation pathway resulting in formation of biologically inactive end products thus 
exhibiting a favourable effect on glomerular injury, various forms of acute and 
chronic renal failure, allograft rejection, structural and functional renal damage in 
cyclosporine nephrotoxicity, hepatorenal syndrome, diabetic nephropathy, renal 
hypertension, vascular access thrombosis of end stage renal disease, idiopathic 
calcium urolithiasis, idiopathic immunoglobulin A nephropathy and lupus nephritis 
[Donadio, 2001; Baggio et al, 2002]. Fish oil was also linked to the management of 
type 2 diabetes [Montori et al, 2000; Mostad et al, 2006]. co-3 are "Tenoprotective" 
fatty acids and portray as potential new treatments for immune renal diseases. 
(E) Omega fatty acids ancCgastrointestinaCpatfioCogies: In past few years there have 
been many advances in the area of small bowel physiology, pathology and therapy. 
Dietary PUFA influence the natural history of intestinal inflammatory diseases. 
Inflammatory bowel diseases (IBD) include: Crohn's disease (CD) and ulcerative 
colitis. CD is a chronic, transmural, inflammatory process that results in bloody stools 
and malabsorption problems whereas ulcerative colitis is a chronic relapsing 
inflammatory disease of the colonic and rectal mucosa resulting in ulceration, 
hemorrhage, edema, and regenerating epithelium. a)-3 fatty acids found in fish oil 
have an anti-inflammatory activity and have given spectacular results in treatment of 
patients with CD [Belluzzi et al, 1996; Tsujikawa et al, 2000] and have shown 
marked clinical improvement of active, mild to moderate ulcerative colitis [Salomon 
et al. 1990; Barbosa et al, 2003]. FO showed significant protective effect in different 
experimental models [Lichtenberger et al, 1998; Manjari and Das, 2000] of gastric 
ulceration by inhibition of offensive mucosal factors and oxidative stress, and 
augmentation of defensive mucosal factors [Bhattacharya et al, 2006]. Dietary FO 
has been shown to protect against ethanol-induced gastric mucosal injur}' [Leung, 
1992]. Dietary co-3 fatty acids are preferentially incorporated into the mucosal 
phospholipids at the expense of co-6 fatty acids resulting in immunomodulatory 
effects including alteration of lymphocyte proliferation, neutrophil function, antigen 
presentation and induction of apoptosis in addition to changes in intestinal structure 
and function including changes in cellular glycoproteins and tight junctions, co-3 fatty 
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acids have been shown to influence the intestinal BBM uptake of glucose, galactose 
and cholesterol [Thompson e/a/., 1988; 1989]. 
8.3 Beneticial health eKects of co-S PUFA from plant sources 
fALA") in health and diseases '**Seeds oj hooe** for 
vegetarians; 
The health benefits of dietary consumption of food rich in marine 00-3 PUFA are well 
established. Whether plant ca-3 PUFAs are as beneficial as the o)-3 PUFA from 
fish/marine food has not been investigated extensively. a-Linolenic acid (ALA), is a 
major co-3 FA in plants (Harris, 2005). It is a precursor of EPA but not DHA and must 
be converted to EPA for its bioeffector role [Mantzioris et al, 1994]. ALA is 
metabolized to EPA in humans to a significant extent [Valsta et al., 1996]. ALA from 
vegetable sources including grains and oils, offer an alternative source for those who 
are unable to regularly consume fish for religious or other reasons [Harper and 
.lacobson, 2001]. Although plants, sea microalgae and seaweeds are primary source of 
EPA and DHA, but most are not concentrated sources. They do not contribute 
significantly to EPA intakes in the western world but are important sources where 
people use large quantities of seaweeds on a daily basis (e.g. Japan and other parts of 
Asia). Thus vegetarians can rely to some extent on eggs/microalgae supplements for 
the supply of essential fatty acids. 
ALA from vegetable oils and EPA and DHA from fish oil have several parallel 
beneficial health effects [Ide et al, 2000; Kim and Choi, 2001]. Recent epidemiologic 
studies have shown that dietary ALA is associated with a lower risk of CVD in men 
and women [Djousse et al., 2001]. ALA has been associated with a lower rate of fatal 
and non-fatal coronary events [Nannicini et al., 2006]. Hypotensive effect of flaxseed 
oil have been documented lately thus constituting another mechanism for 
cardioprotective effect of ALA [Paschos et al., 2007], The consumption of ALA rich 
I'XO offers protective effects against cardiovascular disorders compared to LA-rich 
sunflower oil via their ability to decrease the tendency of platelet to aggregate 
jAUman, 1995] and inhibition of progression of arterial atherosclerosis [Lorgeril and 
Salen. 2004; Mozaffarian, 2005]. co-3 ALA has been shown to have greater 
hypolipidemic effect than co-6 LA [Kim and Choi, 2001]. Role of ALA in flaxseed oil 
in prevention of cancer has also been demonstrated [Kelley et al., 1991; Williams et 
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ai. 2007J. Utility of flax and flaxseed oil in lupus nephritis and renal failure have also 
been accounted [Kelley et ai, 1991; Basch et al., 2007]. Dietary supplementation 
with flaxseed oil affects the biochemistry of fatty acid metabolism and thus the 
balance of proinflammatory mediators and atherogenic lipids, holding a great promise 
for modulating inflammatory diseases (Chilton et al., 2008). Flaxseed oil has been 
shown to increase life span of irradiated mice suggesting its prophylactic potential 
against radiation-induced degenerative changes in liver (Bhatia et al., 2007). 
9. KIDNEY ANATOMY AND PHYSIOLOGY! 
The kidney is a vital organ that plays an essential role in health and disease. The main 
function of the kidney is to maintain total body fluid volume, its composition and pH 
within physiologic range. This is achieved collectively by the presence of several 
millions of architectural and functional units of the kidney, known as "nephron". A 
nephron consists of glomerulus with an extended tubular structtire. A rat kidney 
contains 30,000-35,000 nephrons whereas a human kidney is made up of about 
1.30,000 nephrons. All these nephrons contribute to maintain renal functions by 
selective reabsorption of various ions and solutes. 
9.1 The structure and lunction of Iddney: 
The structure of the mammalian kidney apparently looks very homogenous, however, 
can be viewed as a composite of several tissue organs, geometrically, functionally and 
metabolically [Schmidt and Guder, 1976] (Figure 7). Thus each nephron consists of 
group of organs arranged in series coursing through four concentric tissue planes, the 
cortex, outer and inner zones of the outer medulla and the inner medulla (papilla) 
[Schmidt and Guder, 1976] (Figure 8). Each tissue plane also has individual "organ" 
characteristics with respect to their ionic contents and metabolic rates [Guder, 1973; 
Schmidt and Guder, 1976]. The luminal brush border membrane (BBM) of renal 
proximal tubule is the major site for reabsorption of various solutes including amino 
acids, sugars and other nutrients, certain ions and minerals such as Na"^  and inorganic 
phospliate (Pi). Reabsorption of most ions and solutes from the tubular lumen is 
coupled by an active transport with sodium (Na )^ via a carrier located on apical side 
and is driven by an electrochemical gradient of Na* generated by Na'*"/K'^ -ATPase 
located on basolateral side [Massary and Fleisch, 1980; Bonjour and Caverzasio, 
1984]. Thus the transport of Na"*" is considered to be a major work function of the 
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kidney upon which all other transports are dependent [Ullrich ei al, 1974; 1977]. The 
energy for the sodium transport is mainly provided by the hydrolysis of ATP at 
antiluminal membrane site involving NaVK'*"ATPase [Balagura-Baruch et al, 1973; 
Evan (it al, 1983]. Since the production of ATP is usually coupled to oxidative 
metabolism occurring in mitochondria, Na^  transport appears to be linked with 
the o.vidative metabolism or oxygen tension (PO2) of the renal tubular cells. A 
direct linear relationship between O2 uptake/utilization and Na"^  reabsorption has been 
found [Thurau, 1961; Torelli et al, 1986]. There appears to be a reverse cortico-
medullary gradient for tissue oxygen tension (PO2) i.e., p02 in inner medulla is far 
lower than in cortical tissue [Aukland and Krog, 1960; 1961; Aukland, 1962; Aperia 
and Liebow, 1964]. 
The proximal tubule in cortex has been demonstrated to be the major site for ions and 
solute reabsorption including water reabsorption which occurs at luminal or brush 
border membrane (BBM) site of the proximal tubules [Evan et al., 1983]. Thus ions 
and solutes such as sodium, phosphate, sugars and amino acids etc. are reabsorbed at 
the BBM of the proximal tubule as secondary active transport which is energized by 
the transcellular transport of sodiimi ions (primary active transport) from luminal 
membrane (in wardly) out of the epithelial cell by basolateral membrane 
[Hammerman and Schwab, 1984; Kempson and Dousa, 1986]. 
According to several studies, fatty acids, glutamine, lactate, citrate and glucose in 
particular are the major substrates which support the transport work of the kidney 
[Pitts and Macleod, 1975; Pitts, 1975; Mandel and Balaban, 1981]. It is well 
established that various nephron subsegments located in different tissue zones of the 
kidney have different functions in solute and fluid transport, as well as in substrate 
metabolism. For example, the renal cortex is characterized mostly by aerobic 
oxidative metabolism [Lee et al, 1962] while the renal medulla is the site of 
anaerobic metabolism and glycolysis. Moreover, the renal cortex is also capable of 
producing glucose [Guder, 1973; Burchera/., 1978; Maleque, 1980]. 
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Figure 8: Structure of nephron. 
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rhe oxidation of glucose in kidney may occur by several different metabolic 
pathways depending on the location and type of a particular nephron segment in the 
kidney; (i) the tricarboxylic acid (TCA) cycle, in which glucose undergoes glycolysis 
to pyruvate, which distributed differentially in the kidney. The renal medulla is the 
major region for the production of lactate from glucose by glycolytic enzymes [Hems 
and Gaja, 1972; Guder, 1973] while the oxidative conversion of glucose to CO2 was 
shown in renal cortex [Lee etal, 1962; Cohen, 1979]. 
Nephron, which consists of various subsegments, shows distinct structural and 
functional differences (Figure 8). Thus nephron heterogeneity also adds to the 
variation in the kidney functions. Both inter- and intra-nephronal heterogeneity exists 
in the mammalian kidney that depends on the origin and location of the nephrons in 
the cortical region of the kidney [Use et al., 1987; Francois and Danielle, 1985]. The 
nephron which originates in the glomerulus located in superficial cortex is known as 
"supertlcial nephron" while the nephron which originates from deep cortical region is 
called as "deep" or "juxtameduUary nephron". These populations of nephrons have 
been found to be distinct structurally and functionally [Francois and Danielle, 1985]. 
In inter-nephronal heterogeneity, proximal convoluted tubules of superficial 
nephrons always touch the surface of the kidney. In intra-nephron or axial 
heterogeneity, the proximal tubules have been divided into three distinct 
morphological subsegments namely Si, S2, and S3. The early proximal convoluted 
tubules (PCT) both in superficial and juxtameduUary nephrons is defined as S\-
segment and can be identified by its attachment with glomeruli on one side. 82 is 
defined as the late superficial proximal convoluted tubule, early superficial proximal 
straight tubule and late juxtameduUary proximal convoluted tubule. S3 is located 
principally in the outer stripe of outer medulla and terminal superficial proximal 
straight tubule and entire juxtameduUary proximal straight tubule. S3 is identified by 
its medullary location and by its connection with thin limbs on distal part. All S3-
subsegments (pars recta), as they descend from cortex into the outer stripe of the outer 
medulla, change from S2 to S3 cell type. Thus the outer stripe of the outer medulla 
contains proximal tubular cells but only the S3 type [Woodhall et al., 1978]. These 
segments can be characterized by their biomarker enzymes [Yusufi et al., 1994]. 
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Figure 9: Schematic outline of glucose homeostasis pathways: Glycolysis [I], TCA cycle 
[II], Gluconeogenesis [III], HMP shunt pathway [IV]. 
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9.a Acute Renal Failure: 
Acute Renal Failure (ARF) is a process rather than a state. Often it denotes a 
reversible insufficiency of the glomerular and tubular excretory functions which may 
be triggered by renal or extra-renal mechanisms. ARF denotes a dramatic clinical 
situation in which both the kidneys stop their function within a short period of time or 
immediately depending on the severity of ARF. It is best characterized by increase of 
nitrogenous waste products, such as serum creatinine and blood urea nitrogen and 
appearance of proteinic and enzymic components in the urine. 
ARF can be grossly divided into three phases; pathogenic phase, manifestation phase 
and recovery phase. In the first phase, a progressive disintegration and necrosis 
especially of tubular epithelial cells has been observed, leading to the functional loss 
of the kidney which is manifested by the reduction of inulin clearance [Steinhausen 
and Parekh, 1984]. In the second phase, long lasting effects are observed that severely 
affect the clearance of both creatinine and inulin and which can continue for several 
days after recovery begins, depending on the degree of renal damage. In the recovery 
phase, there is an increase in concentrating ability of the kidney with eventual 
normalization of kidney functions. 
A number of environmental variables and heavy metals like chromium, mercury, 
cadmium, lead, uranium [Bank et ai, 1967; Cronin, 1986; Banday et al, 2008b] 
chemicals [Yagil, 1990; Weinberg et al, 1990] including drugs like aminoglycosides, 
cephalosporin, cisplatin etc. [Porter and Bennett, 1981; Harris et al, 1990; Basnakian 
et al. 2002; Banday et al, 2008a] affect the structure and function of the kidney 
leading to ARF. Generally, ARF caused by drugs and chemicals is much more severe 
and irreversible and the recovery sometimes is not possible [Steinhausen and Parekh, 
1984]. Ihe pathophysiologic mechanism of ARF has been investigated extensively in 
the last few decades. Four major possible causes of ARF have been generalized which 
include renal vasoconstriction, glomerular permeability, tubular obstruction and 
tubular leakage [Mason, 1986]. For many causes of ARF, ROS have been invoked as 
a pathway for renal injury. The kidney has been studied as an organ that can generate 
ROS and is vulnerable to the damaging effects of ROS. That ROS contribute to the 
pathogenesis of ARF is supported by the presence of oxidative stress in models of 
ARF, the amelioration of renal injury in these models by antioxidant maneuvers, and 
the worsening of renal injury in such models by manipulations that exacerbate 
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sustained oxidative stress. Oxygen radicals are important mediators of renal damage 
in ARF causing lipid peroxidation of cell and organelle membranes, disrupting the 
structural integrity and capacity for cell transport and energy production (Greene and 
Paller. 1991). Several preventive measures have also been utilized but a definite 
answer for the pathogenesis and control of acute renal failure, however, remains the 
topic of future studies. 
10. INTESTINAL ANATOMY AND PHYSIOLOGY; 
The digestion and absorption of food components are major functions of the intestinal 
mucosa. It is the most metabolically active tissue in the body. Many complex 
compounds while passing through the small intestine are degraded into simple 
compounds which cross the intestinal epithelium before reaching the various body 
organs. Thus intestinal epithelium not only regulates diverse absorptive and secretory 
processes but also process the substances that traverse it. 
10.1 The structure and timction of intestinet 
The small intestine extends from the pyloric orifice where it is continuous with the 
stomach to the ileocecal junction where it continues to the large intestine. It is divided 
into three distinct structural and functional parts: 
(i) Duodenum 
(ii) Jejunum 
(iii) Ileum 
lo perform the entitled functions, the absorptive surface of small intestine is greatly 
amplified by transverse folds of mucous membrane (Figure 10). The small intestine is 
consisting of four layers: 
(i) serosa (outermost) 
(ii) muscularis mucosa 
(iii) submucosa 
(iv) mucosa (innermost) 
The absorptive cells of the small intestine are highly polarized tall columnar cells with 
a general architecture and structure that is similar to a number of other epithelial cell 
types whose major function is absorption [Grosser et al, 1992J. They are 
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distinguished by the presence of an apical striated border which forms the absorbing 
surface in contact with luminal contents. The plasma membrane of these enterocytes 
consists mainly of two structurally and functionally different. 
The mucosa of the small intestine has transverse folds known as villi, which are finger 
like projections 0.5-1.5 mm in length. The villi are lined with a single layer of 
epithelial cells and contain a network of capillaries and lymphatic vessels (Lacteals). 
The free edges of the cells of the epithelium of the villi are divided into minute 
microvilli (Figure 11). The microvilli increase the apical surface area ~ 14-40 fold 
(Zetterquist, 1956]. The plasma membrane covering the microvilli is covered with a 
polysaccharide coat referred to as glycocalyx and consists of glycolipids and 
glycoproteinic enzymes that hydrolyze carbohydrates and peptides. The cytoplasm 
beneath the microvilli contains fine filaments known as terminal web. The products of 
digestion may go through the microvillar membrane traversing the terminal web into 
cytoplasm. 
Brush Border membrane (BBM) lining the enterocytes (intestinal cells) constitutes 
one of the most important cellular membranes owing to its role in terminal digestion 
and absorption fianctions which are carried out by certain hydrolytic enzymes e.g. 
disaccharidases, dipeptidases, oligopeptidases, y-glutamyl transferase, maltase, 
lactase, sucrase and alkaline phosphatase [Kenny and Booth, 1978]. These enzymes 
are differentially distributed in the thickness of BBM e.g. sucrase being superficially 
located [Brasitus, 1979] whereas alkaline phosphatase and ATPase are more deeply 
embedded within the membrane [Sigrist-Nelson et al, 1977]. 
The absorption of digestive food and various ions occurs by passive as well as active 
transport [Hopfer et al, 1973; Schultz, 1977]. The transport of water, sugars and 
amino acids is a Na"^  dependent secondary active transport energized by an 
electrochemical gradient due to differences in Na^ concentrations across the BBM 
[Hopfer et al, 1973; Schultz, 1977; Hopfer, 1978; Ramaswamy et al, 1991]. The 
role of proton motive force as a source of energy (in terms of ATP) has also been 
demonstrated [Rajendran et al, 1987; Vorum et al, 1988; Ganapathy et al, 1991]. 
This is carried out by sodium pump (Na'^/K^ATPase); which is a highly conserved 
integral membrane protein. 
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The activities of certain enzymes belonging to glycolysis, TCA cycle, HMP shunt 
pathway, have been reported under various experimental conditions [Budhoski et al, 
1982; Farooq et al, 2004; 2006]. The presence of hexokinase, glucokinase, 6-
phosphofructokinase, glucose-6-phosphatase, fructose-1, 6-bisphosphatase, 
oxoglutarate dehydrogenase, citrate synthase, PEP carboxykinase, NADP-malic 
enzyme and glutamine indicate that gluconeogenesis is also operational in the small 
intestine [Ockermann, 1965; Budhoski et al, 1982]. The function of small intestine 
appears to be metabolic as opposed to be absorptive. Thus the studies involving 
metabolic activities may in some way reflect the absorption properties of the intestinal 
mucosa. 
10.2 Gastrointestinal pathophysiology; 
Small intestinal mucosa is one of the largest areas of contact of the human organism 
with the environment [Schumann et al, 1999]. It is constantly challenged by diet 
derived oxidants, mutagens and carcinogens as well as by endogenously generated 
ROS [Tak Yee, 1999]. 
The small intestine is thus primary site for great exposure to hazardous and life 
threatening environmental toxicants such as heavy metals (uranium) and drugs 
(aminoglycoside antibiotics and antineoplastic agents). Recent studies have clearly 
demon.strated that the enzymes present in the small intestine are not only altered by 
dietary stress such as starvation and fasting [Farooq et al, 2004; 2006] but also by 
antineoplastic and antibiotics drugs such as cisplatin and gentamicin [Arivarasu and 
Mahmood, 2007; Farooq et al, 2007]. 
Most prominent pathophysiological mechanism of gastrointestinal toxicity include 
direct effects on cell membrane, inhibition or stimulation of mucosal proliferation, 
nerve damage, activation of emetic pathways, disruption of intracellular signal 
transduction, generation of reactive oxygen substances, activation or inhibition of 
metabolic enzymes, intracellular toxicity etc. Reactive oxygen metabolites/species are 
the major causative factors for the mucosal lesions through oxidative stress. The 
major toxic effects of ROS include direct cytotoxicity towards epithelial cells, net 
(luid secretion into the lumen and alteration in functions of intestinal 
microvasculature that lead to increased permeability and membrane damage [Grisham 
etal. 1990]. 
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1 1 . STRUCTURE A N D FUWCTIOW OF LIVER: 
The liver weighing roughly 1.2-1.6 kg performs many of the functions necessary for 
staying healthy. The liver is the first organ that comes into contact with enterally 
absorbed nutrients and xenobiotics via portal blood (Kahl, 1999). Two large vessels 
carry blood to the liver: the hepatic artery comes from the heart and carries blood rich 
in oxygen, whereas the portal vein brings to the liver, blood rich in nutrients from the 
small intestine. These vessels are divided into smaller and smaller vessels, ending in 
capillaries, which further divide into thousands of lobules. Each lobule is composed of 
hepatocytes, and as blood passes through, they are able to monitor, add or remove 
substances from it (Sherwood, 1997). 
Among the most important functions of the liver are: 
1) Removing and excreting body wastes and hormones as well as drugs and other 
foreign substances. Enzymes in the liver alter some toxins so they can be more 
easily excreted in the urine. 
2) Synthesizing plasma proteins, including those necessary for blood clotting. Most 
of the 12 clotting factors are plasma proteins produced by the liver. 
3) Producing immune factors and removing bacteria, helping the body fight 
infection. 
4) Producing bile to aid in digestion. Bile salts aid in fat digestion and absorption. 
5) Bilirubin is one of the waste products excreted in bile. Macrophages in the liver 
renn)ve worn out red blood cells from the blood. Bilirubin results from the 
breakdown of hemoglobin and is excreted by hepatocytes. 
6) Storing certain vitamins, minerals and sugars. The liver stores enough glucose in 
the form of glycogen to provide a days energy. 
One of liver's most interesting ability is self repair and the regeneration of the 
damaged tissues. In clearing the body of toxins, the liver is damaged by exposure to 
harmful substances, demonstrating why this capability is important (Tzanakakis et al, 
2000). Toxic damage to the liver parenchymal cells presents histologically as 
degenerative alterations of the cell or as abnormal storage, usually of fat (steatosis) 
(Arias ct al, 1994). Cell death in liver injury may be of two types; it can be 
programmed cell death, or necrosis-a toxic lysis of the cell (Zimmerman, 1993). 
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12. Scope ot the Thesist 
The preventive and therapeutic value of food is a hot topic today. From ancient times, 
the physicians and scholars in Asia have understood that food has both preventive and 
therapeutic value and is an integral part of human health. The concept of chemo-
prevention of certain diseases using naturally occurring substances that can be 
included in the diet consumed by human populations is gaining attention. 
A number of environmental contaminants, chemical and drugs e.g. cisplatin (CP), 
gentamicin (GM), uranyl nitrate (UN) dramatically alter the structure and function of 
various tissues and produce multiple adverse effects in the liver, kidney, heart and 
intestine [Fatima et al, 2004; Barbier et al, 2005; Priyamvada et al, 2008, 2010; 
KJian et al.. 2009 a, b]. Various metabolites and donors of nitric oxide (NO) have 
been used as useful chemicals for the treatment of various diseases [Nickerson, 1970; 
Chow and Hong, 2002]. Nitrate and nitrite are used as food preservatives and 
colouring agents in meat, fish products and cheese [Lundberg et al., 2004]. In 
addition, potassium nitrate has been used as a diuretic agent and nitrite as a 
vasodilator, circulatory depressant or an antidote for cyanide poisoning [Bruijns, 
1982; Chow and Hong, 2002]. Other precursors or sources of nitrite include N-
containing foods, nitrogen containing drugs/chemicals (e.g. nitroglycerin - an anti-
microbial agent and coronary dilator, sodium nitroprusside Na2[Fe(CN)6NO] - an 
anti-hypertensive agent and nitric oxide (NO) [Chow and Hong, 2002]. 
However, excessive amounts of NO donors/metabolites have been shown to exert 
adverse effects since nitrate, nitrite and NO can be recycled back and forth. Nitrates 
are not toxic per se; ingestion of large amounts of nitrates may cause severe 
gastroenteritis. Methemoglobinemia, anemia and nephritis caused by prolonged 
exposure to small amounts of nitrates are likely resulting from its reduction to nitrite 
by bacteria [Dollahite and Rowe, 1974]. A high dietary intake of nitrite has been 
implicated as a risk factor for human cancer, and formation of nitroso-compounds in 
the stomach during inflammation is correlated with nitrate in food and water [Ames, 
1983; Mirvish, 1995]. A number of biochemical changes, functional impairments and 
histipathological lesions have been observed in nitrite-treated rats [Abuharfeil et al., 
2001]. The major health concerns with nitrite are the risk of methemoglobinaemia and 
its potential carcinogenic, mutagenic and cytotoxic effects [Stuethr and Nathan, 1989; 
Ignarro. 1989; Moncada et al., 1991]. On the other hand, excessive and unregulated 
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NO synthesis has been implicated as causal or contributing to pathophysiological 
conditions including many lethal and debilitating human disorders: arthritis, 
atherosclerosis, cancer, diabetes, numerous degenerative neuronal diseases, stroke, 
and myocardial infarction to name a few [Culotta and Koshland, 1992, Gross and 
Wolin, 1995]. It has now been documented that reactions of H2O2 with nitrite and of 
superoxide with NO have a common intermediate-peroxynitrite (ONOO') 
[Carmichael et al, 1993], which is responsible for nitration of proteins, DNA strand 
breaks and mutations, and with interference of protein functions [Sampson et al, 
1998 J. 
The quest for protective dietary nutrients for the control and management of various 
chronic diseases has spanned generations of scientific research. Of late, renewed 
interest and vigor has been showered on the role of omega fatty acids. Fish oil 
enriched in co-3 PUFA (EPA and DHA) provide one such dietary source of 
biologically active components that has been shown to be co-preventative and co-
therapeutic in a wide variety of ailments [Doughman et al, 2007]. 
A number of investigations have already demonstrated that diet supplemented with 
fish oil (FO) enriched in co-3 PUFA has profound beneficial health effects against 
various pathologies including cancers, cardiovascular diseases, diabetes, depression, 
arthritis, asthma and inflammatory and immune disorders of kidney and intestine. 
Recently a)-3 PUFA from some plants/seeds e.g. flaxseed oil (FXO) showed many 
similar health benefits as demonstrated by co-3 PUFA from FO. Dietary fatty acids are 
known to be incorporated in cellular membranes especially plasma membranes 
affecting membrane fluidity and the organization of various membrane enzymes and 
transport proteins [Kogteva and Bezuglov, 1998] influencing the functional aspects of 
various organs especially of kidney and intestine; leading to "positive" end points 
relating to health and disease [Seo, 2005]. 
Recently we have shown that FO enriched in av3 sucessfuUy prevented gentamicin 
and uranyl nitrate induced nephrotoxicty [Priyamvada et al, 2008, 2010]. In the 
present studies we hypothesized that: dietary FO and FXO enriched in (o-3 PUFA, 
would he able to prevent/reduce NO donors/metabolites induced nephrotoxic and 
other adverse effects in rat kidney, intestine and liver. 
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To address this hypothesis the present work was undertaken to study detailed 
biochemical events/cellular response/mechanism of NO donors/metabolites induced 
nephrotoxic and other adverse effects in rat kidney, intestine and liver. NO donors 
used in this study were, L-arginine which is an essential amino acid substrate for 
nitric oxide synthase (NOS) and pharmacological donors like sodium nitroprusside 
(SNP). SNT was used as a metabolite of NO and also as a donor since it is converted 
to NO in vivo. The effects of dietary o)-3 PUFA was also determined to observe any 
protection provided by them against NO donors/metabolites nephrotoxicity and other 
adverse effects. The specific objectives of the planned research included: 
O In the first part: 
Experiments were conducted to study the effects of dietary fish oil (FO) and flaxseed 
oil (FXO) both enriched in co-3 on sodium nitrite (SNT) induced adverse effects on 
various biochemical parameters in serum/urine and on the enzymes of carbohydrate 
metabolism, brush border membrane (BBM), lysosomes and oxidative stress in renal 
cortex, medulla, small intestine and liver of rats. The effect of PUFA on the renal 
transport of Pi was also determined. 
O In the second part: 
Experiments were conducted to study the effects of dietary fish oil (FO) and flaxseed 
oil (FXO) both enriched in ©-3 on sodium nitroprusside (SNP) induced adverse 
effects on various biochemical parameters in serum/urine and on the enzymes of 
carbohydrate metabolism, brush border membrane (BBM), lysosomes and oxidative 
stress in renal cortex, medulla, small intestine and liver of rats. The effect of PUFA on 
the renal transport of Pi was also determined. 
O In the third part: 
Experiments were conducted to study the effects of dietary fish oil (FO) and flaxseed 
oil (FXO) both enriched in co-3 on L-argine (L-ARG) induced adverse effects on 
various biochemical parameters in serum/urine and on the enzymes of carbohydrate 
metabolism, brush border membrane (BBM), lysosomes and oxidative stress in renal 
cortex, medulla, small intestine and liver of rats. The effect of PUFA on the renal 
transport of Pi was also determined. 
The results of the present studies showed that NO donors/metabolites treatment 
caused specific alterations in various serum/urine biochemical parameters and in the 
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enzyme activities of various systems. The results further indicate that dietary FO and 
FXO, largely prevented/ameliorated NO donors/metabolites-induced alterations in 
various parameters. These studies would be helpful in further understanding the 
pathogenesis of NO donors/metabolites-induced toxic insult and its possible 
prevention or protection by dietary a)-3 PUPA from fish oil and flaxseed oil (FXO 
being a potential alternative source of co-3 PUPA for vegetarians). Putting forth a 
good basis for the clinical use of omega-3 fatty acids both as dietary components and 
as future drugs/adjuvants which are relatively safe and inexpensive, confirming the 
dicta- ''h/iAXrCU(>rvCi'the^fbu4xdattoyu/br alihealt^^ 
SO 
H^at/uJ4 
HaiitM 
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A: MATERIALS 
Animals: 
Adult male Albino rats (Wistar strain) were purchased from Central Animal House 
Facility. Jamia Hamdard University, New Delhi, India. 
Substrates for carbohydrate metabolism and lysosomal enzymes: 
Sodium pyruvate for lactate dehydrogenase, oxaloacetate for malate dehydrogenase, 
L-malic acid for malic enzyme, D-glucose-6-phosphate for glucose-6-phosphate 
dehydrogenase and glucose-6-phosphatase, fructose-1,6-diphosphate for fructose-1,6-
bis phosphatase and p-nitrophenyl phosphate for acid phosphatase were piurchased 
from Sisco Research Laboratory (SRL, Mumbai, India). 
Substrates for BBM marker enzymes of kidney and intestine: 
p-nitrophenyl phosphate for alkaline phosphatase, y-glutamyl-p-nitroanilide for y-
glutamyl transferase and L-leucine-p-nitroaniline for leucine amino peptidase were 
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Sucrose for sucrase was 
purchased from SRL (Mumbai, India). 
Substrates for enzymes involved in free radical scavenging: 
Pyrogallol for superoxide dismutase and hydrogen peroxide for catalase were 
purchased from SRL (Mumbai, India). Glutathione reductase required in assay of 
glutathione peroxidase was purchased from Sigma Chemical Co. (St Louis, MO, 
USA). 
Radio Chemicals: 
Radioactive phosphate (^ ^Pi) was purchased from Bhabha Atomic Research Center, 
India. 
Diet: 
The standard rat pellet diet was obtained from Aashirwaad Industries, Chandigarh, 
India. 
Oil: 
Fish oil: Menhaden, Sigma Chemical Co. (St. Louis, MO, USA). 
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Flaxseed oil: Omega Nutrition, Canada Inc., Vancouver. 
Miscellaneous: All chemicals used were of the finest quality commercially available 
and their sources are indicated against them. Glass double distilled water was used in 
all experiments. 
SRL, India: Acetic acid, Ammonium molybdate, Bovine serum albumin, Calcium 
chloride (CaCl2), Cholesterol, Cocktail-T (Scintillation liquid), Copper sulphate 
(CUSO4), Creatinine, 5, 5'-Dithio-bis 2-nitrobenzoic acid. Ferric chloride (FeCb), 
Ferrous sulphate (FCSOA), Folin's phenol reagent, Glucose, Glutathione reduced 
(GSH), Glycine, Glycylglycine, Hydrochloric acid (HCl), Maleic acid, Mannitol, 
Nicotinamide adenine dinucleotide phosphate, Nicotinamide adenine dinucleotide 
phosphate reduced. Nicotinamide adenine dinucleotide reduced, Sodium acetate, 
Sodium azide. Sodium carbonate (Na2C03), Sodium chloride (NaCl), Sodium 
hydroxide (NaOH), Sodium potassium tartarate. 
Sigma Chemical Co., USA; Sodium nitrite, sodiimi nitroprusside, L-arginine, 
Glutathione reductase,Adenosine triphosphate (ATP), Cysteine hydrochloride, N-2-
Hydroxyethyl-piperazine-N-2-ethane Sulphonic acid (HEPES), p-nitroaniline. 
Sodium dodecyl sulphate, Thiobarbituric acid (TBA), Griess Reagent. 
Quaiigens, India; Barium hydroxide {Ba(0H)2}, Calcium carbonate. Chloroform, 
Di-potassium hydrogen orthophosphate (K2HPO4), Di-sodium hydrogen 
orthophosphate (Na2HP04), Ethylene diamine tetra-acetic acid (EDTA), Ethanol, 
Hydrogen peroxide. Magnesium chloride (MgCb), Perchloric acid. Picric acid. 
Potassium dihydrogen orthophosphate (KH2PO4), Sodium arsenate. Sodium 
dihydrogen orthophosphate (NaH2P04), Sodium fluoride (NaF), Succinic acid. 
Sulphuric acid (H2SO4), Trichloroacetic acid (TCA), Tris-(Hydroxymethyl) 
aminomethane (Tris-base), Zinc sulphate (ZnS04). 
Others: 
3. 5-Dinitro salicylic acid 
Vitamin E 
p-nitrophenol 
Lancaster, England. 
Merck Ltd., India. 
Loba Chem. Co., India. 
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Bt METHODS 
1. Animal Protocol; 
Male Wistar rats weighing 150-200 gm were used in all studies. Animals were 
acclimatized for a week prior to the experiment on standard rat pellet diet with free 
access to water. The animal experiments were conducted according to the guidelines 
of Committee for Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA), Ministry of Environment and Forests, Government of India. Body 
weights of rats were recorded at the start and completion of the procedure. 
Diet-
A nutritionally adequate laboratory pellet diet was obtained from Aashirwaad 
Industries, Chandigarh (India). Pellets were crushed finely and mixed with (a) 15% 
Fish oil (b) 15% Flaxseed oil and stored in airtight containers. Vitamin E as DL-a-
tocopherol (270 mg/kg chow) was added to each of the modified rat chows in order to 
meet the increased metabolic requirement for antioxidants on a diet high in 
polyunsaturated fatty acids. The oil diets were prepared in small batches (for 3d 
consumption) and supplied everyday to ensure freshness, the left over diet from each 
cage was discarded. With the exception of the dietary oils, all components of the diet 
were identical. 
General Experimental desisn-
After acclimatization (7 days) the animals were divided into different dietary groups 
fed on (a) standard rat diet (control rats) and (b) co-3 PUFA supplemented diet (FO 
rats and FXO rats). 
(i) In first series of experiments, effect of dietary consumption of co-B fatty 
acid enriched fish oil/flaxseed oil with sodium nitrite treatment. 
(ii) In second series of experiments, effect of dietary consumption of a)-3 fatty 
acid enriched fish oil/flaxseed oil with sodium nitroprusside treatment. 
(iii) In third series of experiments, effect of dietary consumption of co-3 fatty 
acid enriched fish oil/flaxseed oil with L-arginine treatment. 
Body weights of rats were recorded before and after inducing specific experimental 
conditions. The rats were anesthetized with anesthetic ether and sacrificed. Blood and 
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urine samples were collected. Kidney and small intestine were harvested and 
processed for the preparation of homogenates and BBMV, utilized for further 
analyses as described in "Methods". 
Blood collection: Before sacrifice of the rats blood was withdrawn from the left 
jugular vein with the help of a disposable syringe. Serum was obtained by 
centrifugation at 2000 x g for 10 min. 
Urine collection: Three or four rats of each group were placed in standard metabolic 
cages and the urine was collected for 3 hrs at initiation of the experimental conditions 
and prior to the day of sacrifice. Urine volumes were recorded and the urine samples 
were frozen and stored at -80°C for subsequent analyses. 
Z. Analysis ot Serwrn and Urine Parameters; 
The serum samples were deproteinated with 3% TCA in a ratio of 1:3. After incubation 
tor 10 min at room temperature, the samples were centrifuged at 4000 rpm (Remi 
Centrifuge, India) for 10 min. The protein free supernatant was used to quantitate 
serum creatinine (Scr) and inorganic phosphate (Pi) and the precipitate was saved to 
quantitate total phospholipids. Cholesterol was determined directly in the serum 
samples. 
(i) Quandtiative determination of creatinine: Creatinine was determined by the 
method of Levinson and MacFate (1969). To 0.5 ml of the deproteinated 
serum supernatant, 50 ^1 of 10% NaOH and 200 |il of saturated picric acid 
were added and incubated for exactly 20 min at room temperature. A 
calibration curve was simultaneously prepared using known concentrations of 
creatinine solution ranging between 2.0-5.0 }.ig. The sample and the standards 
were read at 520 nm in Cintra 5, GBC, Scientific Equipment. Pty. Australia. 
Creatinine was determined in urine samples after a dilution of 1:10 with 
distilled water following the same procedure. 
(ii) Determination of inorganic phosphate: The inorganic phosphate (Pi) was 
measured in protein free (TCA precipitated) serum supernatant by the method 
ofTausky and Shorr (1953). The serum supernatant (0.5 ml) was diluted to 3 
ml with 1.3 ml of glass distilled water and 1.2 ml of FeS04 reagent (5 gm 
FeS04 was dissolved in 10 ml, of 10% w/v ammonium molybdate in 10 N 
S4 
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H2SO4 and diluted to 100 ml with glass distilled water) was added. A 
calibration curve was prepared simultaneously with test samples using known 
concentrations of KH2PO4 (0.018|^moles-0.28^moles). The blue colour 
obtained was read at 820 nm after 20 min incubation at room temperature in 
Cintra 5, GBC, Scientific Equipment Pty, Australia. Pi was determined in 
urine samples after a dilution of 1:10 with distilled water following the same 
procedure. 
(iii) Quantitative determination of phospholipids: Phospholipids are determined 
in the serum TCA-precipitates by the method of Bartlett (1959) as modified by 
Marinetti (1962). The precipitates were digested with 1 ml of 70% perchloric 
acid on an electric digestion unit. On cooling to room temperature 3 ml of 
glass distilled water was added. The phosphate (inorganic) released was 
estimated by adding 2 ml of FeS04 reagent by the method of Tausky and 
Sliorr (1953) as described above in Pi estimation. The phospholipid values 
were obtained after multiplying the phospholipid phosphorus by a factor of 25. 
(iv) Quantitative determination of cholesterol: Cholesterol was determined by 
the method of Zlatkis et al., (1953). To 3 ml acetic acid, 30 i^l serum sample 
was added. To this, 2 ml of FeClj reagent (prepared by diluting 1 ml of 10% 
FeCb w/v in glacial acetic acid to 100 ml with concentrated H2SO4) was 
added carefully from the side to allow the formation of a brown ring. The 
samples were shaken thoroughly, cooled and colour density was read in Cintra 
5. GBC, Scientific Equipment Pty. Australia, at 560 nm against a reagent 
blank. A calibration curve was simultaneously prepared using known 
concentration (0.02 - 0.2 mg) of cholesterol. 
(v) Determination of blood urea nitrogen and glucose: Levels of urea and 
glucose were assayed by standard colorimetric procedures, urea by reaction 
with diacetyl monoxime and glucose by reaction with o-toluidine using kits 
from Span diagnostics (Surat, India). Glucose was also assayed in the urine 
samples by reaction with o-toluidine using kit from Span diagnostics (Surat, 
India). 
(vi) Determination of urinary protein: The urine collected was filtered, 
precipitated by 13% (final concentration) TCA and was then centrifuged at 
S5 
3000 rpm for 10 niin. The protein content was assayed by the method of 
Lovvryera/., (1951). 
3* Preparation o8 ttssne homogenates: 
(i) Kidney homogenate (cortex and medulla) for the determination of 
metabolic enzymes: After the completion of treatment schedule (SNT, SNP 
or ARG), the kidneys were carefully separated from the treated and control 
animals, and homogenized in 0,1 M Tris-HCl buffer pH 7.5 by a glass-teflon 
homogenizer (Thomas PA, USA) by passing 5 pulses; at 4°C to make a 15% 
w/v homogenate. The homogenate was then subjected to high speed Ultra-
Turrex Kunkel homogenizer (Type T-25, Janke & Kunkel GMBH & Co. KG. 
Staufen) for 3 pulses of 30 s each with an interval of 30 s between each stroke. 
Homogenate was centrifuged at 2000 rpm at 4"C for 10 min in Beckman J2-
Ml (Beckman instruments. Inc Palo Alto. C.A. USA) high-speed refrigerated 
centrifuge to remove the cell debris. The supernatant was saved in aliquots and 
stored at -20''C for analyses of metabolic enzymes (Figure 13). 
(ii) Intestinal mucosal homogenate for the determination of metabolic 
enzymes: After the completion of treatment schedule (SNP, SNT or ARG) the 
small intestines from the treated and control animals were removed, washed 
with 1 mM Tris-HCl, 0.9% NaCl, pH 7.5 and slit open in the middle. The 
mucosa was gently scraped with a glass slide and was used in the preparation 
of homogenate. Mucosal scrapings were homogenized in 0.1 M Tris-HCl 
bulTer. pH 7.5. in a glass-teflon homogenizer at 4°C to make a 10% w/v 
homogenate. The homogenate was then subjected to high speed Ultra-Turrex 
Kunkel homogenizer for 3 pulses of 30 s each with an interval of 30 s between 
each stroke. Homogenate was centrifuged at 2000 rpm at 4°C for 10 min in 
Beckman J2-M1 high-speed refrigerated centrifuge to remove the cell debris. 
The supernatant was saved in aliquots and stored at -20°C for analyses of 
metabolic enzymes (Figure 13). 
(iii) Liver homogenate for the determination of metabolic enzymes: After the 
completion of treatment schedule (SNT, SNP or ARG), liver was carefully 
separated from the treated and control animals, and homogenized in 0.1 M 
Tris-HCl buffer pH 7.5 by a glass-teflon homogenizer (Thomas PA, USA) by 
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passing 5 pulses; at 4°C to make a 10% w/v homogenate. The homogenate was 
then subjected to high speed Ultra-Turrex Kunkel homogenizer (Type T-25, 
Janke & Kunkel GMBH & Co. KG. Staufen) for 3 pulses of 30 s each with an 
interval of 30 s between each stroke. Homogenate was centriifuged at 2000 
rpm at 4°C for 10 min in Beckman J2-M1 (Beckman instruments. Inc Palo 
Alto, C.A. USA) high-speed refrigerated centrifuge to remove the cell debris. 
The supernatant was saved in aliquots and stored at -20''C for analyses of 
metabolic enzymes. 
Homogenate for enzymatic and non-enzymatic antioxidant parameters: A 
10% homogenate of cortex, medulla, intestinal mucosa and liver was prepared 
in O.l M Tris-HCl buffer, pH 7.5, in a glass-teflon homogenizer with 5 
complete strokes. The homogenate was then subjected to high speed Ultra-
furrex Kunkel homogenizer for 3 pulses of 30 s each with an interval of 30 s 
between each stroke. One part of the homogenate was saved at -20°C for 
estimation of total-SH and lipid peroxidation and other was centriftiged at 
5000 rpm for 15 min at 4°C and supernatant was stored at -20°C for analyses 
of free-radical scavenging enzymes. 
4. Preparation ot bnish border membranes; 
(i) Cortical Brush Border Membrane (BBM) Preparation: After the 
completion of treatment schedule (SNT, SNP or ARG), the kidneys from 
treated and control animals were removed, decapsulated and kept in ice-cold 
buffered saline (154 mM NaCl, 5 mM Tris-HEPES, pH 7.4). Each kidney was 
cut horizontally into two halves and the whole cortex (WC) was carefully 
separated from medullary and papillary portions. The BBM vesicles (BBMV) 
were prepared by the method of Schimtz et ai, (1973) using MgCh for 
precipitation of membranes other than BBM as described by Yusufi and 
r3ousa (1987]) and as outlined in schematic diagram (Figure 13). In each 
experiment, tissues from three to six animals (control and experimental) were 
pooled to obtain a sufficient amount of starting material. All the steps involved 
were strictly carried out at 0-4°C unless otherwise specified. 
a) The cortical tissue for the preparation of BBMV was homogenized in a 
buffered solution containing 50 mM mannitol, 5 mM Tris base/HEPES, 
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pH 7.5 (5ml/gni tissue) with four complete passes by glass-teflon 
homogenizer. 
b) The homogenate (10% w/v) was diluted with the above solution 
(20ml/gm tissue) followed by high speed homogenization (Ultra-Turrex 
Kunkel homogenizer) with three pulses of 30 s each with 30 s interval 
between each pulse. Aliquots of cortical homogenates were saved and 
quickly frozen for further analyses. 
c) 1 M MgCli was added to the homogenate (to a final concentration of 10 
mM) and kept on ice for 20 min with intermittent shaking. 
d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min 
in a Beckman J2-M1 refrigerated centrifuge using JA-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 17,000 
rpm (35,000 x g) for 30 min. 
0 The pellet thus obtained was resuspended in a solution containing 300 
mM mannitol, 5 mM Tris base/ HEPES, pH 7.5 with four passes by a 
loose fitting Dounce homogenizer (Wheaton IL, Thomas PA, USA) and 
centrifuged at 17,000 rpm (35,000 x g) for 30 min in 15 ml corex glass 
tube using JA-20 rotor. 
g) The supernatant was discarded and the white outer portion of the fluffy 
pellet was resuspended carefully in a small volume of buffered 300 mM 
mannitol, leaving the dark brown centre of the pellet undisturbed 
(mitochondrial contamination). 
The suspension thus obtained was homogenized by hand held Douncer or passed 
through a gauge needle number 21. This BBM suspension was quickly frozen in small 
aliquots and used for enzyme analysis while aliquots of freshly prepared membranes 
were used for transport studies. 
(ii) Intestinal Brush Border Membrane (BBM) Preparation: After the 
completion of treatment schedule (SNT, SNP or ARG), the small intestines from 
treated and control animals were removed, washed with I mM Tris-HCl, 0.9% NaCl, 
pH 7.5 and slit open in the middle. The mucosa was gently scraped with a glass slide 
and was used in the preparation of intestinal BBM. The intestinal BBM was prepared 
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as described by Kessler el al, (1978) using CaC^ for precipitation of membranes 
other than BBM with a few modifications, as outlined in schematic diagram (Figure 
13). All procedures were carried out at 0-4°C unless otherwise specified. 
(a) The mucosal scrapings for the preparation of BBMV were homogenized in 
a buffered solution containing 50 mM mannitol, 2 mM Tris-HCl, pH 7.5 
with four complete passes by a glass-teflon homogenizer. 
(b) The mucosal homogenate was diluted with the above Tris-mannitol buffer 
(15 ml/gm tissue) and further homogenized using Ultra Turrex Kunkel 
homogenizer at high speed with three pulses for 30 s each with 30 s 
interval between each pulse. Aliquots of mucosal homogenates were saved 
and quickly frozen for further analyses. 
(c) Homogenate was then passed through four layers of cheesecloth and CaCb 
was added to the filtrate (to a final concentration of 10 mM), with constant 
stirring and the solution was left on ice for 15-20 min. 
(d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min 
in a Beckman J2-M1 refrigerated centrifuge using a JA-17 rotor. 
(e) The pellet was discarded and supernatant was centriftxged at 17000 rpm 
(35000 X g) in JA-17 rotor for 30 min. 
(0 Pellet was resuspended in a small volume (1-2 ml) of 50 mM sodium 
maleate, pH 6.8, buffer with four complete passes by a loose fitting dounce 
homogenizer (Wheaton, USA) and centrifuged at 17000 rpm (35000 x g) 
for 30 min in a 15 ml corex tube using a JA-20 rotor. 
(g) Pellet was resuspended in a small volume (1-2 ml) of 50 mM sodium 
maleate, pH 6.8, buffer with four complete passes by a loose fitting dounce 
homogenizer (Wheaton, USA) and centrifuged at 17000 rpm (35000 x g) 
for 30 min in a 15 ml corex tube using a JA-20 rotor. 
(h) The white outer fluffy portion of the pellet was resuspended in 50 mM 
sodium maleate, pH 6.8, buffer leaving the dark brown center of pellet 
undisturbed (mitochondrial contamination). 
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RAT RENAL CORTEX RAT INTESTINE 
CORTICAL HOMOGENATE 
Everted and washed with 
Tris buffered saline pH 7.5 
MUCOSAL SCRAPING 
50 mM Mannitol, 5 mM Tris-HEPES, pH 7.5 
High speed Homogenization (Ultra-Turrex) 
CBBMV IN HOMOGENATE 
Mg" precipitation 
IBBMV IN HOMOGENATE 
' Centrifugation at 2000 x g for 10 min' ,2+ Ca precipitation 
CBBMV IN SUPERNATANT IBBMV IN SUPERNATANT 
PELLET 
DISCARDED 
CBBMV/IBBMV purification by 
centrifugation at 35000 x g for 
30 min 
CBBMV IN PELLET 
SUPERNATANT 
DISCARDED 
•Centrifugation at 35000 x g 
for 30 min 
CBBMV IN PELLET 
Suspended in 300 mM Mannitol 
5mM Tris-HEPES pH 7.4 SUPERNATANT DISCARDED 
IBBMV IN PELLET 
IBBMV IN PELLET 
Suspended in 50 mM Sodium 
Maleate pH 6.8 6.8 
Figure 13: Schematic representation of BBMV preparation from rat renal cortex 
and intestinal mucosa (CBBMV^cortical BBMV, IBBMV= intestinal 
BBMV). 
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(i) The suspension thus obtained was homogenized by hand held Douncer or 
passed through a gauge needle number 21. This BBM suspension was 
quickly frozen in small aliquots and used for enzyme analysis. 
5* Enzyme Assays: 
v^  All enzymes were assayed at zero order kinetics unless otherwise specified. 
^ The activities of each enzyme from various comparing groups were determined 
simultaneously under similar conditions by using same solutions to avoid day to 
day experimental variations. 
^ One unit of enzyme activity is defined as the amount of enzyme required to 
catalyze the formation of 1 ^mole of product per min or hour under the 
specified experimental conditions. 
^ Specific activity is defined as the enzyme unit per mg protein. 
^ The enzymes of carbohydrate metabolism, enzymatic and non-enzymatic 
antioxidant parameters were assayed in cortical, medullary and intestinal 
homogenates and marker enzymes of brush border membrane were measured in 
respective homogenates and BBMV. 
(A) Assay of carbohydrate metabolism enzymes: The assays were carried out in 
kidney {cortical homogenate (CH) and medullary homogenate (MH)}, intestine 
[mucosal homogenate (IH)} and liver {liver homogenate (LH)}by measuring 
the extinction changes in a Cintra 5 (GBC, Scientific Equipment Pty. Australia) 
in a final volume of 3 ml at room temperature (28-30°C). The net reaction rate 
was measured by difference of the extinction values obtained from addition of 
the substrate only and for actual enzymatic reaction following the addition of 
substrate. The molar extinction coefficient of NADH and NADPH used in 
calculation of reaction rate was 6.22 mM-'cm-' at 340 nm. G6Pase and FBPase 
were assayed at 37°C. 
(i) Lactate dehydrogenase (L-Lactate: NAD oxidoreductase; LDH; E.C. 
1.1.1.27): The activity of LDH was measured by the method of 
Romberg (1955). The reaction mixture, in a total volume of 3 ml, 
contained 150 [amoles Tris-HCl buffer pH 7.4; 10 ^moles MgCh; 5 
fimoles sodium pyruvate; 0.24 |imoles NADH and 4.0-6.0 ng protein. 
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The activity was measured as decrease in absorbance, by pyruvate 
dependent NADH oxidation to NAD"^  for 5 min at 340 nm. 
(ii) Malate dehydrogenase (L-Malate: NAD oxidoreductase; MDH; E.C. 
1.1.1.37): The activity of MDH was measured by the method of Meyer 
et al, (1948). The reaction mixture, in a total volume of 3 ml, contained 
100 nmoles Tris-HCl buffer, pH 7.4; 2.5 fimoles oxaloacetate (OAA, pH 
neutralized to 7.4); 0.24 nmoles NADH and 2.0-3.0 |ag protein. The 
activity was measured as decrease in absorbance, by OAA dependent 
NADH oxidation to NAD"" for 5 min at 340 nm. 
(iii) Malic enzyme (L-Malate: NADP oxidoreductase; ME; E.C. 
1.1.1.40): ME was assayed according to the method of Ochoa et al., 
(1948). The reaction mixture, in a total volume of 3 ml, contained Tris-
HCl buffer, pH 7.4, 100 fimoles; 10 jamoles MnCb; 5 ^moles L-malic 
acid (pH adjusted to 7.4); 0.24 fimoles NADP"*" and 0.6-1.2 mg protein. 
The activity was measured as increase in absorbance, by monitoring the 
malic acid dependent reduction of NADP* to NADPH for 5 min at 340 
nm. 
(iv) GIucose-6-phosphate dehydrogenase (D-Glucose-6-phosphate: 
NADP oxidoreductase; G6PDH; E.C. 1.1.1.49): G6PDH was assayed 
by the method of Shonk and Boxer (1964). The reaction mixture, in a 
total volume of 3 ml, contained Tris-HCl buffer, pH 7.4, 150 ^moles; 10 
.^moles MgCh; 5 famoles glucose-6-phosphate; 0.24 iimoles NADP"^ ; 
and 0.6-1.2 mg protein. The activity was measured by monitoring 
increase in absorbance, by glucose-6-phosphate dependent reduction of 
NADP* to NADPH for 5 min at 340 nm. 
(v) Hexokinase (ATP:gIucose phospho transferase; HK; E.C. 2.7.1.1.): It 
was assayed according to the method of Crane and Sols (1953). The 
reaction mixture in a total volume of 1ml contained Tris-HCl buffer, pH 
7.4, 50 )j.moles; 2 fxmoles KH2PO4; 10 f.imoles MgC^; 5 fimoles ATP; 2 
jimoles glucose and 1-1.5 mg protein. The reaction was carried out at 
37°C and stopped with 0.5 ml of 10% ZnS04 and Ba(0H)2 each, after 60 
min. The samples were centrifuged at 4000 rpm (Remi centrifuge. 
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Mumbai, India) and the remaining glucose was estimated in the protein 
and phosphorylated derivatives free supernatant by the method of Nelson 
[1944], A calibration curve was simultaneously prepared using a known 
concentration of glucose solution ranging between 5-45 ^g. 
(vi) GIucose-6-phosphatase (D-glucose-6-phosphate phosphohydrolase; 
G6Pase; E.G. 3.1.3.9): It was assayed according to the method of Shull 
et al, (1956). The reaction mixture in a total volume of 1.5 ml contained 
Tris-HCl buffer pH 7.4, 50 i^ moles; 10 ^moles MgCh; 10 pmoles 
glucose-6-phosphate and 2-3 mg protein. The reaction was carried out at 
37°C and stopped with 1ml of 10% TCA after 60 min. The samples were 
centrifiiged at 4000 rpm (Remi Centrifuge, Mumbai, India) and 
phosphorus was estimated in the protein free supernatant by the method 
of Tausky and Shorr [1953]. 
(vii) Fructose-1, 6-Bisphosphatase (D-fructose-l,6-bisphosphate-l-
phosphohydrolase; FBPase; E.C. 3.1.3.11): It was assayed according 
to the method of Freedland and Harper (1959). The reaction mixture in a 
total volume of 1.5 ml contained Tris-HCl buffer pH 8.4, 50 fimoles; 10 
fxmoles MgCb; 12 |imoles cysteine-HCl; 10 (imoles fructose-1,6-
diphosphate; 0.6-0.8 mg protein. The reaction was carried out at 37°C 
and stopped with 1 ml of 10% TCA after 60 min. The samples were 
centrifuged at 4000 rpm (Remi Centrifuge, Mumbai, India) and 
phosphate released was estimated in protein free supernatant by the 
method of Tausky and Shorr (1953). 
(B) Assay of lysosomal marker enzymes: 
(i) Acid phosphatase (ACPase, E.C. 3.1.3.2): The activity of acid 
phosphatase (ACPase) in cortical, medullary and intestinal homogenates 
was determined by the method of Verjee (1969). The reaction mixture 
contained 2.4 ml acetate buffer (0.05 M sodium acetate, pH 4.5) and 100 
\x\ enzyme (35-40 ng). The reaction was started by the addition of 0.5 ml 
p-nitrophenyl phosphate (final concentration 0.8 mM in 3ml) and 
incubated for 15 min at 30°C. The reaction was stopped by adding 2ml, 2 
N NaOH. A calibration curve of known concentrations of p-nitrophenol 
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(0.05-0.4 iimoles) was prepared simultaneously. The yellow colour 
developed was read at 405 nm against a reagent blank. 
{C) Assay of marker enzymes of brush border membrane: The enzymes were 
assayed simultaneously in kidney {cortical homogenate (CH) and cortical 
BBMV (CBBMV)}, intestine {mucosal homogenate (IH) and intestinal 
BBMV (IBBMV)} and liver {liver homogenate (LH)} under similar 
conditions by using same solutions to avoid day-to-day experimental 
variations. Aliquots of CH and CBBMV were diluted with 10 mM Tris-HCl 
buffer, pH 7.5 and those of IH and IBBMV with 5 mM Tris-HCl buffer, pH 
7.5 to obtain suitable enzyme protein concentration. 
(i) Alkaline phosphatase (AlkPase, E.G. 3.1.3.1): The activity of AlkPase 
in CH, IH and respective BBMV was determined according to the 
method of Shah et al, (1979) as modified by Kempson et ai, (1979). 
The reaction mixture contained 1.4 ml assay buffer (55 mM glycine; 36 
mM NaCl and 45 mM NaOH, pH 10.5) and 100 \i\ enzyme protein (10-
25 |ig protein for CH, IH and 4-8 }.ig for BBMV). The reaction was 
started by adding 15 ^1 p-nitrophenyl phosphate (final concentration 5.8 
mM in 1.5 ml) and incubated at 37"C for the required time (5-20 min). 
The reaction was stopped by adding 50 juil of 5 N NaOH. A calibration 
curve was prepared simultaneously by using known concentration of p-
nitrophenol (0.01-0.2 lamoles). The colour was read at 405 nm against a 
reagent blank. 
(ii) y-GIutamyl transferase (GGTase, E.G. 2.3.2.2): The activity of 
GGTase in CH, IH and respective BBMV was determined according to 
the method of Glossman and Neville (1972) as described by Kempson et 
ai, (1985). The reaction was started by adding 100 ^1 enzyme protein 
(15-20 ^g for CH; 100 ^g for IH; 2-5^g for cortical BBMV and 50 |ag 
for intestinal BBMV) to 1.9 ml substrate buffer (20 mM MgClj, 2 mM y-
glutamyl-p-nitroanilide, 4 mM glycylglycine, 100 mM Tris-base, pH 
8.2) and incubated in a shaking water bath maintained at 37°C for the 
required time (15-30 min). The reaction was stopped by adding 100 i^ l of 
15 M acetic acid. A calibration curve of known concentration of standard 
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p-nitroaniline (0.025-0.2 |amoles) was prepared simultaneously. The 
yellow colour developed was read at 405 nm against a reagent blank, 
(iii) L-Leucine aminopeptidase (LAP, E.C. 3.4.11.2): This enzyme was 
assayed by the method of Goldmann et al, (1976). The reaction was 
started by the addition of 100 [il cortical, medullary or intestinal 
homogenates or BBMV (40-60 ^g protein for homogenate and 10-15 ^g 
for BBMV) to 1.9 ml substrate buffer (50 mM sodium phosphate buffer, 
0.33 mM L-leucine p-nitroanilide, pH 7.2) and incubated at 25°C for the 
required time (15-30 min). The reaction was stopped with 100 )il of 15 
M acetic acid. A calibration curve of standard p-nitroaniline (0.025-0.20 
jimoles) was also prepared simultaneously. The yellow color obtained 
was read at 405 nm against a reagent blank. 
(iv) Sucrase (E.C. 3.2.1.48): Sucrase was assayed by the method of 
Goldstein and Lampen (1975). The reaction mixture (0.3 ml) contained 
50 1^ of 0.1 M sodium maleate buffer, pH 6.0, 200 ^1 of diluted BBM or 
intestinal homogenate and 50 |il of 0.1 M sucrose solution. The assay 
mixture was incubated at 37°C for 10 min and the reaction was 
terminated by addition of 200 f.il of 0.2 M phosphate buffer, pH 7.0, 
immediately followed by heating in a boiling water bath. The tubes were 
cooled and 0.5 ml of distilled water was added. Glucose thus liberated 
was determined by adding 1 ml of 3, 5-dinitrosalicylic acid reagent and 
kept in a boiling water bath for 5 min, and 3 ml of distilled water was 
again added. A calibration curve was simultaneously prepared using 
known amounts of glucose (0.5-2.5 f.imoles) and the colour was read at 
540 nm against a reagent blank. 
(D) Assay of enzymatic antioxidant parameters: The activities of the three key 
enzymes of the antioxidant defense system i.e. superoxide dismutase, catalase 
and glutathione peroxidase were measured simultaneously in the homogenates 
of cortex, medulla, intestine and liver under similar conditions by using same 
solutions to avoid day-to-day experimental variations. 
(i) Superoxide dismutase (SOD, E.C. 1.15.1.1): It was assayed by the 
method of Marklund and Marklund (1974). To 0.08 ml of supernatant 2.82 
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ml of 0,05 mM Tris-succinate buffer, pH 8.2 was added, mixed well and 
incubated at 25°C for 20 min. The reaction was started by adding 0.1 ml of 
8 mM pyrogallol solution. Change in absorbance per minute was 
immediately recorded for the initial 3 min at 420 nm. A reference set, 
containing 0.08 ml distilled water instead of supernatant solution, was also 
run simultaneously. 
(ii) Catalase (E.C. 1.11.1.6): This enzyme was assayed according to the 
method of Claiborne [1985] as described by Giri et al, (1996). The assay 
mixture consisted of 1.95 ml of 0.05 M potassium phosphate buffer pH 
7.0, 1 ml of 0.019 M hydrogen peroxide and 0.05 ml homogenate (50-100 
jig protein) in a final volume of 3 ml. The decrease in absorbance at 240 
nm was immediately noted after every 30 seconds for 3 min. Enzyme 
activity was calculated using the molar extinction coefficient of H2O2 (436 
M"' cm"' at 240 nm). 
(iii)GJutathione peroxidase (GSH-Px, E.C, 1.11.1.9): The activity of GSH-
Px was determined by the method of Flohe and Gunzler (1984). The assay 
mixture contained 500 \i\ of 0.1 M potassium phosphate/1 mM EDTA 
buffer (pH 7.0), 50 |il of 1 mM of sodium azide, 50 i^l of homogenate 
(100-200 fig protein), 100 fil glutathione reductase (0.24 U), and exactly 
100 |ii of 10 mM GSH. The mixture was preincubated for 10 min at 37°C. 
Then 100 1^ of 1.5 mM NADPH solution was added and the hydrogen 
peroxide independent consumption of NADPH was monitored for 3 min. 
The overall reaction was started by adding 100 fil of prewarmed 1.5 mM 
hydrogen peroxide solution and the decrease in absorbance at 340 nm was 
monitored for 5 min. Enzyme activity was calculated using the molar 
extinction coefficient of NAPDH (e = 6.22 x 10^  M"' cm"'). 
(E) Assay of non-enzymatic antioxidant parameters: 
(i) Total-SH groups: Total-SH groups were determined by the method of 
Sedlak and Lindsay (1968). To 0.4 ml of 10% tissue homogenate, 2.1 ml 
of 0.1 M Tris-HCl (pH 8.2), 0.5 ml of 10% SDS and 0.3 ml of 0.1 M 
EDTA were added. The reaction was incubated in a boiling water bath for 
5 min. Then, O.l ml DTNB (40 mg/100 ml methanol) was added. After 30 
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min at room temperature, the absorbance was read at 412 run. A 
calibration curve with different amounts of cysteine (20-160 nmoles) was 
constructed by the same procedure as described above and used to 
calculate the total-SH groups in the samples. 
(ii) Lipid Peroxidation: Lipid peroxidation (LPO) in various tissue 
homogenates was determined spectrophotometrically by the method of 
Ohkawa et al. [1979]. To 0.1 ml of tissue homogenate 1.5 ml of 20% 
trichloroacetic acid, 0.2 ml of 8% SDS, 0.7 ml of distilled water and 1.5 ml 
of 0.8% thiobarbituric acid were added and after mixing incubated at 95°C 
for 20 min. After cooling to room temperature and centrifugation at 10,000 
rpm for 10 min the absorbance of the supernatant was read at 532 nm a 
against reagent blank. Amount of malondiaidehyde (MDA, end product of 
LPO) was calculated using the molar extinction coefficient of 
thiobarbituric acid (s = 1.56 x lO'' M'' cm''). 
6. Phosphate Transport: 
Measurment of inorganic phosphate (^ P^i) uptake in BBMVs was carried out at 25''C 
by the rapid filtration technique as described by Yusufi et al, (1994) either in the 
presence or absence of a Na-gradient. Uptake was initiated by addition of 30 1^ 
incubation medium (100 mM NaCl/KCl, 5 mM Tris-HEPES, pH 7.5, 5 mM K2HPO4) 
and radioactive substrate (^ ^Pi) to 15 |al BBM suspension (50-100 |ag protein) and 
incubated for the desired time intervals (see "Results"). At the end of the incubation 
period the uptake was stopped by rapid addition of 3 ml ice cold stop solution 
(delivered by a Cornwall Syringe type pipette) containing 135 mM NaCl, 10 mM 
sodium arsenate, 5 mM Tris-HEPES, pH 7.5, and filtered immediately through 0.45 
).im DAWP millipore filters and washed 3 times with the same ice cold stop solution. 
Correction for non-specific binding to filters was made by subtracting from all data 
the value of the corresponding blank obtained by filtration of the incubation medium 
without vesicles. The radioactivity of the dried filters was measured by liquid 
scintillation counting (Pharmacia, Sweden) with 10 ml scintillation fluid ("Cocktail-
T". SRL. Mumbai, India). 
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7. Protein Estimation; 
Protein was measured by the method of Lowry e/«/., (1951) with minor modifications 
as described by Yusufi et ai, (1983). The samples were made to 0.8 ml with 0.5% 
SDS. Then 2 ml alkaline copper reagent was added and after 10 min incubation at 
room temperature 0.2 ml Folin's reagent (1 N) was added with brisk shaking and 
incubated for 30 min at room temperature. A calibration curve of standard BSA (5-80 
).ig) was prepared simultaneously. The blue colour obtained was read at 660 nm. 
8. Estimation of Tissue Nitrite Concentrations: 
In biological systems conversion of NO in aqueous solution to nitrite and nitrate is 
thought to favour nitrite production [Butler et ai, 1995]. It has been reported that 
nitrite is the only stable end-product of the autooxidation of NO in aqueous solution 
[Ignarro et ai, 1993] and measurement of nitrite concentrations in the serum and 
tissue homogenates widely accepted as an index for NOS activity [Tucntan and Altug, 
2004; Tunctan et al, 1998, 2000, 2003]. Therefore, concentrations of nitrite in tissue 
homogenates were measured by using the diazotization method based on the Griess 
reaction, which is an indirect assay for NO production [Tunctan et al, 1998]. Kidney, 
intestine and liver homogenates were centrifuged at 5000 g for 10 min. 500nl 
supernatant was removed and an equal volume of modified Griess reagent was added 
and the samples were incubated in the dark for 20 min. Standard curves were 
generated using 0-20 ^M sodium nitrite. Absorbance was measured in standards and 
samples at 550 nm. Concentrations of nitrite were determined from the standard 
curve, which was linear over the entire concentration range tested. Values were 
expressed as nanomols per gram tissue. 
Q. Statistical Analysis: 
Unless specified, all experiments were repeated at least four or five times to document 
reproducibility. All data are expressed as Mean ± SEM. Significance of difference in 
mean values were evaluated using either one-way analysis of variance (ANOVA) 
followed by a student's group t-test for comparison between two mean values using 
SPSS 7.5 software. A probability level of p < 0.05 was selected as indicating 
statistical significance. Most of the changes between various groups were compared 
with control values for better understanding and clarity. However, specific differences 
and statistical significance between other groups were evaluated separately e.g. (i) 
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SNP vs. FOSNP; SNP vs. FXOSNP, (ii) SNT vs. FOSNT; SNT vs. FXOSNT and (iii) 
ARG vs. FOARG; ARC vs. FXOARG 
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O H Y P O T H E S I S I: 
Fish oil (FO) and flaxseed oil (FXO) enriched in co-3 fatty acids -would similarly protect 
against SNT induced nephrotoxic and other deleterious effects in different rat tissues. 
O EXPERIMENTAL DESIGN It 
As shown in Figure 14, initially four groups (viz Control, SNT, FOSNT and FXOSNT) 
of rats (10 rats/group) entered the study after acclimatization. They were fed on normal 
diet (control/SNT) or diet containing 15% fish oil (FOSNT), 15% flaxseed oil 
(FXOSNT). SNT (15 mg/kg bwt/d) was administered intraperitonealy in 0.9% saline 
dail>' for 10 days to the groups designated as SNT, FOSNT and FXOSNT. Control 
animals received an equivalent volume of normal saline for the same period. The rats 
were sacrificed 24 h after the last injection under light ether anesthesia. Blood was 
withdrawn from left jugular vein and serum was separated by centriftjgation at 2000 x g 
for 10 min. Urine samples were collected for 4 h in standard metabolic cages a day before 
the sacrifice of rats. The kidneys, intestine and liver were extracted and processed for the 
preparation of homogenates and brush border membrane vesicles (BBMV) as described 
in "Methods". Body weights of rats were recorded at the start and completion of 
experimental procedure. 
O RESULTS It 
O Effect of dietary fish oil and flaxseed oil on SNT induced toxicity in serum and 
urinary parameters: 
in general the rats remained clinically well throughout the study. There was no significant 
difference in daily food intake and body weights between control and other experimental 
rats (data not shown). SNT treatment to control rats resulted in significant increase in 
serum creatinine (Scr), blood urea nitrogen (BUN), cholesterol, glucose and 
phospholipids but decrease in inorganic phosphate (Pi) compared to control rats (Table 
1). These changes were associated with profound phosphaturia, proteinuria and 
glycosuria (Table 2) accompanied by decrease in creatinine clearance (Table 2). Feeding 
of FO or FXO diet to SNT administered (FOSNT and FXOSNT) rats resulted in 
significant reversal of various SNT elicited deleterious effects on serum and urine 
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parameters. Both FO and FXO diets prevented SNT-induced increase of Scr, BUN, 
glucose and cholesterol and decrease of serum Pi (Table I). FO/FXO diets appear to 
greatly improve renal functions in a similar manner as evident by the increase of 
creatinine clearance and decrease in the excretion of protein, phosphate and glucose in 
the urine (Table 2). 
O Effect of dietary fish oil and flaxseed oil on SNT induced alterations in metabolic 
enzyme activities in renal cortex, medulla, small intestine and liver: 
The main function of kidney i.e. reabsorption of various ions and solutes depends on the 
continuous energy supply as ATP which is generated by various metabolic pathways 
including glycolysis and oxidative metabolism. The acute renal failure produced by toxic 
insult lesults in reduced oxygen consumption due to damage caused to mitochondria and 
other organelles. The effect of SNT, FO, FXO and MO-diets and their combined 
treatment was determined on the activities of various enzymes of carbohydrate 
metabolism involved in glycolysis, TCA cycle, gluconeogenesis and HMP shunt pathway 
in various organs including kidney, small intestine and liver in rats (Table 3,4, 5, 6). 
(a) Effect on carbohydrate metabolism in renal cortex: 
As shown in Table 3 and 4, SNT treatment to control rats significantly increased the 
activit)' of lactate dehydrogenase (LDH) but decreased malate dehydrogenase (MDH), 
hexokinase (HK); glucose-6-phosphatase (G6Pase) and fructose-1, 6-bisphosphatase 
(l"BPase) activities in the renal cortex (Table 3, 4). When SNT treatment was extended to 
FO and FXO-fed rats, SNT-induced alterations in metabolic enzyme activities were not 
only prevented by FO and FXO diets, but G6Pase remained significantly higher in 
lOSN T and FXOSNT compared to control as well as SNT rats in the renal cortex. 
The effect of FO, FXO and SNT combined was also determined on glucose-6-phosphate 
dehydrogenase (G6PDH) and NADP-malic enzyme (ME), source of NADPH production 
needed in various anabolic reactions (Table 4). SNT treatment to control rats significantly 
increased G6PDH but decreased ME activity. SNT elicited increase of G6PDH activity 
was normalized to near control values by both FO and FXO diets. SNT induced decrease 
in MB activity, however was arrested by both FO and FXO diet. 
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Table 3: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and 
MDH in homogenates of a) cortex and b) medulla with SNT treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNT 
FOSNT 
FXOSNT 
b) Medulla 
Control 
SNT 
FOSNT 
FXOSNT 
HK 
(Hmols/mg protein/h) 
64.21 ±0.76 
46.71 ±0.29* 
(-27%) 
59.87 ± 0.77*^ 
(-7%) 
67.78 ± 0 . i r 
(+6%) 
69.33 ± 0.39 
46.21 ±0.77* 
(-33%) 
60.03 ± 0.73* 
(-13%) 
63.71 ±0.45* 
(-8%) 
LDH 
((.imols/mg protein/h) 
27.72 ±0.01 
35.61 ±0.22* 
(+29%) 
28.89 ±0.77* 
(+4%) 
30.04 ± 0.07* 
(+8%) 
40.91 ±0.09 
49.69 ± 0.06' 
(+21%) 
43.87 ±0.54 
(+7%) 
42.87 ±0.12 
(+5%) 
MDH 
(nmols/mg protem/h) 
94.71 ±0.01 
61.09±0.6r 
(-35%) 
97.61 ±0.23* 
(+3%) 
90.66 ±0.96* 
(-4%) 
86.41 ±0.13 
64.21 ±0.07* 
(-25%) 
88.22 ± 1.35* 
(+2%) 
77.87 ± 0.66* 
(-10%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
•Significantly different from control, fsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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needed in various anabolic reactions (Table 4). SNT treatment to control rats significantly 
increased G6PDH but decreased ME activity. SNT elicited increase of G6PDH activity 
was normalized to near control values by both FO and FXO diets. SNT induced decrease 
in ME activity, however was arrested by both FO and FXO diet. 
(b) Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates were 
similarly affected by SNT treatment (Table 3. 4) as in the cortical homogenates. Feeding 
of FO and FXO containing diets to SNT treated rats prevented SNT induced alterations in 
various enzyme activities. Similar to cortex, G6PDH activity increased whereas ME 
activity decreased by SNT in the medulla (Table 4). FO and FXO diet to SNT treated rats 
decreased G6PDH activity and increased ME activity. 
(c) Effect on carbohydrate metabolism in small intestine: 
The effect of SNT and dietary oils was also determined on the enzymes of carbohydrate 
metabolism in mucosal homogenates from different experimental rats (Table 5, 6). SNT 
treatment to control rats caused significant increase in LDH (+40%) and hexokinase (HK) 
but decrease in MDH (-20%) activities. SNT caused significant decrease in 
gluconeogenic enzymes, G6Pase and FBPase in mucosal humogenates. The activities of 
LDH, G6Pase and to some extent FBPase remained significantly higher after SNT 
treatment to FO and FXO-fed rats compared to control rats, thus reversing the SNT-
induced decrease in G6Pase and FBPase activities. SNT-induced decline in MDH activity 
was also restored to near control values by both FO and FXO-diets. 
The effect of SNT and dietary FO/FXO was also determined on G6PDH and malic 
enzyme (ME), sources of NADPH (Table 6). The activity of G6PDH significantly 
increased (+34%) but that of ME decreased (-21%) by SNT treatment compared to 
control rats. However, when SNT treatment was given to FO/FXO diet fed rats, SNT 
induced increase in G6PDH and decrease in ME activities were not observed indicating 
that both VO and FXO diet significantly prevented the alterations caused by SNT. 
(d)Effect on carbohydrate metabolism in liver: 
In addition to the kidney and intestine, the effect of SNT and FO/FXO combinations was 
also observed in rat liver homogenates. SNT treatment significantly increased the 
activities of LDH (+62%), HK (+43%) and G6PDH (+30%) whereas decreased G6Pase, 
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FBPase and ME activities in the liver (Table 5, 6). When Jw^Hr^tment was^ g^ jl^ iMlea to 
FO-fed rats, SNT-induced decrease of metabolic enzyrne afct« j^ti£:^ ]_^ j^iagjfificantly 
prevented by FO and FXO diets alike except HK and MDH, whose activities remained 
significantly higher than control values. 
O Effect of dietary fish oil and flaxseed oil on SNT induced alterations on marker 
enzymes of BBM and Ivsosomes in cortical/medullarv homogenates and in isolated 
BBMV: 
To assess the structural integrity of certain organelles e.g., plasma membrane (BBM) and 
lysosomes, the effect of SNT alone and in combination with FO or FXO diets was 
determined on biomarker enzymes of BBM and lysosomes in the homogenates of renal 
cortex and medulla and isolated BBM preparations from renal cortex. 
a) Effect of SNT alone and with FO or FXO diet on biomarkers of BBM and lysosomes 
in cortical/medullary homogenates: 
The activates of alkaline phosphatase (AlkPase), y-glutamyl transpeptidase (GGTase) and 
leucine aminopeptidase (LAP) and acid phosphatase were determined under different 
experimental conditions in the homogenates of renal cortex and medulla (Table 7). SNT 
treatment to control rats caused significant reduction in the specific activities of AlkPase 
(-35%). GGTase (-57%) and LAP (-56%) in cortical homogenate. The prior feeding of 
10 or FXO diet with SNT treatment prevented SNT elicited decrease in BBM enzyme 
activities. As can be seen from the data SNT induced decrease in BBM enzyme activities 
were similarly prevented by FO or FXO diet. The activity of acid phosphatase (ACPase) 
was also decreased (-54%) by SNT in cortical homogenates and FO/FXO diet was able to 
prevent the decrease in enzyme activity in a similar manner (Table 7). 
The activites of BBM enzymes similar to the cortex were also lowered in the medulla by 
SNT administration although to a lower extent than observed with cortex (Table 7). The 
consumption of FO/FXO enriched diet in combination with SNT treatment resulted in the 
reversal of SNT induced decrease in AlkPase (-19%), GGTase (-33%) and LAP (-42%) 
in the medulla. The activity of ACPase was not affected by SNT and SNT+FO. However, 
it was found to be lower in SNT+FXO rats (-18%) than in control rats. 
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Table 4: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, FBPase, 
G6PDH and ME in homogenates of a) cortex and b) medulla with SNT 
treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNT 
FOSNT 
FXOSNT 
b) Medulla 
Control 
SNT 
FOSNT 
FXOSNT 
G6Pase 
(nmols/mg protein/h) 
0.56 ± 0.02 
0.33 ± 0.07* 
(-41%) 
0.65 ± 0.08*^ 
(+16%) 
0.68 ±0.11** 
(+21%) 
0.80 ±0.03 
0.53 ± 0.24* 
(-34%) 
0.71 ±0.12' 
(-11%) 
0.86 ±0.81* 
(+8%) 
FBPase 
((imols/mg protein/Ti) 
1.91+0.02 
1.57 ±0.08* 
(-18%) 
1.82±0.4r 
(-5%) 
1.74 ±0.23 
(-9%) 
1.61±0.11 
1.21 ±0.05* 
(-25%) 
1.84±0.i2* 
(+14%) 
1.51 + 0.86* 
(-6%) 
G6PDH 
(nmols/mg protemyh) 
0.34 ± 0.02 
0.48 ± 0.02* 
(+42%) 
0.38 + 0.77* 
(+11%) 
0.39 + 0.01** 
(+15%) 
0.25 ± 0.03 
0.31 + 0.02* 
(+24%) 
0.24 ± 0.09* 
(-4%) 
0.20 ± 0.99* 
(-20%) 
ME 
((imols/mg protein/h) 
1.42 ± 0.63 
1.15±0.7r 
(-19%) 
1.55 ±0.67* 
(+9%) 
1.335 + 0.34* 
(-6%) 
1.02 ±0.21 
0.89 ±0.01* 
(-13%) 
0.94 ± 0.87 
(-8%) 
0.99 ±0.71 
(-3%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
*Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and MDH 
in homogenates of a) intestine and b) liver with SNT treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
SNT 
FOSNT 
FXOSNT 
b) Liver 
Control 
SNT 
FOSNT 
FXOSNT 
HK 
(nmols/ing protein/h) 
251.86±6.13 
289.50 ±3.01 
(+15%) 
279.17 iO.Sr 
(+11%) 
233.08 ±0.14^ 
(-7%) 
44.68 ± 2.82 
64.17± 1.17* 
(+43%) 
49.03 ± 0.53* 
(+10%) 
51.61+0.15*^ 
(+16%) 
LDH 
(nmols/mg prolein/h) 
73.21+0.01 
102.21+0.67* 
(+40%) 
86.81+0.53' 
(+18%) 
88.04 ± 0.42*' 
(+20%) 
57.89 + 0.02 
93.61 ±0.24* 
(+62%) 
62.07 ± 0.64' 
(+7%) 
54.18 + 0.19' 
(-6%) 
MDH 
(nmols/mg protein/h) 
36.40 + 0.31 
29.24 ± 0.82* 
(-20%) 
46.91 + 0.61*' 
(+29%) 
40.86 ±0.76' 
(+12%) 
33.67 ± 0.08 
37.37 ±0.12 
(+11%) 
38.12 + 0.95' 
(+13%) 
40.07 ± 0.62*' 
(+19%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
•Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 6: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, FBPase, 
G6PDH and ME in homogenates of a) intestine and b) liver with SNT treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
SNT 
FOSNT 
FXOSNT 
G6Pase 
(nmols/mg protein/h) 
1.81 ±0.02 
1.62 ±0.73 
(-10%) 
1.98 ±0.23^ 
(+9%) 
2.18 ±0.41** 
(+20%) 
FBPase 
(nmols/mg protein/li) 
2.64 ±0.12 
2.02 ± 0.79* 
(-23%) 
2.82 ± 0.56* 
(+7%) 
2.39 ±0.23* 
(-10%) 
G6PDH 
(nmols/mg protein/h) 
0.62 ± 0.04 
0.83 ±0.10* 
(+34%) 
0.58 ±0.77* 
(-6%) 
0.56 ±0.01** 
(-10%) 
ME 
(nmols/mg protein/h) 
0.73 ±0.19 
0.58 ± 0.06* 
(-21%) 
0.85 ± 0.62* 
(+16%) 
0.77 ± 0.54* 
(+5%) 
b) Liver 
Control 
SNT 
FOSNT 
FXOSNT 
0.56 + 0.09 
0.39 ± 0.02* 
(-30%) 
0.71 ±0.12** 
(+27%) 
0.66 + 0.81** 
(+17%) 
1.21 ±0.03 
1.15±0.12 
(-5%) 
1.44 ±0.12** 
(+19%) 
1.53 + 0.86** 
(+26%) 
0.37 + 0.03 
0.48 ± 0.02* 
(+30%) 
0.34 ± 0.34* 
(-8%) 
0.40 ± 0.79* 
(+8%) 
1.22 + 0.24 
1.35 + 0.18 
(-11%) 
1.44 + 0.87' 
(+18%) 
I.I6 + 0.34 
(-5%) 
Results (specific activities) are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. Values in parentheses represent percent change from control 
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b) Effect ofSNT and SNTplus FO and FXO diet on BBM marker enzymes in isolated 
BBMV: 
The effect of SNT, FO and FXO on BBM marker enzymes was further analyzed in 
BBMV preparations isolated from the rena! cortex (Table 8, Figure 15). The data shows a 
similar activity pattern of BBM enzymes as observed in cortical homogenates. However 
the magnitude of the effects was much more pronounced in BBMV than in cortical 
homogenates. Activities of AlkPase (-67%), GGTase (-53%) and LAP (-51%) profoundly 
declined by SNT treatment as compared to control rats. Fish oil (FO) and flaxseed oil 
(FXO) dietary supplementation similar to the effect in the homogenates appeared to 
lower the severity of the SNT treatment. SNT-induced decrease in BBM enzyme 
activities was significantly prevented by dietary FO and to a much greater extent by FXO 
diet. 
Effect of dietary fish oil and flaxseed oil on SNT induced alterations on marker 
enzymes of BBM and lysosomes in mucosal homogenates and in isolated BBMV: 
rhe etfect of SNT, FO and FXO was determined on BBM marker enzymes involved in 
terminal digestion and absorption in mucosal homogenates (Table 9) and in isolated 
BBMV preparations (Table 10, Figure 15) from rat small intestine. SNT treatment to 
control rats caused significant decrease in AlkPase. GGTase, LAP and sucrase in mucosal 
homogenates. SNT treatment also resulted in the decrease of ACPase activity. When SNT 
treatment was given to FO/FXO fed rats normalization of the activities of AlkPase, 
GGTase, and LAP appeared to be normalized wheres sucrase and ACPase activities was 
slightly improved by FXO diet but not by FO diet. 
The effect of SNT, FO and FXO diets was also observed on BBM marker enzymes in 
isolated BBMV preparations. The results showed a similar activity pattern of various 
enzymes in the BBMV as observed in mucosal homogenates (Table 10, Figure 16). SNT 
treatment profoundly decreased the activities of all BBM enzymes but sucrase was 
elevated. FO/FXO diet caused marked increase in AlkPase and GGTase but LAP and 
sucra.se activities were significantly normalized by both FO/FXO diets. SNT induced 
decrease in the BBMV and lysosomal marker enzymes was not only reversed by 
FO/FXO diets but the activities were restored to near control values. 
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Table 7: Effect of Fish oil (FO) and Flaxseed oil (FXO) on biomarkers of BBM and 
lysosomes in homogenates of a) cortex and b) medulla with SNT treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNT 
FOSNT 
FXOSNT 
b) Medulla 
Control 
SNT 
FOSNT 
FXOSNT 
AlkPase 
(nmols/mg protein/h) 
25.41 ±0.51 
16.33 ±1.24* 
(-35%) 
23.67 ±0.56* 
(-7%) 
20.71 ±0.223** 
(-18%) 
11.121 ± 1.24 
9.038 ±0.19* 
(-19%) 
13.765 ±0.93** 
(+24%) 
10.346 ±0.38* 
(-7%) 
GGTase 
(Hmols/mg protein/h) 
34.62 ±0.31 
14.21 ±0.08* 
(-57%) 
25.36 ±0.09** 
(-26%) 
28.45 ± 0.43** 
(-18%) 
18.03 ±0.05 
12.06 ±0.22* 
(-33%) 
15.76 ±0.46** 
(-13%) 
17.45 ±0.6r 
(-3%) 
LAP 
(nmols/mg protein/h) 
4.55 ± 0.29 
2.01 ±0.62* 
(-56%) 
5.13 ±0.48 
(+13%) 
3.87 ±0.09* 
(-15%) 
4.143 ±0.60 
2.38 ± 1.04* 
(-42%) 
3.34 ± 0.67* 
(-19%) 
3.985 ± 0.88* 
(-4%) 
ACPase 
(Mmols/mg protein/h) 
12.21 ±0.45 
5.61 ±0.312* 
(-54%) 
10.63 ±0.93* 
(-13%) 
11.09 ±1.08* 
(-9%) 
6.53 ±0.13 
5.99 ± 0.82 
(-8%) 
6.87 ±0.77 
(+5%) 
5.33 ± 0.34** 
(-18%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
*Signil1cantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 8: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker enzymes of BBM 
in cortical BBMV with SNT treatment. 
Enzyme 
Groups 
Control 
SNT 
FOSNT 
FXOSNT 
AlkPase 
(fimols/mg protein/h) 
105.81 ±0.64 
34.55 ±0.21* 
(-67%) 
125.80 ±0.62*^ 
(+19%) 
147.40 ±0.33'^ 
(+39%) 
GGTase 
(Hmols/mg protein/h) 
219.61 ± 1.11 
103.29 ±0.99* 
(-53%) 
234.32 + 0.12^ 
(+7%) 
i 95.62 ± 1.54* 
(-11%) 
LAP 
((itnols/mg protein/h) 
33.61 ±0.35 
13.11 ±0.01* 
(-61%) 
28.54 ± 0.7r 
(-15%) 
30.11+0.34* 
(-10%) 
Results (specific activities) are Mean + SEM for five different preparations. 
*Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
Q Control Q SNT B5 FOSNT M FXOSNT 
250 -
200 -
I ISO -
I 100 H 
50 H 
0 
AlkPase GGTase LAP 
Figure 15: Effect of FO and FXO on activities of AlkPase, GGTase and LAP in 
cortical BBM with SNT treatment. 
Above figure is drawn using values from Table 8. Results (^imols/mg protein/hour) are 
Mean ± SEM for five different preparations. 
* Significantly different from control, f significantly different from SNT: at p < 0.05 by 
one way ANOVA 
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Table 10: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker enzymes of 
BBM in intestinal BBMVs with SNT treatment. 
Enzyme 
Groups 
Control 
SNT 
FOSNT 
FXOSNT 
AlkPase 
((imols/mg protein/h) 
45.39 ±1.04 
24.74 ±1.49* 
(-45%) 
53.87 ±0.96*^ 
(+19%) 
50.51 ±0.88^ 
(+11%) 
GGTase 
(nmols/mg protein/h) 
46.31 + 1.31 
27.10 + 0.31* 
(-41%) 
41.56 + 0.66' 
(-10%) 
48.54 ±0 .8 r 
(+5%) 
LAP 
(nmols/mg protein/h) 
33.49 + 3.47 
19.87 + 0.79* 
(-41%) 
29.13+ 0.48* 
(-13%) 
28.87 ± 0.69^ 
(-14%) 
Sucrase 
(nmols/mg protein/h) 
363.74 ±4.98 
442.55 + 3.32* 
(+22%) 
287.83+1.93*' 
(-21%) 
303.19+1.49' 
(-17%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
CI Control 0 SNT B FOSNT E3 FXOSNT 
500 -
400 -
i 300 H 
u e 
75 
200 -
100 -
0 ^ r!?}57?B»ff? 
AlkPase GGTase LAP Sucrase 
Figure 16: Effect of FO and FXO on activities of AlkPase, GGTase and LAP in 
intestinal BBM with SNT treatment. 
Above figure is drawn using values from Table 10. Results (^mols/mg 
protein/hour) are Mean ± SEM for five different preparations. * Significantly 
different from control, f significantly different from SNT: at p < 0.05 by one way 
ANOVA 
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O Effect of dietary fish oil and flaxseed oil on SNT induced alterations on marker 
enzymes of BBM and Ivsosomes in liver homogenates: 
The effect of SNT and FO/FXO diet was also determined on marker enzymes of 
BBM and lysosomes in liver homogenates (Table 9). SNT treatment to rats resulted in 
extensive reduction in the specific activity of alkaline phosphatase (AlkPase) whereas 
other enzymes were not altered significantly in the liver homogenates. The feeding of 
FO and FXO-diet to SNT treated (FOSNT/FXOSNT) rats not only prevented SNT 
elicited changes, but the activities of GGTase, AlkPase and LAP were even increased 
by FO/FXO diet compared to control and much higher compared to SNT-rats. 
5 Effect of dietary fish oil and flaxseed oil on SNT induced alterations in 
antioxidant defense parameters in renal cortex and medulla; 
It is evident that reactive oxygen species generated by various toxicants are important 
mediators of cellular injury and pathogenesis of various diseases [Walker, 1999]. 
Primary components of oxidative stress and cellular injury response include elevation 
of lipid peroxidation (LPO), depletion of GSH and suppression of antioxidant 
enzymes [Banday et al., 2008b; Priyamvada et ciL, 2008, 2010]. To ascertain the role 
of antioxidant system in SNT-induced toxicity, the effect of SNT observed on 
oxidative stress parameters in various tissues. SNT enhanced lipid peroxidation (LPO) 
signitkantly and altered antioxidant enzymes both in cortex and medulla, albeit 
differently (Table 11). LPO measured in terms of malondialdehyde (MDA levels) 
significantly enhanced in the cortex (+46%) and medulla (+40%) to similar extent 
whereas total-SH declined in these tissue (-29% to -33%). SNT treatment caused 
marked increase in superoxide dismutase (SOD, +58%) and glutathione peroxidase 
(GSH-Px. +31%) activities but decrease in catalase (-16%) activity in the renal 
cortex. In medulla however the activity of SOD (-58%) and catalase (-28%) 
significantly decreased but the activitiy of GSH-Px (+45%) was significantly 
increased by SNT administration alone. 
Since diet supplemented with FO enriched in a)-3 fatty acids has been shown to 
reduce cyclosporine A and gentamicin induced nephrotoxicity parameters by 
strengthening antioxidant defense mechanism [Priyamvada et al., 2008, 2010], the 
protective effect of both FO and FXO enriched in (o-3 fatty acids was determined on 
SNT-induced oxidative stress parameters. 
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The results indicate that FO and FXO dietary supplementation was able to ameliorate the 
SNT induced oxidative damage in both renal cortex and medulla. SNT induced increase 
in LPO and decrease in total-SH was not observed by feeding FO or FXO diet to SNT-
treated rats. The activity of SOD and catalase in the cortex and the activity of catalase 
and GSH-Px in the medulla respectively remained significantly higher in FO/FXO + SNT 
rats compared to SNT and/or control rats. The results indicate marked protection by both 
FO/FXO diet against SNT induced oxidative damage to renal tissues. 
O Effect of dietary fish oil and flaxseed oil on SNT induced alterations in antioxidant 
defense parameters in small intestine: 
The effect of SNT, FO and FXO were also determined on various antioxidant parameters 
in mucosal homogenates (Table 12). SNT treatment caused marked increase in SOD 
(+160%), catalase (+55%) and GSH-Px (+28%). These changes were associated with 
significant increase in lipid peroxidation (+87%) measured in terms of MDA levels and 
decrease in total-SH (-21%). Both FO and FXO-diet partially prevented SNT-induced 
increase in SOD, catalase and GSH-Px activities. SNT induced increase in LPO and 
decrease in SH-content were respectively decreased and increased by FO/FXO diet. 
> Effect of dietary fish oil and flaxseed oil on SNT induced alterations in antioxidant 
defense parameters in rat liver: 
The effect of SNT, FO and FXO-diet was also determined on various antioxidant 
parameters in liver homogenates (Table 12). SNT treatment to control rats caused marked 
increase in SOD (+34%) and GSH-Px (+55%) but decrease in catalase (-20%) activities. 
These changes were associated with significant increase in lipid peroxidation (+30%) and 
decrease in total-SH content (-19%). Both FO/FXO-diets prevented SNT-induced 
increase in SOD and GSH-Px activities whereas catalase was significantly lowered by FO 
and FXO diet when given in combination with SNT treatment. Total-SH and LPO were 
also normalized to near control values by both FO/FXO diet to SNT administered rats. 
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Effect of dietary fish oil and flaxseed oil on SNT induced alterations in Na-gradient 
dependent transport of ^^ Pi in BBMV isolated from renal cortex; 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent {Naoutside (Nao)>Nainside (Nai)} transport of Pi in renal proximal tubule 
across its luminal brush border membrane (BBM) is an initial and regulatory step. The Pi 
is transported by secondary active transport mechanism, requires expenditure of energy in 
the form of ATP that is generated by cellular metabolism. The uptake of ^^ Pi was 
determined in the presence and absence of Na-gradient in the initial uphill phase (30s) 
and after equilibrium at 120min in BBM preparations. The rate of concentrative uphill 
uptake of ^^ Pi in the presence of a Na-gradient (NaCl in the medium) was markedly 
decreased by SNT treatment (Table 13). However, the uptake of ^^ Pi at the equilibrium 
phase (120min) when Nao=Nai was not significantly different between the two groups. 
Also Na-independent uptake (in the absence of a Na-gradient, when NaCl in the medium 
was replaced by KCl where Ko> Ki) of ^^ Pi at 30s and 120min was also not affected by 
SNT treatment indicating specific alterations only when Na-gradient was present. When 
SNT treatment was extended to FO and FXO feeding rats, SNT induced decrease in ^ P^i 
transport was not observed. Moreover, the net uptake of ^^ Pi remained significantly 
higher in FOSNT and FXOSNT rats compared to control rats and much more higher 
compared to SNT treated rats. The effect was specific only in the presence of Na-
gradient. The transport of Pi in the absence of Na-gradient (i.e. when Ko>Ki) and after 
120 mins was not affected by any of these treatments. 
O Effect of dietary fish oil and flaxseed oil on SNT induced alterations in nitrite 
concentrations in all tissues; 
Nitrite concentration is an important parameter in cases where nitrogen metabolites 
(nitrite, nitrate and NO) are being overproduced. Since nitrite, nitrate and NO are 
recycled back and forth, the amount of nitrite in the tissues reflects the amount of all 
these metabolites. 
As expected, exposure of SNT to rats increased the tissue concentrations of nitrite in all 
tissues (Figure 17), the accumulation of nitrite being greater in renal cortex (+78%), 
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Table 13: Effect of Fish Oil (FO) and Flaxseed oil (FXO) on uptake of 32Pi in brush border 
membrane vesicles (BBMV) from whole cortex with SNT treatment 
(A) Na^g. 
Group 
Control 
SNT 
FOSNT 
FXOSNT 
(B) K"-grs 
Group 
Control 
SNT 
FOSNT 
FXOSNT 
iidient dependent uptake (Na 
30sec 
2750.73 ± 10.53 
1263.72 ±16.30* 
(-54%) 
2778.57 ±15.98^ 
(+1%) 
2702.3 ±33.87^ 
(-2%) 
o>Nai) (pmol/mg protein) 
120min 
422.50 ±17.89 
372.09 ±15.92 
(-12%) 
482.14 ±12.66 
(+14%) 
472.91 ±12.82 
(+12%) 
idient dependent uptake (K«>Ki) (pmoi/mg protein) 
30$ec 
184.37 ±6.73 
189.48 ±4.228 
(+3%) 
197.88 ±15.56 
(+7%) 
186.33 ±18.72 
(-1%) 
nOmin 
354.96 ± 4.26 
366.06 ±17.20 
(+3%) 
360.81 ±15.25 
(+2%) 
354.36 ±11.28 
(-0.2%) 
(C) Net Na'^-gradient dependent uptake at 30 sec 
Group Na'^-gradient dependent uptake K^-gradient dependent uptake Net uptake (Na^-K*) 
184.37 ±6.73 2566.36 ±25.04 
189.48 ±4.228 1074.24 ±11.24* 
(-57%) 
197.88 ±15.56 2580.69 ± 20.11* 
(+1%) 
186.33 ±18.72 2515.97 ±19.25^ 
(-2%) 
Results are Mean ± SEM for five different preparations. 
•Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. 
Values in parentheses represent percent change from control. 
Control 
SNT 
FOSNT 
FXOSNT 
2750.73 ±10.53 
1263.72 ±16.30 
2778.57 ±15.98 
2702.3 ±33.87 
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Table 14: Effect of Fish oil (FO) and Flaxseed oil (FXO) on tissue nitrite concentrations in 
different tissue homogenates with SNT treatment. 
Groups 
Tissues 
Control 
SNT 
FOSNT 
FXOSNT 
Cortex 
(nanomols/gram tissue) 
16.39 ±0.43 
29.17 ±0.24* 
(+78%) 
20.32 ± 0.72*^  
(+24%) 
18.73 ±0.67'^ 
(+14%) 
Medulla 
(nanomols/gram tissue) 
6.08 ±0.13 
9.18 ±0.39* 
(+49%) 
6.90 ±0.35* 
(+13%) 
6.79 ± 0.26* 
(+12%) 
Intestine 
(nanomols/gram tissue) 
40.03 ± 1.14 
61.01 ±0.91* 
(+52%) 
49.69 ±0.81*^ 
(+24%) 
52.23+1.12*^ 
(+30%) 
Liver 
(nanomols/gram tissue) 
15.47 + 0.35 
21.28 ±0.83* 
(+38%) 
15.48 ±0.42* 
(NA) 
16.70 ±0.26* 
(+8%) 
Results are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNT at p < 0.05 by 
one way ANOVA. Values in parentheses represent percent change from control 
• Control E3 SNT D FOSNT 53 FXOSNT I 
70 -\ 
Cortex Medulla Intestine Liver 
Figure 17: Effect of FO and FXO on tissue nitrite concentration with SNT treatment. 
Above figure is drawn using values from Table 14. Results (nanomols/gram tissue) are Mean ± 
SEM for five different preparations. 
* Significantly different from control, t significantly different from SNT: at p < 0.05 by one 
wav ANOVA 
9 1 
. He^ulcyl 
medulla (+51%) and intestine (+52%). This can be attributed to the fact that most of the 
ingested nitrate gets converted into nitrite by bacterial action in the gut. Also kidneys are 
the major filtration site for nitrite. When FO/FXO was given in combination with SNT, 
SNT-induced increase of tissue nitrite concentrations were ameliorated to near control 
both by FO and FXO diet. The results indicate that either the nitrite was not accumulated 
in the tissues or it was degraded and washed out of the body. 
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DISCUSSION I 
A number of environmental contaminants and pharmaceutical agents have been 
shown to dramatically alter the structure and function of various tissues and produce 
multiple adverse effects in the liver, kidney, intestine and heart [Sanchez et al, 2001; 
Barbier ct al, 2006]. These environmental variables are also known to influence the 
incidence and expression of various diseases including different forms of cancers, 
cardiovascular and renal diseases [Stochs et al, 2000; Fatima et al, 2004]. Nitrite is a 
widel\' used agent in the food processing and colouring industry. When used in 
combination with salts (in the form of SNT), nitrites serve as important antimicrobial 
agents in meat to inhibit the growth of bacterial spores that cause botulism, a deadly 
food-borne illness. Additionally, nitrites have been employed as a vasodilator or a 
circulatory depressant to relieve smooth muscle spasms and an antidote for treating 
cyanide poisoning [Karlik et al, 1995]. Although nitrites play vital roles in the normal 
functioning of the human body when present at their physiological concentrations but 
excessive exposure of nitrite has been shown to cause certain adverse effects. Perhaps 
the most common adverse effect of nitrite toxicity in humans is the formation of 
methemoglobin, a substance that interferes with the ability of red blood cells to carry 
oxygen when concentrations reach 30-40% of total hemoglobin concentration, which 
can be fatal [Starodubtseva et al, 1999]. Nitrites have been shovm to react with 
certain amines in food to produce carcinogenic N-nitroso compounds, nitrosamines 
[Webb el al. 2004; Mirvish et al, 1980] many of which are known to cause cancer. A 
high dietary intake of nitrite, implicated as a risk factor for human cancer and 
formation of nitroso compounds in the stomach during inflammation has been directly 
correlated with the amount of nitrite in food and water [Zaldivar and Robinson, 1973; 
Hawksworth et al, 1974]. A number of biochemical changes, functional impairments 
and histopathological lesions have been observed in nitrite treated rats. SNT has also 
been documented to be mutagenic [Ohnuma et al, 1996] 
Several approaches utilizing different mechanisms have been attempted to reduce 
chemical and drug induced nephrotoxicity and other adverse effects. In past few 
years, much interest has been centered on the role of naturally occurring dietary 
substances for the control and prevention of various chronic diseases such as cancer 
and cardiovascular diseases [De Caterina et al, 1994; Kakar et al, 2008]. Omega-3 
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PUFA and antioxidant rich green tea have been shown to ameliorate many ailments 
[De Caterina et al, 1994; Kakar et al, 2008]. Several epidemiological and clinical 
studies have shown that co-3 fatty acids from marine sources like fish oil (FO) retard 
the progression of various forms of cancers, depression, arthritis, asthma, 
cardiovascular and renal disorders [De Caterina et al, 1994/ ^ Kakar et al, 2008]. 
Recently co-3 fatty acids from plant sources e.g. linolenfc, acid, showed similar 
beneficial health effects in growth and development and-\ardiovascular diseases 
I ' 
[Nannicini et al, 2006; Vijaimohan et al, 2006]. Recently it has been documented 
that co-3 fatty acids also protects against gentamicin and uranyl nitrate-induced 
nephrotoxicity [Priyamvada et al, 2008, 2010]. Since nitrites are a part of the very 
i 
environment in which we live, it is virtually impossible to estap^ from their exposure 
and to eliminate them completely from the body to reduce |the risk of various 
disorders. However attempts were made to reduce SNT-induced toxicity with the use 
of dietary vitamin E and selenium [Chow and Hong, 2002]. 
The present work was designed to study detailed mecihanism of SNT-induced 
nephrotoxic and other adverse alterations and the possible protective effects of FO 
and FXO diets enriched in co-3 PUFA in preventing those alterations caused by SNT 
exposure. 
The results of the present study show that SNT administration produced a typical 
pattern of nephrotoxicity as indicated by marked increased in Scr, BUN accompanied 
by massive proteinuria, glucosuria and phosphaturia indicating that a considerable 
damage has occurred to renal tubules and in brush border membrane (BBM) by SNT 
administration. FO when given for 15 days prior to and during SNT administration 
prevented SNT induced deleterious effects in various blood/urine parameters and 
enzyme activities of various pathways. SNT-induced increase of Scr/BUN and 
hypercholesterolemia, phospholipidosis, proteinuria, glucosuria and phosphaturia 
were all absent in FO-fed SNT treated rats. SNT induced alterations in various serum 
and urine parameters were similarly prevented by FXO-diet when given together with 
SNT. This renoprotective effect was possible by the fact that both FO and FXO alone 
were able to increase serum phosphate and reduce serum cholesterol, glucose, 
phospholipids and BUN along with reduction in urinary excretion of Pi and proteins 
as shown earlier for GM and UN induced adverse effects. 
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The reabsorption of Na"" ions by proximal tubular BBM is considered to be the major 
function of the kidney because the transport of other ions and various solutes depends 
directly or indirectly on Na"" reabsorption [Coux et ai, 2001]. Since these transport 
depends on structural integrity of BBM and available energy as ATP which is 
supplied by various metabolic pathways it is imperative that any alterations to these 
pathways caused by toxic insult would determine the rate of renal transport functions 
[Khundmiri et al, 2004; 2005; Fatima et al, 2005]. As shown in the "Results", the 
activities of various enzymes in glycolysis, TCA cycle, gluconeogenesis and HMP 
shunt pathway were differentially altered by SNT treatment. SNT caused significant 
increase of LDH and G6PDH activities and decrease in the activities of MDH (TCA 
cycle); G6Pase, FBPase (gluconeogenesis) and ME in both renal cortex and medulla 
albeit to different extent. Although the actual rates of glycolysis and other pathways 
were not determined, however marked decrease in MDH activity indicates an 
impaired oxidative metabolism of glucose/fatty acids that will lead to lower ATP 
production due to mitochondrial dysfunction. These results indicate a shift in the 
energy metabolism alternatively from aerobic to anaerobic most likely due to 
mitochondrial dysfunction as evident by significant increase in LDH [Banday et al, 
2008aJ. The decrease in TCA cycle enzymes may have caused decrease in 
gluconeogenic enzymes. This can be explained by the fact that lower TCA cycle 
enzyme activities especially that of MDH will result in lower oxaloacetete production 
from malate which is required not only for the continuation of TCA cycle but also for 
gluconeogenesis. Thus SNT-induced toxicity appeared to be primarily due to renal 
mitochondrial damage similar to genatmicin/urany nitrate/ cisplatin induced toxicity 
[Priyamvada et al, 2008, 2010; Khan et al, 2009 a, b]. 
Dietary FO and FXO were also able to prevent SNT-induced decrease/increase in the 
activities of certain enzymes involved in carbohydrate metabolism both in renal 
cortex and medulla. These protective effects can be attributed to the fact that FO and 
FXO alone were shown to effectively enhance the activities of enzymes [Priyamvada 
el al. 2008, 2010]; resulting in overall improvement of carbohydrate metabolism in 
renal tissues similar to those reported in rat liver [Yilmaz et al, 2004]. (0-3 PUFA 
have been shown to coordinately regulate the expression of several enzymes involved 
in carbohydrate and lipid metabolism [Yoshida et al, 2001]. 
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The structural and functional integrity of BBM and lysosomes was assessed by the 
status of their respective biomarker enzymes. SNT caused significant decrease in the 
activities of AlkPase, GGTase and LAP (BBM enzymes) in cortical homogenates and 
to a much greater extent in BBMV preparations. The decrease in BBM enzyme 
activities might have occurred due to loss of BBM enzyme and other components into 
lumen followed by their excessive excretion in the urine as reported earlier [Bandayfr 
al, 2008b; Priyamvada et ah, 2008, 2010]. A marked reduction observed in Na-
dependent transport of Pi also supports SNT induced severe damage to BBM of 
renal proximal tubules. SNT also caused a significant decline in ACPase activity, 
indicating SNT-induced damage to lysosomes as shown by phospholipidosis [Laurent 
et ai, 1990], Taken together the present results show that SNT treatment indeed 
significantly altered the structural integrity and functional capacity of renal proximal 
tubules and especially its BBM and lysosomes as reflected by marked decrease in the 
activities of BBM enzymes: AlkPase, GGTase, LAP. Na-dependent transport of Pi 
across renal BBM, lysosomal enzyme ACPase and certain enzymes of carbohydrate 
metabolism respectively. 
It has been shown that dietary fatty acids incorporate in the cellular membranes thus 
altering the structural integrity and functional capacities of plasma membrane and 
other organelles leading to altered cellular metabolic activities and those of membrane 
associated enzymes [Thakkar et ai, 2000; Carrillo-Tripp and Feller, 2005]. Dietary 
FO/FXO given together with SNT not only prevented SNT-induced decrease of BBM 
enzymes but the activity of AlkPase and/or GGTase remained higher in FOSNT and 
FXOSNT than control rats in the BBM. Both FO/FXO also resulted in significant 
increase of ^'Pi transport across the renal BBM in SNT treated rats. Thus FO and 
FXO caused reversal of SNT induced alterations because FO/FXO alone have the 
intrinsic capability to significantly enhance AlkPase and GGTase activity and Pi 
transport by themselves suggestive of an overall improvement in renal BBM integrity, 
preventing the loss either by lessening the damage caused by SNT or by increasing 
the regeneration process or both. It appears from the data that SNT by lowering 
oxidative metabolism lowers ATP production whereas dietary FO/FXO 
supplementation increased ATP production by increasing the metabolic activities to 
support many cellular functions especially in the kidney. Further, FO/FXO-diets 
increased the renal Pi transport suggestive of co-3 PUFA induced Pi conservation by 
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the kidneys that maintains and/or improves metabolic activities of not only kidney but 
also of other tissues. 
In contrast to kidney, SNT exerted differential effects on the enzymes of carbohydrate 
metabolism and BBM in the intestine and liver. As have been observed earlier in 
GM/UN/CP induced toxicity [Priyamvada et al, 2008, 2010; Khan et al, 2009 a, b] 
the activity of sucrase was significantly increased whereas AlkPase, GGTase and LAP 
decreased by SNT treatment in intestinal and liver homogenates. SNT also caused 
significant increase in LDH and G6PDH but decreased MDH, ME and ACPase 
activities in mucosal and liver homogenates. Due to the down-regulation of LDH by 
SNT, anaerobic glycolysis remained the major source of energy as reported earlier for 
rat intestine [Farooq et al, 2004]. Thus when SNT treatment was extended to 
FO/FXO fed rats, the activities of almost all metabolic enzymes further improved. 
Reactive nitrogen oxide species (RNOS), are produced when NO reacts with either 
superoxide or oxygen. They were considered to be important mediators of SNT-
induced nephrotoxicity [Wink et al, 1996 a, b]. RNOS produce cellular injury and 
necrosis via several mechanisms including peroxidation of membrane lipids, proteins 
and DNA [Wink et al, 1996 a, b]. A major cellular defense against free radicals is 
provided by SOD and catalase, which together convert superoxide radicals first to 
H2O2 and then to molecular oxygen and water. Other enzymes e.g. GSH-Px use thiol-
reducing power of glutathione to reduce oxidized lipids and protein targets of RNOS. 
The present results show that SNT administration to control rats caused severe 
damage to renal tissues most likely by RNS generation as apparent by altered 
activities of above antioxidant enzymes and total-SH content that lead to increased 
lipid peroxidation (LPO). Enhanced LPO may have resulted in protein damage and 
inacti\ation of membrane bound enzymes either through direct attack by free radicals 
or through chemical modification by its end product (malondialdehyde) [Halliwell 
and Gutteridge, 1999]. Thus, observed increase in LPO could provide an additional 
explanation for decreased activities of BBM enzymes. 
SNT increased the activities of antioxidant enzymes in association with increased 
LPO and decreased total-SH in small intestine. In the liver, SNT increased LPO with 
concomitant decrease in total-SH. Further, SNT decreased the activity of catalase but 
increased the activity of SOD and GSH-Px in liver. The feeding of FO-diet to SNT 
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treated rats prevented SNT-induced augmentation of LPO and suppression of 
antioxidant enzyme activities. Similar protection was also extended by FXO-diet. 
The protection against SNT induced renal dysfunction and decline in activities of 
BBM enzymes by FO and FXO can be attributed to their intrinsic biochemical and 
natural antioxidant properties. The co-3 fatty acids possess antioxidant enhancing 
activity thereby raising the efficiency of antioxidant defence system [Ruiz-Gutierrez 
et ai, 1999; Komatsu et ai, 2003]. 
As can be seen from the results, feeding of FO and FXO alone caused significant 
normalization of SOD, catalase and GSH-Px activities accompanied by lower LPO 
values in renal tissues. Thus it appears FO and FXO enriched in co-3 fatty acids 
enhanced resistance to free radical attack generated by SNT administration. Dietary 
FO supplementation has also been shown to strengthen antioxidant defense 
mechanism in the plasma of normal rats [Erdogan et al, 2004]. FXO may have 
elongated and further desaturated to EPA and/or DHA to exert similar protective 
effects as reported earlier against cylophasphamide and radiation induced oxidative 
stress [Bhatia et al, 2006; 2007]. 
Recently dietary fish oil has been shown to protect against acetaminophen 
(paracetamol)-induced hepatotoxicity [Speck and Lauterburgh, 1991], ethanol-
induced gastric mucosal injury [Leung, 1992] in rats, a number of inflammatory 
diseases including lupus nephritis [Chandrasekar and Fernandas, 1994], IgA 
nephropathy [Donadio, 2001] and murine AIDS [Xi and Chen, 2000]. Recent studies 
also showed partial protection by dietary FO/co-3 fatty acids against GM//UN induced 
nephrotoxicity [Priyamvada et al, 2008, 2010]. Our results thus support the rationale 
that (0-3 fatty acids enriched FO and FXO may be an effective dietary 
supplementation in the management of SNT nephrotoxicity and other pathologies in 
which antioxidant defense mechanism are decelerated. 
The present biochemical studies clearly demonstrate that SNT administration 
produces severe nephrotoxicity and causes profound damage to plasma membranes, 
mitochondria, peroxisomes etc. of renal proximal tubules. The enzymes of oxidative 
carbohydrate metabolism and gluconeogenesis; BBM, antioxidant defense mechanism 
and ^^ Pi transport capacity appeared to be severely affected by SNT treatment. In 
contrast, FO and FXO, major source of co-3 fatty acids by altering membrane fatty 
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acid composition appeared to affect membrane organization and functions. Both FO 
and FXO appear to accelerate repair and/or regeneration of injured organelles e.g. 
mitochondria, peroxisomes and increased activity of TCA cycle and BBM as evident 
by increased activities of the enzymes of carbohydrate metabolism. Most importantly, 
by activating endogenous antioxidant defense mechanism FO and FXO provided 
protection from SNT induced free radical attack. FO/co-3 fatty acids targeted cell 
cycle regulation/cell signaling may also underlie its protective effects [Yusufi et al, 
2003]. 
The underlying mechanisms by which SNT caused nephro/gastro/hepato-toxicity is 
not well understood. It has been documented that nitrite directly causes 
methemoglobinemia by reacting with hemoglobin and produces carcinogenic N-
nitroso compounds after its interaction with amines in vivo [Mirvish, 1975]. Nitrite 
can also produce peroxynitrite (ONOO) by reacting with H2O2 [Carmichael et al., 
1993]. Eventually nitrite is also converted to NO which can induce genotoxic, 
mutagenic, carcinogenic and apoptotic effects [Wink et al, 1991; Nguyen et al, 
1992]. SNT inhibits enzymes of respiratory chain [Brown and Borutaite, 2002] but 
enhances glycolytic enzymes [Maletic et al, 2000] and some enzyme antioxidant 
enzymes viz. catalase and GSH-Px [Brown, 1995; Asahi, 1995] via its conversion to 
NO. Most of these effects are known to be mediated by RNOS generated from NO. 
Taken together, in addition to some direct effects. SNT has the ability to cause many 
more adverse effects by converting to NO as it is both a NO-donor and a NO-
metabolite. In contrast, FO and FXO, major source of (a-3 fatty acids by altering 
membrane fatty acid composition appeared to affect membrane organization and 
functions. Both FO and FXO appear to accelerate repair and/or regeneration of 
injured organelles e.g. mitochondria, peroxisomes and increased activity of TCA 
cycle and BBM as evident by increased activities of the enzymes of carbohydrate 
metabolism. Most importantly, by activating endogenous antioxidant defense 
mechanism FO and FXO provided protection from SNT induced free radical attack. 
FO/co-3 fatty acids targeted cell cycle regulation/cell signaling may also underlie its 
protective effects [Yusufi etal, 2003]. 
We conclude that SNT elicited deleterious nephrotoxic and other adverse alterations 
in rat kidney, intestine and liver by causing major damage to mitochondria, 
lysosomes, and basolateral/brush border membranes as reflected by significant 
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decrease in the activities of specific biomarkers of these intracellular organelles. Most 
of these effects, if not all can be attributed to excessive NO or other nitrogen oxides 
production caused by SNT biotransformation. Dietary supplementation with 
fish/tlaxseed oils diets enriched in co-3 fatty acids caused significant improvement in 
nutrition/energy metabolism, BBM integrity, Pi transport capacity and antioxidant 
defenses and thus prevented SNT induced various deleterious effects. Based on our 
present observations and already known health benefits we propose that dietary 
tlsh/flaxseed oil supplementation may provide a cushion for a prolonged therapeutic 
option against SNT-induced nephrotoxicity/gastrotoxicity/hepatotoxicity without 
harmful side effects. 
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PART4I 
O HYPOTHESIS II; 
Fish oil (FO) and flaxseed oil (FXO) enriched in co-3 fatty acids would similarly 
protect against SNP induced deleterious effects in different rat tissues. 
O EXPERIMENTAL DESIGN II; 
As shown in figure 18, initially four groups (viz Control. SNP, FOSNP and FXOSNP) 
of rats (10 rats/group) entered the study after acclimatization. They were fed on 
normal diet (control/SNP) or diet containing 15% fish oil (FOSNP), 15% flaxseed oil 
(FXOSNP). SNP (1.5 mg/kg bwt/d) was administered intraperitonealy in 0.9% saline 
daily for 5 days to the groups designated as SNP, FOSNP and FXOSNP. Control 
animals received an equivalent volume of normal saline for the same period. The rats 
were sacrificed 24 h after the last injection under light ether anesthesia. Blood was 
withdrawn from left jugular vein and serum was separated by centrifiigation at 2000 x 
g for 10 min. Urine samples were collected for 4 h in standard metabolic cages a day 
before the sacrifice of rats. The kidneys, intestine and liver were extracted and 
processed for the preparation of homogenates and brush border membrane vesicles 
(BBMV) as described in "Methods". Body weights of rats were recorded at the start 
and completion of experimental procedure. 
^ RESULTS II; 
O Effect of dietary fish oil and flaxseed oil on SNP induced deleterious effects in 
serum and urine parameters: 
In general the rats remained clinically well throughout the study. There was no 
significant difference in daily food intake and body weights between control and other 
experimental rats (data not shown). SNP treatment to control rats resulted in 
significant increase in serum creatinine (Scr), blood urea nitrogen (BUN), cholesterol, 
glucose and phospholipids but decrease in inorganic phosphate (Pi) compared to 
control rats (Table 1). These changes where associated with profound phosphaturia, 
proteinuria and glucosuria (Table 2) accompanied by decrease in creatinine clearance 
(Table 2). Feeding of FO or FXO diet to SNP administered (FOSNP and FXOSNP) 
rats resulted in significant reversal of various SNP elicited deleterious effects on 
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serum and urine parameters. Both FO and FXO diets prevented SNP-induced increase 
of Scr. BUN, glucose and cholesterol and decrease of serum Pi (Table 1). FO/FXO 
diets appear to greatly improve renal functions in a similar manner as evident by the 
increase of creatinine clearance and decrease in the excretion of protein, phosphate 
and glucose in the urine (Table 2). 
Effect of dietary fish oil and flaxseed oil on SNP induced alterations in metabolic 
enzyme activities in renal cortex, medulla, small intestine and liver; 
The main function of kidney i.e. reabsorption of various ions and solutes depends on 
the continuous energy supply as ATP which is generated by various metabolic 
pathways including glycolysis and oxidative metabolism. The acute renal failure 
produced by toxic insult results in reduced oxygen consumption due to damage 
caused to mitochondria and other organelles. The effect of SNP, FO, FXO and MO-
diets and their combined treatment was determined on the activities of various 
enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis and HMP shunt pathway in kidney, small intestine and liver (Table 
3. 4. 5. 6). 
(a) Effect on carbohydrate metabolism in renal cortex: 
As shown in Table 3 and 4, SNP treatment to control rats significantly increased the 
activity of lactate dehydrogenase (LDH) and hexokinase (HK) but decreased malate 
dehydrogenase (MDH), glucose-6-phosphatase (G6Pase) and fructose-1, 6-
bisphosphatase (FBPase) activities in the renal cortex (Table 3). When SNP treatment 
was extended to FO and FXO-fed rats, SNP-induced alterations in metabolic enzyme 
activities were not only prevented by FO and FXO diets, but G6Pase remained 
significantly higher in FOSNP and FXOSNP compared to control as well as SNP rats 
in the renal cortex. 
The effect of FO, FXO and SNP combined was also determined on glucose-6-
phosphate dehydrogenase (G6PDH) and NADP-malic enzyme (ME), source of 
NADPH production needed in various anabolic reactions (Table 4). SNP treatment to 
control rats significantly increased G6PDH but decreased ME activity. SNP elicited 
increase of G6PDH activity was normalized to near control values by both FO and 
FXO diets. SNP induced ME activity decrease was arrested by both FO and FXO diet. 
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Table 3: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and 
MDH in homogenates of a) cortex and b) medulla with SNP treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNP 
FOSNP 
FXOSNP 
b) Medulla 
Control 
SNP 
FOSNP 
FXOSNP 
HK 
(nmols/mg protein/h) 
48.51 ±0.93 
59.71 ±0.29* 
(+23%) 
47.81 ± 0 . 7 r 
(-1%) 
54.08 ± 0.92 
(+11%) 
72.34 ±1.09 
99.71 ±0.67* 
(+38%) 
80.03 + 0.83' 
(+11%) 
75.41 + 1.45' 
(+4%) 
LDH 
(nmols/me protein/h) 
28.12 ± 1.86 
34.84 ± 1.89* 
(+23%) 
33.11 + 1.45* 
(+17%) 
27.28+1.12' 
(-4%) 
39.65 + 0.80 
47.46 + 3.08* 
(+20%) 
37.15+ 1.91' 
(-7%) 
42.03 ± 0.89' 
(+6%) 
MDH 
(nmols/mg protein/h) 
73.84+1.83 
51.30+1.18* 
(-30%) 
81.69 + 2.21' 
(+11%) 
73.66 + 2.10' 
(NA) 
74.19+1.42 
46.20+1.35* 
(-38%) 
76.86 + 0.84' 
(+4%) 
66.41 + 1.62' 
(-10%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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(b)Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by SNP treatment (Table 3) as in the cortical homogenates. 
Feeding of FO and FXO to SNP treated rats prevented SNP induced alterations in 
various enzyme activities. Similar to cortex, G6PDH activity increased whereas ME 
activity decreased by SNP in the medulla (Table 4). FO and FXO diet to SNP treated 
rats decreased G6PDH activity and increased ME activity. 
(c)Effect on carbohydrate metabolism in small intestine: 
The effect of SNP and dietary oils was also determined on the enzymes of 
carbohydrate metabolism in mucosal homogenates from different experimental rats 
(Table 5. 6). SNP treatment to control rats caused significant increase in LDH (+29%) 
and hexokinase (HK) but decrease in MDH activities. SNP caused significant 
decrease in gluconeogenic enzymes, G6Pase and FBPase in the intestine. The 
activities of LDH, G6Pase and to some extent FBPase remained significantly higher 
after SNP treatment to FO and FXO-fed rats compared to control rats reversing the 
SNP-induced decrease in G6Pase and FBPase activities. SNP-induced decline in 
MDH activity was also restored by both FO and FXO-diets. 
The effect of SNP and dietary FO/FXO was also determined on G6PDH and malic 
enzyme (ME), sources of NADPH (Table 6). The activity of G6PDH significantly 
increased (+29%) but that of ME decreased (-19%) by SNP treatment compared to 
control rats. However, when SNP treatment was given to FO/FXO diet fed rats, SNP 
induced increased in G6PDH and decrease in ME activities were not observed 
indicating that both FO and FXO diet significantly prevented the alterations caused by 
SNP. 
(d) Effect on carbohydrate metabolism in liver: 
In addition to the kidney and intestine, the effect of SNP and FO/FXO combinations 
was also observed in rat liver homogenates. SNP treatment significantly increased the 
activities of LDH (+35%.) and HK (+59%.) whereas decreased G6Pase, FBPase, ME 
and G6PDH activities in the liver (Table 5, 6). When SNP treatment was extended to 
FO-fed rats, SNP-induced decrease of metabolic enzyme activities was prevented by 
FO and FXO alike except HK and MDH, whose activities remained significantly 
higher than control by FXO. 
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Table 4: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, 
FBPase, G6PDH and ME in homogenates of a) cortex and b) medulla with 
SNP treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNP 
FOSNP 
FXOSNP 
b) Medulla 
Control 
SNP 
FOSNP 
FXOSNP 
G6Pase 
(l^mols/mg protein/h) 
0.61 ±0.01 
0.50±0.0r 
(-18%) 
0.69 ±0.01*' 
(+13%) 
o.63±o.or 
(+3%) 
0.58 ±0.01 
0.38 ±0.01* 
(-34%) 
o.6i±o.ir 
(+5%) 
o.6i±o.or 
(+5%) 
FBPase 
()imols/mg protein/h) 
1.73 ±0.03 
1.35 ±0.02* 
(-22%) 
2.44 ±0.10*' 
(+41%) 
1.97 ±0.05*' 
(+14%) 
1.32 + 0.02 
0.81 ±0.04* 
(-38%) 
1.40 ±0.03' 
(+6%) 
1.59 + 0.01' 
(+20%) 
G6PDH 
{nmols/mg protein/h) 
0.36 + 0.01 
0.48 ±0.01* 
(+33%) 
0.38 + 0.01' 
(+5%) 
0.35 + 0.04' 
(-3%) 
0.27 + 0.01 
0.39 + 0.08* 
(+44%) 
0.32 + 0.01*' 
(+18%) 
0.29 + 0.03' 
(+7%) 
ME 
((.tmols/mg protein/h) 
1.55 + 0.06 
1.18 + 0.07* 
(-24%) 
1.58 + 0.03' 
(+2%) 
1.49 + 0.02' 
(-4%) 
1.02 + 0.01 
0.75 + 0.01* 
(-26%) 
1.15 + 0.03' 
(+13%) 
1.03 + 0.04' 
(+1%) 
Results (specific activities) are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and 
MDH in homogenates of a) intestine and b) liver with SNP treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
SNP 
FOSNP 
FXOSNP 
b) Liver 
Control 
SNP 
FOSNP 
FXOSNP 
HK 
((imols/mg protein/h) 
179.06 ±5.09 
207.51 ±1.71* 
(+16%) 
189.27 ±2.87 
(+6%) 
167.28 ±1.34* 
(-7%) 
41.98 ±0.84 
66.97 ± 0.97* 
(+59%) 
45.23 ±1.03' 
(+8%) 
51.88 + 0.55*' 
(+24%) 
LDH 
(^uiiols/tng protein/h) 
87.19+ 1.34 
112.41+0.89* 
(+29%) 
86.07 + 0.92' 
(-1%) 
78.04 + 0.42' 
(-10%) 
47.09 + 0.82 
63.61 + 1.37* 
(+35%) 
37.17 + 0.94*' 
(-21%) 
50.58+ 1.04' 
(+7%) 
MDH 
(jimols/mg protein/h) 
46.31 + 1.01 
29.23 + 0.88* 
(-37%) 
56.01 + 1.66*' 
(+21%) 
50.87 + 0.96' 
(+10%) 
29.98 + 0.68 
18.77+1.12 
(-37%) 
33.92 + 0.75' 
(+13%) 
35.87 + 0.92*' 
(+20%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 6: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, 
FBPase, G6PDH and ME in homogenates of a) intestine and b) liver with 
SNP treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
SNP 
FOSNP 
FXOSNP 
G6Pase 
(l^mols/mg protein/h) 
1.61 ±0.12 
0.89 ±0.17 
(-45%) 
1.74 ±0.23^ 
(+8%) 
1.88±0.3r 
(+17%) 
FBPase 
(nmols/mg protein/h) 
2.18 ±0.02 
1.62 ±0.09* 
(-26%) 
2.52 ±0.16' 
(+16%) 
2.09 ±0.03* 
(-4%) 
G6PDH 
(|.imols/mg protein/h) 
0.49 ±0.01 
0.63 ± 0.09* 
(+29%) 
o.54±o.or 
(+10%) 
0.38 + 0.01*' 
(-22%) 
ME 
(|.imols/mg protein/h) 
0.85 ± 0.09 
0.69 ± 0.04* 
(-19%) 
0.78 ± 0.02' 
(-8%) 
0.81 ±0.04' 
(-5%) 
b) Liver 
Control 
SNP 
FOSNP 
FXOSNP 
0.67 ±0.05 
0.59 ±0.02 
(-12%) 
0.76 ±0.07' 
(+13%) 
0.70 + 0.01 
(+4%) 
1.43 + 0.13 
1.09 + 0.12 
(-24%) 
1.34 + 0.12' 
(-6%) 
1.30 + 0.06 
(-9%) 
0.38 ±0.03 
0.29± 0.02' 
(-24%) 
0.34 ±0.04 
(-11%) 
0.40 ± 0.09' 
(+5%) 
1.09 ±0.14 
0.75 ±0.08* 
(-31%) 
1.24 ±0.07*' 
(+14%) 
1.16 + 0.04' 
(+6%) 
Results (specific activities) are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
I l l 
ReiuUyll 
O Effect of dietary fish oil and flaxseed oil on SNP induced alterations on marker 
enzymes of BBM and lysosomes in cortical/medullary homogenates and in 
isolated BBMV; 
To assess the structural integrity of certain organelles e.g., plasma membrane (BBM) 
and 1> sosomes, the effect of SNP alone and in combination with FO or FXO diets was 
determined on biomarker enzymes of BBM and lysosomes in the homogenates of 
renal cortex and medulla and isolated BBM preparations from renal cortex. 
a) Effect of SNP alone and with FO or FXO diet on biomarkers of BBM and 
lysosomes in cortical/medullary homogenates: 
The activites of alkaline phosphatase (AlkPase). y-glutamyl transpeptidase (GGTase) 
and leucine aminopeptidase (LAP) and acid phosphatase were determined under 
different experimental conditions in the homogenates of renal cortex and medulla 
(Table 7). SNP treatment to control rats caused significant reduction in the specific 
activities of GGTase (-24%) and LAP (-56%) in cortical homogenates. The prior 
(Ceding of FO or FXO diet with SNP treatment prevented SNP elicited decrease in 
BBM enzyme activities. As can be seen from the data SNP induced decrease in BBM 
enzyme activities were similarly prevented by FO or FXO diet. The activity of acid 
phosphatase (ACPase) was increased (+31%) by SNP in cortical homogenates and 
FO/FXO diet was able to restore the enzyme activity in a similar manner (Table 4). 
The activites of BBM enzymes similar to the cortex were also lowered in the medulla 
by SNP administration although to a lower extent (Table 7). The consumption of 
FO/FXO in combination with SNP treatment resulted in the reversal of SNP induced 
decrease in GGTase (-29%) and LAP (-48%) in the medulla. The activity of ACPase 
was increased (+46%) by SNP. 
b) Effect of SNP and SNP plus FO and FXO diet on BBM markers in isolated 
BBMV: 
The effect of SNP, FO and FXO on BBM marker enzymes was ftirther analyzed in 
BBMV preparations isolated from the renal cortex (Table 8, Figure 19). The data 
shows a similar activity pattern of BBM enzymes as observed in cortical 
homogenates. However the magnitude of the effects was much more pronounced in 
BBMV than in cortical homogenates. Activities of AlkPase (-25%), GGTase (-13%) 
and LAP (-43%) profoundly declined by SNP treatment as compared to control rats. 
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Table 7: Effect of Fish oil (FO) and Flaxseed oil (FXO) on biomarkers of BBM and 
lysosomes in homogenates of a) cortex and b) medulla with SNP treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
SNP 
FOSNP 
FXOSNP 
b) Medulla 
Control 
SNP 
FOSNP 
FXOSNP 
AlkPase 
((.imols/mg protein/h) 
27.56 ±0.95 
41.30±1.2r 
(+50%) 
30.72 ± 0.62' 
(+12%) 
33.61 ±0.93*' 
(+22%) 
14.00 ± 0.76 
16.90 ±1.08* 
(+21%) 
13.37 + 0.70' 
(-4%) 
14.25 ± 1.14' 
(+2%) 
GGTase 
(Hmols/tng protein/li) 
28.63 + 0.51 
21.77 ±0.54* 
(-24%) 
27.60 ±0.67' 
(-4%) 
28.92 + 0.61' 
(+1%) 
17.33 + 0.33 
12.30 ±0.77* 
(-29%) 
19.29 ±0,54' 
(+11%) 
17.05 + 0.44' 
(-2%) 
LAP 
((.imol/mg protein/h) 
5.03 + 0.09 
2.23 + 0.11* 
(-56%) 
6.03 ± 0.0*' 
(+20%) 
5.86 + 0.25*' 
(+17%) 
3.86 + 0.25 
2.01 + 0.30* 
(-48%) 
3.79 +0.10^ 
(-2%) 
4.97 ± 0.29*' 
(+29%) 
ACPase 
(|jmol/mg protein/h) 
12.16 + 0.15 
16.02 + 0.23* 
(+31%) 
10.45 + 0.21' 
(-14%) 
13.35 + 0.33' 
(+10%) 
6.17 + 0.15 
8.99 ± 0.42 
(+46%) 
5.90 + 0.10' 
(-4%) 
5.71+0.07' 
(-7%) 
Results (specific activities) are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
1 1 3 
Fish oil (FO) and flaxseed oil (FXO) dietary supplementation similar to the effect in 
the homogenates appeared to lower the severity of the SNP treatment. SNP-induced 
decrease in BBM enzyme activities was significantly prevented by dietary FO and to 
greater extent by FXO diet. 
5 Effect of dietary fish oil, flaxseed oil and corn oil on SNP induced alterations on 
marker enzymes of BBM and Ivsosomes in mucosal homogenates and in isolated 
BBMV: 
The effect of SNP, FO and FXO was determined on BBM marker enzymes involved 
in terminal digestion and absorption in mucosal homogenates (Table 9) and isolated 
BBMV preparations (Table 10, Figure 20) from rat small intestine. SNP treatment to 
control rats caused significant decrease in AlkPase, GGTase and LAP in mucosal 
homogenates. SNP treatment also resulted in the decrease of ACPase activity. When 
SNP treatment was given to FO/FXO fed rats normalization of the activities of 
AlkPase, GGTase, LAP and sucrase whereas ACPase was partially restored to control 
values. 
The effect of SNP, FO and FXO diets was also observed on BBM marker enzymes in 
isolated BBMV preparations. The results showed a similar activity pattern of various 
enzymes in the BBMV as observed in mucosal homogenates (Table 10, Figure 20). 
SNP treatment profoundly decreased the activities of all BBM enzymes, FO/FXO 
caused significant normalization in the values of AlkPase, GGTase and sucrase. SNP 
induced decrease in the BBMV and lysosomal marker enzymes was not only 
preserved by FO/FXO diets but the activities were restored to near control values. 
O Effect of dietary fish oil and flaxseed oil on SNP induced alterations on marker 
enzymes of BBM and lysosomes in liver homogenates: 
The effect of SNP and FO/FXO diet was also determined on marker enzymes of BBM 
and lysosomes in liver homogenates (Table 9). SNP treatment to rats resulted in 
extensive reduction in the specific activity of GGTase and LAP whereas AlkPase and 
ACPase where increased in the liver homogenates. The feeding of FO and FXO-diet 
to SNP treated (FOSNP/FXOSNP) rats not only prevented SNP elicited changes, but 
the activities of GGTase and LAP were even increased by FO/FXO diet. 
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Table 8: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker enzymes of 
BBM in cortical BBMV with SNP treatment. 
Enzyme 
Groups 
Control 
SNP 
FOSNP 
FXOSNP 
AlkPase 
(|imois/mg protein/h) 
117.38 ±4.06 
87.78 ±1.92* 
(-25%) 
106.65 ±3.88' 
(-9%) 
104.06 ±4.19' 
(-11%) 
GGTase 
(|Limols/mg protein/h) 
195.67 ±4.09 
169.61 ±2.75* 
(-13%) 
234.32 ±0.12*' 
(+19%) 
209.08 ± 1.83' 
(+7%) 
LAP 
()imols/mg protein/h) 
35.54 ±2.46 
20,29 ± 1.03* 
(-43%) 
39.04 ± 1.09' 
(+10%) 
43.07 ±1.27*' 
(+21%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
El Control 0 SNP H FOSNP El FXOSNP 
AlkPase 
'fll?^mii 
GGTase LAP 
Figure 19: Effect of FO and FXO on activities of AlkPase, GGTase and LAP in 
cortical BBM with SNP treatment. 
Above figure is drawn using values from Table 8. Results (pimols/mg 
protein/hour) are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from SNP: 
at p < 0.05 by one way ANOVA. 
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Table 10: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker enzymes of 
BBM in intestinal BBMVs with SNP treatment. 
Enzyme 
Groups 
Control 
SNP 
FOSNP 
FXOSNP 
AlkPase 
(|imols/mg protein/h) 
51.09±1.38 
32.14 ±0.49* 
(-37%) 
45.87 ±2.92^ 
(-10%) 
50.11 ±1.08^ 
(-2%) 
GGTase 
(nmols/mg protein/h) 
46.89 ±2.38 
21.93 ± 1.81* 
(-53%) 
48.56 ±1.96' 
(+4%) 
44.54 ±2.72' 
(-5%) 
LAP 
(|.imols/mg protein/h) 
28.89 ±1.62 
14.07 ±0.49* 
(-52%) 
23.13 ±0.58*' 
(-20%) 
21.87 ±0.89*' 
(-24%) 
Sucrase 
(|imols/mg protein/h) 
287.14 ±5.08 
242.85 ±4.82* 
(-15%) 
307.96 ±6.03' 
(+7%) 
277.92 ± 7.49 
(-3%) 
Results (specific activity expressed as |imoles/mg protein/h) are Mean ± SEM for five 
different preparations. 
* Significantly different from control, tsignificantly different fi-om SNP at p < 0.05 
by one way ANOVA. Values in parentheses represent percent change from control 
Q Control Q SNP ffl FOSNP El FXOSNP 
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Figure 20: Effect of FO and FXO on activities of AlkPase, GGTase and LAP in 
intestinal BBM with SNP treatment. 
Above figure is drawn using values from Table 10. Results (|imols/mg 
protein/hour) are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from SNP: 
at p < 0.05 by one way ANOVA. 
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Effect of dietary fish oil and flaxseed oil on SNP induced alterations in 
antioxidant defense parameters in renal cortex and medulla; 
Primary coniponents of oxidative stress and cellular injury response include elevation 
of lipid peroxidation (LPO), depletion of GSH and suppression of antioxidant 
enzymes [Priyamvada et al, 2008, 2010]. To ascertain the role of antioxidant system 
in SNP-induced toxicity, the effect of SNP observed on oxidative stress parameters. 
SNP enhanced lipid peroxidation (LPO) and significantly altered antioxidant enzymes 
both in cortex and medulla, albeit differently (Table 11). LPO measured in terms of 
malodialdehyde (MDA levels) significantly enhanced in the cortex (+42%) and 
medulla (+75%) to similar extent whereas total-SH declined in these tissue (-22% to -
37%). SNP treatment caused marked increase in superoxide dismutase (SOD, +40%) 
but decrease in Glutathione peroxidase (GSH-Px. -29%) and catalase (-18%) activities 
in the renal cortex. In medulla however the activity of SOD (-87%), catalase (-35%) 
and GSH-Px (-42%) significantly decreased by SNP administration alone. 
Since diet supplemented with FO enriched in co-3 fatty acids has been shown to 
reduce gentamicin/uranyl nitrate induced nephrotoxicity parameters by strengthening 
antioxidant defense mechanism [Priyamvada et al., 2008, 2010], the protective effect 
of both FO and FXO enriched in (0-3 fatty acids was determined on SNP-induced 
oxidative stress parameters. The results indicate that FO and FXO dietary 
supplementation was able to ameliorate the SNP induced oxidative damage in both 
renal cortex and medulla. SNP induced increase in LPO and decrease in total-SH was 
not observed by feeding FO or FXO diet to SNP-treated rats. The activity of catalase 
and GSH-Px in the cortex and medulla remained significantly higher in FO/FXO + 
SNP rats compared to SNP rats. The results indicate marked protection by both 
FO/FXO diet against SNP induced oxidative damage to renal tissues. 
Effect of dietary fish oil and flaxseed oil on SNP induced alterations in 
antioxidant defense parameters in rat intestine: 
The effect of SNP, FO and FXO were determined on various antioxidant parameters 
in mucosal homogenates (Table 12). SNP treatment caused marked increase in SOD 
(+46%) but decrease in catalase (-36%) and GSH-Px (-39%). These changes were 
associated with significant increase in lipid peroxidation (+60%) measured in terms of 
MDA levels and decrease in total-SH (-23%). Both FO and FXO-diet partially 
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prevented SNP-induced alteration in SOD, catalase and GSH-Px activities. SNP 
induced increase in LPO and decreased SH-content were prevented by FO/FXO diet. 
Effect of dietary fish oil and flaxseed oil on SNP induced alterations in 
antioxidant defense parameters in rat liver: 
'['he effect of SNP, FO and FXO-diet was determined on various antioxidant 
parameters in liver homogenates (Table 12). SNP treatment to control rats caused 
marked decrease in SOD (-21%) and GSH-Px (-43%) activities. These changes were 
associated with significant increase in lipid peroxidation (+34%o) and decrease in 
total-SH content (-40%). Both FO/FXO-diets prevented SNP-induced increase in 
SOD and GSH-Px activities whereas catalase was significantly elevated by FO and 
FXO diet when given in combination with SNP treatment. Total-SH and LPO were 
also normalized to near control values. 
Effect of dietary fish oil and flaxseed oil on SNP induced alterations in Na-
gradient dependent transport of ^^ Pi in BBMV isolated from renal cortex: 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent {Naoutside (Nao)>Nainside (Nai)} transport of Pi in renal proximal 
tubule across its luminal brush border membrane (BBM) is an initial and regulatory 
step. The Pi is transported by secondary active transport mechanism, requires 
expenditure of energy in the form of ATP that is generated by cellular metabolism. 
The uptake of ~^Pi was determined in the presence and absence of Na-gradient in the 
initial uphill phase (30s) and after equilibrium at 120min in BBM preparations. The 
rate of concentrative uphill uptake of "'^ Pi in the presence of a Na-gradient (NaCl in 
the medium) was markedly decreased by SNP treatment (Table 13). However, the 
uptake of ''"Pi at the equilibrium phase (120min) when Nao=Nai was not significantly 
different between the two groups. Also Na-independent uptake (in the absence of a Na 
gradient, when NaCl in the medium was replaced by KCl where Ko> Kj) of Pi at 30s 
and 120min was also not affected by SNP treatment indicating specific alterations 
only when Na-gradient was present. When SNP treatment was extended to FO and 
FXO feeding rats, SNP induced decrease in ^^ Pi transport was not observed. 
Moreover, the net uptake of "'^ Pi remained significantly higher in FOSNT and 
FXOSNT rats compared to control rats and much more higher compared to SNT 
treated rats. The effect was specific only in the presence of Na-gradient. The transport 
1 2 1 
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Table 13: Effect of Fish Oil (FO) and Flaxseed oil (FXO) on uptake of 32Pi in brush 
border membrane vesicles (BBMV) from whole cortex with SNP treatment. 
(A) Na*-gradient dependent uptake (Nao>Nai) (pmol/mg protein) 
Group 
Control 
SNP 
FOSNP 
FXOSNP 
(B) K -^gradi 
Group 
Control 
SNP 
FOSNP 
FXOSNP 
30sec 
1698.02 ±54.72 
725.26 ±73.71* 
(-57%) 
2117.01 ±36.49^ 
(+25%) 
2136.39 ±59.63* 
(+26%) 
120min 
354.71 ±48.97 
452.24 ±24.41 
(+27%) 
410.73 + 23.81 
(+16%) 
428.14 + 56.3 
(+20%) 
ent dependent uptake (Ko>K|) (pmol/mg protein) 
30sec 
142.25 ±7.53 
173.36 ± 12.44 
(+21%) 
162.08 ±21.29 
(+14%) 
155.86 ±10.08 
(+10%) 
120min 
373.40 ±2.31 
285.49 ±20.39 
(-23%) 
367.39 ± 11.25 
(-2%) 
413.02 ± 10.67 
(+11%) 
(C) Net Na'-gradient dependent uptake at 30 sec 
Na*-gradient dependent uptake K*-gradient dependent uptake Net uptake (Na*-K*) 
142.25 + 7.53 1555.77 ± 35.64 
173.36+ 12.44 55I.90±9.72* 
(-65%) 
162.08 ±21.29 1954.93 ± 18.76* 
(+26%) 
155.86+10.08 1980.53 ±19.25* 
(+27%) 
Results are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
Group 
Control 
SNP 
FOSNP 
FXOSNP 
a*-gradient depei 
1698.02 + 54.72 
725.26 ±73.71 
2117.01 ±36.49 
2136.39 ±59.63 
1 2 2 
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Table 14: Effect of Fish oil (FO) and Flaxseed oil (FXO) on tissue nitrite concentrations 
in different tissue homogenates with SNP treatment. 
Groups 
Tissues 
Control 
SNP 
FOSNP 
FXOSNP 
Cortex 
(nanomols/gm tissue) 
21.72 ± 1.03 
30.36 ±0.54* 
(+40%) 
24.36 ±0.68'^ 
(+14%) 
23.53 ±0.93^ 
(+8%) 
Medulla 
(nanomols/gm tissue) 
8.34 + 0.63 
14.18 + 0.83* 
(+70%) 
10.04 + 0.77*' 
(+20%) 
11.18 + 0.72*' 
(+34%) 
Intestine 
(nanomols/gm tissue) 
33.14 + 0.96 
47.01 + 1.95* 
(+42%) 
39.06 + 0.81*' 
(+18%) 
37.53+1.75^ 
(+13%) 
Liver 
(nanomols/gm tissue) 
22.71 + 1.07 
31.58 + 0.67* 
(+39%) 
25.48 + 0.42' 
(+12%) 
26.70 + 0.26*' 
(+18%) 
Results are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from SNP at p < 0.05 
b>' one way ANOVA. 
Values in parentheses represent percent change from control 
Control 0 SNP ES FOSNP H FXOSNP 
Cortex Medulla Intestine Lrver 
Figure 20: Effect of FO and FXO on tissue nitrite concentration with SNP 
treatment. 
Above figure is drawn using values from Table 14. Results (nanomoles/gm tissue) 
are Mean + SEM for five different preparations. 
* Significantly different from control, t significantly different from SNT: at p < 0.05 
by one way ANOVA 
1X3 
of Pi in the absence of Na-gradient (i.e. when Ko>K,) and after 120 mins was not 
affected by any of these treatments. 
Effect of dietary fish oil and flaxseed oil on tissue nitrite concentration after SNP 
treatment in different rat tissues: 
Nitrite is the predominant metaboHte of nitric oxide in vivo therefore. The effect of 
SNP. FO and FXO on tissue accumulation of nitrite was determined by the Griess 
reagent assay as described in methods (Table 14; Figure 21). SNP significantly 
increased nitrite accumulation in all tissues however the effect was maximum in renal 
medulla. Both FO and FXO reduced the amount of nitrite in rat tissues. Thus we can 
say that feeding of FO/FXO successfully scavenged excess NO produced by SNP. 
Further we can also say that by improving renal function, renal clearance of nitrite 
was enhanced, which did not let nitrite accumulate in the tissues. 
1 2 4 
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DISCUSSION n 
Nitric oxide (NO) has become one of the most important molecules in the area of 
biological and medical investigation in recent years [Kerwin et al, 1995; Moncada at 
al. 1991: Nathan, 1992]. NO is a ubiquitous, physiologically active molecule involved 
in many biological functions and disease states including vasodilation, endotoxic 
shock, sexual fimction, neurotransmission, cerebral ischemia and inflammation 
[Kerwin et al, 1995; Moncada at al. 1991; Nathan, 1992]. Beckman, 1991 and 
Schimdt et al, 1992have suggested that NO has a double-edged role in specialized 
tissues and cells. This means that NO is not only an important bioregulatory agent but 
may also be an endogenous cytotoxin, mutagenand/or carcinogen. Sodium 
nitroprusside (disodium pentacyanonitrosylferrate(2-) dihydrate, 
Na2Fe(CN)5NO«2H20) comprises of a ferrous ion center complexed with five cyanide 
moieties and a nitrosyl group. SNP spontaneously generates NO, thus functioning as a 
prodrug [Moncada et al, 1991]. Sodium nitroprusside (SNP) is an NO donor 
compound that has been used as an anti-hypertensive agent since the 1920s [Scimdt et 
al, 1992]. Although the data are very limited, it has been shown that long-term use of 
nitrates as donors of nitric oxide has the potential to induce many pathophysiological 
conditions. It has been reported that SNP-induced toxicities are associated with 
increased generation of reactive oxygen species (ROS) [Bastianetto et al, 2000]. 
SNP has been documented to induce genotoxicity as assessed by the measurement of 
micronucleated lymphocytes [Andreassi et al, 2001] and to cause DNA strand breaks 
[Asaka ct al. 1997]. SNP generates ROS during the redox cycling of nitroprusside 
[Ramakrishna et al, 1996]. It is converted to nitrite, NO, cyanide and oxygen free 
radicals such as superoxide and hydroxyl radicals [Ramakrishna et al, 1996]. Since 
SNP is a NO donor, it can also be converted to peroxynitrite (ONOO) and thus can 
cause mutagenesis [Lin et al, 1998]. The potential of SNP to induce apoptosis 
directly from NO liberation has been well established [Feldman et al, 1997]. Thus 
NO and its derivatives (e.g. ONOO) can induce a variety of toxic effects including 
DNA damage, inhibition of DNA synthesis, cell cycle arrest [Wink et al, 1991; 
Nguyen et al, 1992] and inhibition of respiratory chain [Brown and Borutaite, 2002]. 
On the other hand SNP has been shown to induce stimulation of glycolysis and 
glycolytic production of ATP [Maletic et al, 2000]. However it may not be sufficient 
1 2 5 
to compensate decrease in ATP production due to inhibition of oxidative 
phosphorylation. Hence total energy production was found to be decreased by SNP 
and SNP-induced NO formation. Thus, the mitochondria appears to be the primary 
site of SNP effects. 
Several approaches utilizing different mechanisms have been attempted to reduce 
chemical and drug induced nephrotoxicity and other adverse effects. In past few 
years, much interest has been centered on the role of naturally occurring dietary 
substances for the control and prevention of various chronic diseases such as cancer 
and cardiovascular diseases. Omega-3 PUFA have been shown to ameliorate many 
ailments [Simopoulos, 2001; Kromann and Green, 1980; Dyerberg et ai, 1975; Bang 
et al, 1976]. Recent studies have shown that co-3 fatty acids retard the progression of 
various forms of cancers, depression, arthritis, asthma, cardiovascular and renal 
disorders [De Caterina et al, 1994; Kakar et al, 2008]. Recently it has been 
documented that o)-3 fatty acids protects against gentamicin and uranyl nitrate-
induced nephrotoxicity [Priyamvada et al, 2008. 2010]. Attempts were also made to 
reduce SNP-induced toxicity with the use of resveratrol and red wine due to their 
antioxidant properties [Bastianetto et al 2000] and tea [Paquay JBG et al 2000]. 
The present work was designed to study detailed mechanism of SNP-induced 
nephrotoxic alterations and other adverse effects and the possible mechanism by 
which FO/FXO consumption exerts their protective effect in ameliorating SNP 
induced nephrotoxicity. The results show that SNP administration produced a typical 
pattern of nephrotoxicity/hepatotoxicity/gastrotoxicity as indicated by increased Scr, 
BUN accompanied by massive proteinuria, glucosuria and phosphaturia indicating 
that significant kidney damage has occurred and that SNP administration has caused 
alterations in structure and function of renal proximal tubular membrane. FO when 
given for 15 days prior to and during SNP administration prevented SNP induced 
deleterious effects in various blood/urine parameters and enzyme activities of various 
pathways in different rat tissues. SNP-induced increase of Scr/BUN and proteinuria, 
glucosuria and phosphaturia were all absent in FO-fed SNP treated rats. SNP induced 
alterations in various serum and urine parameters were similarly prevented by FXO-
diet when given together with SNP administration. This renoprotective effect was 
possible by the fact that both FO and FXO alone were able to increase serum 
phosphate, serum cholesterol, phospholipids, phosphate and reduce, glucose, and 
1 2 6 
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BUN along with reduction in urinary excretion of Pi and proteins as has been 
described elsewhere [Priyamvada et al, 2008, 2010] 
The reabsorption of Na"^  ions by proximal tubular BBM is considered to be the major 
function of the kidney because the transport of other ions and various solutes depends 
directly or indirectly on Na"*^  reabsorption [Coux et al, 2001]. Since these transport 
depends on structural integrity of BBM and available energy as ATP which is 
supplied by various metabolic pathways it is imperative that any alterations to these 
pathways caused by toxic insult would determine the rate of renal transport functions 
[Khundmiri et al, 2004; 2005; Fatima et al, 2005]. As shown in the "Resuhs", the 
activities of various enzymes in glycolysis, TCA cycle, gluconeogenesis and HMP 
shunt pathway were differentially altered by SNP treatment. SNP caused significant 
increase of LDH and G6PDH activities and decrease in the activities of MDH (TCA 
cycle); G6Pase, FBPase (gluconeogenesis) and ME in both renal cortex and medulla 
albeit to different extent. Although the actual rates of glycolysis and other pathways 
were not determined, however marked decrease in MDH activity indicates an 
impaired oxidative metabolism of glucose/fatty acids that will lead to lower ATP 
production due to mitochondrial dysfunction. These results also indicate a shift in the 
energy metabolism alternatively from aerobic to anaerobic most likely due to 
mitochondrial dysftmction as evident by significant increase in LDH [Banday et al, 
2008a]. The decrease in TCA cycle enzymes may have caused decrease in 
gluconeogenic enzymes. This can be explained by the fact that lower TCA cycle 
enzyme activities especially that of MDH will result in lower oxaloacetete production 
from malate which is required not only for the continuation of TCA cycle but also for 
gluconeogenesis. Thus SNP-induced toxicity appeared to be primarily due to renal 
mitochondrial damage similar to GM/UN/CP induced damage [Priyamvada et al, 
2008. 2010; Kiian et al, 2009 a, b]. 
Dietary FO and FXO were also able to prevent SNP-induced decrease/increase in the 
activities of certain enzymes involved in carbohydrate metabolism both in renal 
cortex and medulla. These protective effects can be attributed to the fact that both FO 
and FXO alone were able to effectively enhance the activities of enzymes 
[Priyamvada et al, 2008, 2010] resulting in overall improvement of carbohydrate 
metabolism in renal tissues similar to those reported in rat liver [Yilmaz et al, 2004]. 
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(0-3 PUFA have been shown to coordinately regulate the expression of several 
enzymes involved in carbohydrate and lipid metabolism [Yoshida et al, 2001]. 
Since BBM of renal proximal tubules and other intracellular organelles such as 
mitochondria and lysosomes are known targets of free radicals [Cronin and Henrich, 
1996], the structural and functional integrity was assessed by the status of their 
respective biomarker enzymes. SNP caused significant decrease in the activities of 
AlkPase. GGTase and LAP (BBM enzymes) in cortical homogenates and to a much 
greater extent in BBMV preparations. The decrease in BBM enzyme activities might 
have occurred due to loss of BBM enzyme and other components into lumen followed 
by their excessive excretion in the urine as reported earlier [Banday et al, 2008a; 
Priyamvada et al, 2008, 2010]. A marked reduction observed in Na-dependent 
transport of ^^ Pi also supports SNP induced severe damage to BBM of renal proximal 
tubules. However, SNP caused significant increase in ACPase activity both in the 
cortex and medulla. Taken together the present results show that SNP treatment 
indeed significantly altered the structural integrity and functional capacity of renal 
proximal tubules and particularly BBM and lysosomes as reflected by marked 
decrease in the activities of BBM enzymes: AlkPase, GGTase, LAP, Na-dependent 
transport of ^^ Pi across renal BBM and increase in lysosomal enzyme ACPase and 
certain specific alteration in the enzyme sof carbohydrate metabolism. 
It has been shown that dietary fatty acids incorporate in the cellular membranes 
altering structural integrity and functional capacity of plasma membrane and other 
organelles leading to altered cellular metabolic activities and those of membrane 
associated enzymes [Brasitus et al, 1985; Thakkar el al, 2000; Carrillo-Tripp and 
Feller. 2005]. Dietary FO/FXO given together with SNP not only prevented/retarded 
SNP-induced decrease of BBM enzymes but the activity of AlkPase and/or GGTase 
remained higher in FOSNP and FXOSNP than control rats in the BBM. Both 
FO/FXO also resulted in significant increase of ^'Pi transport across the renal BBM in 
SNP treated rats. Thus FO and FXO caused reversal of SNP induced alterations 
because FO/FXO alone have the intrinsic capability to significantly enhance AlkPase 
and GGTase activity and Pi transport by themselves suggestive of an overall 
improvement in renal BBM integrity by FO/FXO diet thus, preventing the loss either 
by lessening the damage caused by SNP or by increasing the regeneration process or 
both [Masters, 1996; Ozgocmen et al, 2000]. It appears from the data that SNP by 
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lowering oxidative metabolism lowers ATP production whereas dietary FO/FXO 
supplementation increased ATP production by increasing the metabolic activities to 
support many cellular functions especially in the kidney. Further, FO/FXO-diets 
increased the renal Pi transport suggestive of coo PUFA induced Pi conservation by 
the kidneys that maintains and/or improves metabolic activities of not only kidney but 
also of other tissues. 
In contrast to kidney, SNP exerted differential effects on the enzymes of carbohydrate 
metabolism and BBM in the intestine and liver. As observed earlier for GMAJN/CP 
induced toxicity [Priyamvada et al, 2008, 2010; Khan et al.,2009 a, b] the activity of 
sucrase was significantly increased whereas AlkPase, GGTase and LAP decreased by 
SNP treatment in intestinal and liver homogenates. SNP also caused significant 
increase in LDH and G6PDH but decreased MDH, ME and ACPase activities in 
mucosal and liver homogenates. Due to the down-regulation of LDH by SNP, 
anaerobic glycolysis remained the major source of energy as reported earlier for rat 
intestine [Farooq et al., 2004]. Thus when SNP treatment was extended to FO/FXO 
fed rats. SNP induced decrease/increase were not observed and the activities of almost 
all metabolic enzymes further improved. 
Excessive production/accumulation of NO always has the ability to result in the 
formation of other reactive intermediates of nitrogen. Reactive nitrogen species 
(RNS) produce cellular injury and necrosis via several mechanisms including 
peroxidation of membrane lipids, proteins and DNA [Dawson and Dawson, 1996]. 
Several studies have shown that NO-induced toxicity is engendered by its reaction 
with superoxide radical to yield the highly toxic ROS peroxynitrite. Peroxynitrite then 
decomposes to form nitrogen dioxide and the hydroxyl free radical that leads to lipid 
peroxidation, protein oxidation and DNA damage [Dawson and Dawson, 1996]. A 
major cellular defense against free radicals is provided by SOD and catalase, which 
together convert superoxide radicals first to H2O2 and then to molecular oxygen and 
water. Other enzymes e.g. GSH-Px use thiol-reducing power of glutathione to reduce 
oxidized lipids and protein targets of RNS. The present results show that SNP 
administration to control rats caused severe damage to renal tissues most likely by 
RNS/ROS generation as apparent by altered activities of above antioxidant enzymes 
and total-SH content that resulted in increased lipid peroxidation. As consisitent with 
previous studies, catalase and GSH-Px were inhibited by SNP induced NO production 
» 9 ^"^ 
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[Brown. 1995; Asahx et ai, 1995]. Enhanced LPO may result in protein damage and 
inactivation of membrane bound enzymes either through direct attack by free radicals 
or through chemical modification by its end product (malondialdehyde) [Halliwell 
and Gutteridge, 1999]. Thus, observed increase in LPO could provide an additional 
explanation for decreased activities of BBM enzymes and other proteins. 
SNP decreased the activities of antioxidant enzymes in association with increased 
LPO and decreased total-SH in small intestine similarly as observed in renal tissues. 
However, SNP induced increase in LPO was associated with concomitant decrease in 
total-SH most likely due to SNP induced decrease in the activity of SOD and GSH-Px 
in the liver. The feeding of FO-diet to SNP treated rats prevented SNP-induced 
augmentation of LPO and suppression of antioxidant enzyme activities. Similar 
protection was also extended by FXO-diet. 
The protection against SNP induced renal dysfunction and decline in activities of 
BBM enzymes by FO and FXO can be attributed to their intrinsic biochemical and 
natural antioxidant properties. The (o-3 fatty acids possess antioxidant enhancing 
activity thereby raising the efficiency of antioxidant defence system [Ruiz-Gutierrez 
et al.. 1999; Komatsu et ai, 2003]. These observations were recently confirmed by 
Priyamvada et al., 2008, 2010]. 
As can be seen from the results, feeding of FO and FXO alone caused significant 
normalization of SOD, catalase and GSH-Px activities accompanied by lower LPO 
values in renal tissues. Thus it appears FO and FXO enriched in co-S fatty acids 
enhanced resistance to free radical attack generated by SNP administration similiarly 
as demonstrated in lupus nephritis and other pathologies [Chandrasekar and 
Femandes, 1994; Donadio, 2001] including Crohn's disease, ulcerative colitis and 
gastric ulceration [Manjari and Das, 2000; Barbosa el al., 2003; Bhattacharya et al., 
2006]. Dietary FO supplementation has also been shown to strengthen antioxidant 
defense mechanism in the plasma of normal rats [Erdogan et ai, 2004]. FXO must 
have elongated and further desaturated to EPA and/or DHA to exert similar protective 
effects as reported earlier in protection against cylophasphamide and radiation 
induced oxidative stress [Bhatia et ai, 2006; 2007]. 
Recently dietary fish oil has been shown to protect against acetaminophen 
(paracetamol)-induced hepatotoxicity [Speck and Lauterburgh, 1991], ethanol-
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induced gastric mucosal injury [Leung, 1992] in rats, a number of inflammatory 
diseases including lupus nephritis [Chandrasekar and Femandes, 1994], IgA 
nephropathy [Donadio, 2001] and murine AIDS [Xi and Chen, 2000]. Recent reports 
also showed partial protection by dietary FO/co-3 fatty acids against 
GM/cyclosporine/UN induced nephrotoxicity [Ali and Bashir, 1994; Thakkar et al, 
2000; Priyamvada et al, 2008, 2010] however, mechanism involved was not studied 
in detail. Our results thus support the rationale that co-3 fatty acids enriched FO and 
FXO may be an effective dietary supplementation in the management of SNP induced 
nephrotoxicity and other pathologies in which antioxidant defense mechanism are 
decelerated. 
The present biochemical studies clearly demonstrate that long-term SNP 
administration produces severe nephrotoxicity and causes profound damage to plasma 
membranes, mitochondria, peroxisomes etc. of renal proximal tubules. The enzymes 
of oxidative carbohydrate metabolism and gluconeogenesis; BBM, antioxidant 
defense mechanism and ^^ Pi transport capacity appeared to be severely affected by 
SNP treatment. Most of the SNP induced effects can be attributed to NO because SNP 
is a potential NO-donor. In contrast, FO and FXO, major source of co-3 fatty acids by 
altering membrane fatty acid composition appeared to affect membrane organization 
and functions. Both FO and FXO appear to accelerate repair and/or regeneration of 
injured organelles e.g. mitochondria, peroxisomes and increased activity of TCA 
cycle and BBM as evident by increased activities of the enzymes of carbohydrate 
metabolism. Most importantly, by activating endogenous antioxidant defense 
mechanism FO and FXO provided protection from SNP induced free radical attack. 
F0/a)-3 fatty &cids targeted cell cycle regulation/cell signaling may also underlie its 
protective effects [Yusufi et al, 2003]. 
We conclude that while SNP elicited deleterious nephrotoxic/hepatotoxic/gastrotoxic 
effects by causing severe damage to renal mitochondria, brush border membrane and 
other organelles and by suppressing antioxidant defense mechanism, dietary 
supplementation with fish/flaxseed oil enriched in co-3 fatty acids caused 
improvement in nutrition/energy metabolism, BBM integrity. Pi transport capacity 
and antioxidant defenses and thus prevented SNP induced various deleterious effects. 
Since SNP is a NO donor, most of these effects can be attributed to NO induced 
RNOS formation. Based on our present observations and already known health 
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benefits we propose that dietary fish/flaxseed oil supplementation may provide a 
cushion for a prolonged therapeutic option against SNP nephropathy and other 
adverse alterations without harmful side effects. 
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O HYPOTHESIS Ml: 
Fish oil (FO) and flcaseed oil (FXO) enriched in co-3 fatty acids would similarly 
protect against ARG induced deleterious effects in different rat tissues. 
O EXPERIMENTAL DESIGN Hit 
As shown in Figure 22, initially four groups (viz Control, ARG, FOARG and 
FXOARG) of rats (10 rats/group) entered the study after acclimatization. They were 
fed on normal diet (control/ARG) or diet containing 15% fish oil (FOARG), 15% 
flaxseed oil (FXOARG). ARG (500 mg/kg bwt/d) was administered intraperitonealy 
in 0.9% saline daily for 10 days to the groups designated as ARG, FOARG and 
FXOARG. Control animals received an equivalent volume of normal saline for the 
same period. The rats were sacrificed 24 h after the last injection imder light ether 
anesthesia. Blood was withdrawn from left jugular vein and serum was separated by 
centrifugation at 2000 x g for 10 min. Urine samples were collected for 4 h in 
standard metabolic cages a day before the sacrifice of rats. The kidneys, intestine and 
liver were extracted and processed for the preparation of homogenates and brush 
border membrane vesicles (BBMV) as described in "Methods". Body weights of rats 
were recorded at the start and completion of experimental procedure. 
O RESULTS III: 
O Effect of dietary fish oil and flaxseed oil on ARG induced deleterious effects in 
serum and urine parameters: 
In general the rats remained clinically well throughout the study. There was no 
significant difference in daily food intake and body weights between control and other 
experimental rats (data not shown). ARG treatment to control rats resulted in 
significant increase in serum creatinine (Scr), blood urea nitrogen (BUN), glucose and 
phospholipids but decrease in inorganic phosphate (Pi) compared to control rats 
(Table 1). These changes where associated with profound phosphaturia, proteinuria 
and glucosuria (Table 2) accompanied by decrease in creatinine clearance (Table 2). 
Feeding of FO or FXO diet to ARG administered (FOARG and FXOARG) rats 
resulted in significant reversal of various ARG elicited deleterious effects on serum 
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and urine parameters. Both FO and FXO diets prevented ARG-induced increase of 
Scr. BUN, glucose and renal functions in a similar manner as evident by the increase 
of creatinine clearance and decrease in the excretion of protein, phosphate and 
glucose in the urine (Table 2). 
Effect of dietary fish oil and flaxseed oil on ARG induced alterations in 
metabolic enzyme activities in renal cortex, medulla, small intestine and liver: 
The main function of kidney i.e. reabsorption of various ions and solutes depends on 
the continuous energy supply as ATP which is generated by various metabolic 
pathways including glycolysis and oxidative metabolism. The acute renal failure 
produced by toxic insuh results in reduced oxygen consumption due to damage 
caused to mitochondria and other organelles. The effect of ARG, FO, FXO and MO-
diets and their combined treatment was determined on the activities of various 
enzymes of carbohydrate metabolism involved in glycolysis, TCA cycle, 
gluconeogenesis and HMP shunt pathway in kidney, small intestine and liver (Table 
3. 4. 5. 6). 
(a) Effect on carbohydrate metabolism in renal cortex: 
As shown in Table 3 and 4, ARG treatment to control rats significantly increased the 
activity of lactate dehydrogenase (LDH) and hexokinase (HK) but decreased malate 
dehydrogenase (MDH), glucose-6-phosphatase (G6Pase) and fructose-1, 6-
bisphosphatase (FBPase) activities in the renal cortex (Table 3, 4). When ARG 
treatment was extended to FO and FXO-fed rats, ARG-induced alterations in 
metabolic enzyme activities were not only prevented by FO and FXO diets, but MDH 
remained significantly higher in FOARG compared to control as well as ARG rats in 
the renal cortex. 
rhe effect of FO, FXO and ARG combined was also determined on glucose-6-
phosphate dehydrogenase (G6PDH) and NADP-malic enzyme (ME), source of 
NADPH production needed in various anabolic reactions (Table 4). ARG treatment to 
control rats significantly increased G6PDH but decreased ME activity. ARG elicited 
increase of G6PDH activity was normalized to near control values by both FO and 
FXO diets. ARG induced ME activity decrease was arrested by both FO and FXO 
diet. 
135 
.
.
.
 
\li
 
~
 
T
ab
le
 1
: 
E
ff
ec
t o
f E
ff
ec
t o
f F
ish
 o
il 
(F
O)
 an
d 
Fl
ax
se
ed
 o
il 
(F
XO
) o
n
 s
er
u
m
 p
ar
am
et
er
s w
ith
 L
-A
rg
in
in
e 
(A
RG
) t
re
at
m
en
t. 
G
ro
up
 
C
re
at
in
in
e 
BU
N 
C
ho
le
st
er
ol
 
Ph
os
ph
ol
ip
id
 
Ph
os
ph
at
e 
G
ro
up
s 
(m
gld
l) 
(m
g!
dl)
 
(m
g!
dl)
 
(m
gld
l) 
(J.
Ul
lol
s/m
l) 
C
on
tr
ol
 
1.
00
 ±
 0
.0
2 
16
.0
2 
±
 0
.0
5 
11
1.
46
 ±
 2
. 9
3 
11
.9
2 
±
 0
.7
0 
1.
83
 ±
 0
.0
1 
1.
28
 ±
 0
.0
3·
 
•
 
I 0
2.
08
 ±
 2
.5
5 
•
 
1.
33
 ±
0.
02
. 
A
R
G
 
20
.6
4 
±
0.
66
 
14
.4
4 
±
 0
.5
3 
(+
28
%
) 
(+
29
%
) 
(-8
%)
 
(+
21
%
) 
(-2
7%
) 
FO
A
R
G
 
o
.7
o5
 ±
 o
.o
1·
t 
14
.2
8 
±
 0
.3
2 
t 
11
3.
66
 ±
 4
.4
 
10
.7
5 
±
 0
.7
2t
 
2.
67
 ±
 0
.1
8•
t 
(-2
9%
) 
(-1
1%
) 
(+
2%
) 
(-1
0%
) 
(+
46
%)
 
FX
O
A
R
G
 
o
.7
6 
±
 o
.o
2·
t 
14
.2
2 
±
 0
.2
1t
 
10
8.
79
 ±
 2
.9
6 
9.
82
 ±
 I
.s
tt
 
2.
24
 ±
 0
.1
9•
t 
(-2
4%
) 
(-1
1 %
) 
(-2
%)
 
(-1
8%
) 
(+
22
%)
 
R
es
ul
ts
 a
re
 M
ea
n±
 S
EM
 fo
r f
iv
e 
di
ff
er
en
t p
re
pa
ra
tio
ns
. 
Si
gn
ifi
ca
nt
ly
 d
iff
er
en
t f
ro
m
 c
o
n
tr
ol
, t
si
gn
if
ic
an
tly
 d
iff
er
en
t f
ro
m
 A
RG
 a
t 
p 
<
 0
.0
5 
by
 o
n
e 
w
ay
 A
N
O
V
 A
. 
V
al
ue
s 
in
 p
ar
en
th
es
es
 re
pr
es
en
t p
er
ce
nt
 c
ha
ng
e 
fr
om
 c
o
n
tr
ol
. 
G
lu
co
se
 
(m
g!
dl)
 
88
.8
5 
±
 1
.4
3 
63
.2
1 
±
 0
.8
· 
(-2
9%
) 
82
.3
 ±
 0
.8
9t
 
(-7
%)
 
76
.0
 ±
 0
.0
34
t 
(-1
4%
) 
I ~ ..., 
KeiuUyllJ 
I I 
< 
I 
fc. 
W 
V 
s 
u 
08 a 
B 
•c 
s 
B 
O 
o 
a 
o 
e 
-«• 
w 
is 
it 
H 
u 
.S 
« .S 
S s 
E 
a <° 
« o 
O ^ 
ia O 
E 
E 
CO 
O 
-H 
O -H "=> 
o +^  
en 
1 ^ 
ON 
d 
-H 
08 ^ g 
«-^ '5 © o g 
^ 3; 
rn 
O 
d 
-H 
m W-l 
d 
OJ JO 
• S a l 
i 21 
u " ^ 
o 
d d 
+ 
O 
d 
-H 
so 
d 
+ 
o 
d 
-H 
00 
o 
d 41 0\ 
<U 
4) 
s 
08 
es 
a s o 
a 
o 
<N 
00 
-H ^ 
2 
a 
o 
d C? 
-H ^ 
I 
ON ^ ^ 
rn 
VO 
O v? 
o 
d 
O ^^ 
-H VO 
OS + 
VO 
d 
-H 
o 
VO 
vS 
OS 
o 
o d 
•M 
(N 
'^ d 
^^  
^ 
o^ (N 
1 
^ + 
CO p 
rn 
-H 
00 + 
o 
o 
X 
< 
> 
o 
< 
CO 
c 
o 
X) 
o 
d 
V 
a 
o 
(/5 J J O 
u 
> 
o 
2 
c o o 
S 
o 
-^ 'h 
^ g 
a 
c 
CO 
2 a u 
u. 
U 
1/1 
Si I 
0) -w ex 
Jg § n 
ill 
Oil c/o > 
137 
H4iiultyni 
Table 3: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and 
MDH in homogenates of a) cortex and b) medulla with L-Arginine (ARG) 
treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
ARG 
FOARG 
FXOARG 
b) Medulla 
Control 
ARG 
FOARG 
FXOARG 
HK 
(|amols/mg protein/h) 
88.09 ±0.76 
107.91 ±0.08* 
(+23%) 
97.47 ±0.37* 
(+11%) 
101.28 ±0.12** 
(+15%) 
42.63 ± 0.69 
53.21 ±0.77* 
(+25%) 
40.03 ± 0.70* 
(-6%) 
39.61 ±0.16* 
(-7%) 
LDH 
(|.imols/mg protein/h) 
23.35±0.45 
27.69 ±0.29* 
(+19%) 
25.48 + 0.35* 
(+9%) 
24.21+0.28* 
(+4%) 
37.63 ±0.12 
43.92 ±0.51* 
(+17) 
39.17 + 0.08* 
(+4%) 
41.31+0.43 
(+10%) 
MDH 
(nmols/mg protein/li) 
83.74 + 0.16 
63.81 ±0.15* 
(-24%) 
98.74 ±0.14** 
(+18%) 
93.83 + 0.17* 
(+12%) 
86.57 + 0.27 
70.02 + 0.19* 
(-19%) 
85.25 ±0.41* 
(-2%) 
89.21 ±0.17* 
(+3%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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(b)Effect on carbohydrate metabolism in renal medulla: 
The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by ARG treatment (Table 3, 4) as in the cortical homogenates. 
Feeding of FO and FXO to ARG treated rats prevented ARG induced alterations in 
various enzyme activities. Similar to cortex, G6PDH activity increased whereas ME 
activity decreased by ARG in the medulla (Table 4). FO and FXO diet to ARG treated 
rats decreased G6PDH activity and increased ME activity 
(c)Effect on carbohydrate metabolism in small intestine: 
The effect of ARG and dietary oils was also determined on the enzymes of 
carbohydrate metabolism in mucosal homogenates from different experimental rats 
(Table 5, 6). ARG treatment to control rats caused significant increase in LDH 
(+26%) but decrease in MDH activities. ARG caused significant decrease in 
gluconeogenic enzyme, G6Pase in the intestine. The activity of G6Pase remained 
significantly higher after ARG treatment to FO and FXO-fed rats compared to control 
rats reversing the ARG-induced decrease in its activity. ARG-induced decline in 
MDH activity was also restored by both FO and FXO-diets. 
The effect of ARG and dietary FO/FXO was also determined on G6PDH and malic 
enzyme (ME), sources of NADPH (Table 6). The activity of G6PDH significantly 
increased (+24%) but that of ME decreased (-39%) by ARG treatment compared to 
control rats. However, when ARG treatment was given to FO/FXO diet fed rats, ARG 
induced increased in G6PDH and decrease in ME activities were not observed 
indicating that both FO and FXO diet significantly prevented the alterations caused by 
ARG. 
(d)Effect on carbohydrate metabolism in liver: 
In addition to the kidney and intestine, the effect of ARG and FO/FXO combinations 
was also observed in rat liver homogenates. ARG treatment significantly increased the 
activities of LDH (+41%), HK (+35%) and G6PDH (+50%) whereas decreased 
G6Pase. MDH and ME activities in the liver (Table 5, 6). When ARG treatment was 
extended to FO-fed rats, ARG-induced decrease of metabolic enzyme activities was 
prevented by FO and FXO. 
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Table 4: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, 
FBPase, G6PDH and ME in homogenates of a) cortex and b) medulla 
with L-Arginine (ARG) treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
ARG 
FOARG 
FXOARG 
b) Medulla 
Control 
ARG 
FOARG 
FXOARG 
G6Pase 
(l^mols/mg protein/h) 
0.66 ±0.93 
0.57 ±0.25* 
(-14%) 
o.68±o.or 
(+3%) 
0.62 ±0.08 
(-7%) 
0.69 ± 0.42 
0.56 ±0.71' 
(-19%) 
0.76 ±0.08* 
(+10%) 
0.73 ± 0.02' 
(+6%) 
FBPase 
(nmols/mg protein/h) 
1.99 ±0.62 
1.61 ±0.34* 
(-19%) 
2.16 ±0.08' 
(+9%) 
2.26 ± 0.07' 
(+14%) 
1.58 ±0.80 
1.37 ±0.45 
(-13%) 
1.54 ±0.06' 
(-3%) 
1.62 ±0.05' 
(+3%) 
G6PDH 
(|.iinols/mg protein/h) 
0,35±0.84 
0.43 ± 0.99* 
(+22%) 
0.33 ±0.02' 
(-6%) 
0.31±0.0r 
(-11%) 
0.27 ±0.36 
0.38 ±0.32* 
(+40%) 
0.28 ± 0.02' 
(+4%) 
0.31+0.34^ 
(+15%) 
ME 
(nmols/mg protein/h) 
1.38+1.65 
0.98 + 0.13* 
(-28%) 
1.25 ±0.63' 
(-9%) 
1.34 ±0.03' 
(-3%) 
1.02 + 0.02 
0.68 ± 0.78* 
(-33%) 
0.89 ± 0.06' 
(-13%) 
0.86 ±0.91' 
(-16%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, fsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 5: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of HK, LDH and 
MDH in homogenates of a) intestine and b) liver with L-Arginine (ARG) 
treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
ARG 
FOARG 
FXOARG 
b) Liver 
Control 
ARG 
FOARG 
FXOARG 
HK 
(nmols/mg protein/h) 
188.56 ±2.09 
213.50±1.38 
(+13%) 
179.50 ± 0 . 3 r 
(-5%) 
201.78 ±0.93* 
(+7%) 
49.33 ± 0.94 
66.48 ±1.17* 
(+35%) 
45.03 ±0.53* 
(-9%) 
44.61 ±0.15* 
(-10%) 
LDH 
(|jmols/mg protein/h) 
71.29±0.14 
89.83 ±1.13* 
(+26%) 
78.408 ± 0.23* 
(+10%) 
75.61+0.19* 
(+6%) 
55.33 + 0.225 
77.82 ±0.07* 
(+41) 
61.17 + 0.86* 
(+11%) 
63.45 + 0.93* 
(+15%) 
MDH 
(nmols/mg protein/h) 
38.41+0.22 
33.42 ±0.27* 
(-13%) 
37.41 ± 0.24 
(-3%) 
39.13 ±0.23 
(+2%) 
36.98+ 0.24 
28.63 ±0.18* 
(-22%) 
32.65 ±0.17* 
(-11%) 
31.74±0.18 
(-14%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 6: Effect of Fish oil (FO) and Flaxseed oil (FXO) on activities of G6Pase, 
FBPase, G6PDH and ME in homogenates of a) intestine and b) liver with 
L-Arginine (ARG) treatment. 
Enzyme 
Groups 
a) Intestine 
Control 
ARG 
FOARG 
FXOARG 
G6Pase 
((^mol/mg protein/h) 
1.89 ±0.08 
1.53 ±0.46* 
(-19%) 
1.99 ±0.78' 
(+5%) 
1.87±0.2r 
(-1%) 
FBPase 
(nmol/mg protein/li) 
2.43 ± 0.292 
2.13 ±0.64 
(-12%) 
2.65 ±0.23' 
(+9%) 
2.77 ±0.97* 
(+14%) 
G6PDH 
(|.imol/mg protein/h) 
0.59 ±0.98 
0.73 ± 0.02* 
(+24%) 
0.58 ± 0.27' 
(-1%) 
0.49 ± 0.34*' 
(-17%) 
ME 
(jjmol/mg protein/h) 
6.39 ±0.47 
3.91 ±0.03' 
(-39%) 
6.21 ±0.23' 
(-3%) 
6.78 ± 0.02' 
(+6%) 
b) Liver 
Control 
ARG 
FOARG 
FXOARG 
12.84 + 0.09 
9.65 ±0.01* 
(-25%) 
11.39 ±0.43' 
(-11%) 
11.60 ±0.88' 
(-10%) 
45.84 ±0.18 
41.64 ±0.05 
(-9%) 
46.98 ±1.42 
(+2%) 
48.23 ± 0.45' 
(+5%) 
0.32 + 0.07 
0.48 ±0.18* 
(+50%) 
0.38 + 0.36*' 
(+19%) 
0.31+0.02' 
(-3%) 
0.93 + 0.21 
0.76 + 0.09* 
(-18%) 
0.89 + 0.01' 
(-4%) 
1.04 + 0.02' 
(+12%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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0 Effect of dietary fish oil and flaxseed oil on ARG induced alterations on marker 
enzymes of BBM and Ivsosomes in cortical/medullary homogenates and in 
isolated BBMV: 
To assess the structural integrity of certain organelles e.g., plasma membrane (BBM) 
and lysosomes, the effect of ARG alone and in combination with FO or FXO diets 
was determined on biomarker enzymes of BBM and lysosomes in the homogenates of 
renal cortex and medulla and isolated BBM preparations from renal cortex. 
a) Effect of ARG atone and with FO or FXO diet on biomarkers of BBM and 
lysosomes in cortical/medullary homogenates: 
The activites of alkaline phosphatase (AlkPase), y-glutamyl transpeptidase (GGTase) 
and leucine aminopeptidase (LAP) and acid phosphatase were determined under 
different experimental conditions in the homogenates of renal cortex and medulla 
(Table 7). ARG treatment to control rats caused significant reduction in the specific 
activities of AlkPase (-28%), GGTase (-15%) and LAP (-29%) in cortical 
homogenate. The prior feeding of FO or FXO diet with ARG treatment prevented 
ARG elicited decrease in BBM enzyme activities. As can be seen from the data ARG 
induced decrease in BBM enzyme activities were similarly prevented by FO or FXO 
diet. The activity of acid phosphatase (ACPase) was also decreased (-17%) by ARG 
in cortical homogenates and FO/FXO diet was able to prevent the decrease in enzyme 
activity in a similar manner (Table 7). 
The activites of BBM enzymes similar to the cortex were also lowered in the medulla 
by ARG administration (Table 7). The consumption of FO/FXO in combination with 
ARG treatment resulted in the reversal of ARG induced decrease in GGTase (-22%) 
and LAP (-40%) in the medulla. The activity of ACPase was also lowered by ARG (-
16%). However it was found to be higher in ARG+FO rats (+19%) compared with the 
control rats. 
b) Effect of ARG and ARG plus FO and FXO diet on BBM markers in isolated 
BBMV: 
The effect of ARG, FO and FXO on BBM marker enzymes was ftirther analyzed in 
BBMV preparations isolated from the renal cortex (Table 8, Figure 23). The data 
shows a similar activity pattern of BBM enzymes as observed in cortical 
homogenates. However the magnitude of the effects was much more pronounced in 
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Table 7: Effect of Fish oil (FO) and Flaxseed oil (FXO) on biomarkers of BBM and 
lysosomes in homogenates of a) cortex and b) medulla with L-Arginine 
(ARG) treatment. 
Enzyme 
Groups 
a) Cortex 
Control 
ARG 
FOARG 
FXOARG 
b) Medulla 
Control 
ARG 
FOARG 
FXOARG 
AlkPase 
{|imoIs/mg protein/h) 
23.35 ±0.62 
16.81 ±0.62* 
(-28%) 
26 .51±l . i r 
(+14%) 
28.22 ± 0.60*^ 
(+21%) 
17.83 + 0.44 
15.74 ±0.79 
(-12%) 
23.73 + 0.53*' 
(+33%) 
19.39 + 0.38' 
(+9%) 
GGTase 
(nmols/mg protein/h) 
32.43 + 0.21 
24.93 ± 0.58* 
(-27%) 
48.93 ± 0.62*' 
(+51%) 
39.99 + 0.35' 
(+23%) 
12.11+0.56 
9.67 + 0.35* 
(-20%) 
14.34 + 0.46*' 
(+18%) 
14.85 + 0.68*' 
(+23%) 
LAP 
(nmols/mg protein/h) 
4.62 ± 0.22 
3.26 + 0.12* 
(-29%) 
4.88 + 0.91* 
(+6%) 
4.512 + 0.17' 
(-2%) 
4.03 ± 0.60 
2.38 + 0.64* 
(-40%) 
3.78 ±0.61' 
(-6%) 
3.43 ± 0.80' 
(-15%) 
ACPase 
(nmols/mg protein/h) 
11.12 + 0.02 
9.18 + 0.39* 
(-17%) 
9.82 + 0.08' 
(-11%) 
10.29 ±0.75' 
(-7%) 
8.29 ±0.13 
6.99 ±0.52* 
(-16%) 
9.87 ±0.77*' 
(+19%) 
8.61 ±0.34' 
(+4%) 
Results (specific activities) are Mean + SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 8: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker 
enzymes of BBM in cortical BBMVs with L-Arginine (ARG) treatment. 
Enzyme 
Groups 
Control 
ARG 
FOARG 
FXOARG 
AlkPase 
(nmols/mg protein/h) 
107.64 ±0.420 
57.63 ± 0.22* 
(-47%) 
113.86 ±1.04^ 
(+6%) 
124.65 ± 0.2 F 
(+16%) 
GGTase 
(|imols/mg protein/h) 
237.24 ±2.01 
129.63 ±3.52* 
(-45%) 
219.89 ±2.63^ 
(-7%) 
229.54 ± 1.68^  
(-3%) 
LAP 
(nmols/mg protein/h) 
33.62 ±0.29 
20.01 ±0.86' 
(-40%) 
36.63 ± 0.29^ 
(+9%) 
38.01 ±0.48^ 
(+13%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different firom control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Figure 23: Effect of FO and FXO on activities of AlkPase, GGTase and LAP 
in cortical BBM with L-Arginine (ARG) treatment. 
Above figure is drawn using values from Table 8. Results (jimols/mg 
protein/hour) are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from ARG: 
at p < 0.05 by one way ANOVA. 
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BBMV than in cortical homogenates. Activities of AlkPase (-47%), GGTase (-45%) 
and LAP (-40%) profoundly declined by ARG treatment as compared to control rats. 
Fish oil (FO) and flaxseed oil (FXO) dietary supplementation similar to the effect in 
the homogenates appeared to lower the severity of the ARG treatment. ARG-induced 
decrease in BBM enzyme activities was significantly prevented by dietary FO and to 
greater extent by FXO diet. 
!> Effect of dietary fish oil and flaxseed oil on ARG induced alterations on marker 
enzymes of BBM and Ivsosomes in mucosal homogenates and in isolated BBMV; 
The effect of ARG, FO and FXO was determined on BBM marker enzymes involved 
in terminal digestion and absorption in mucosal homogenates (Table 9) and isolated 
BBMV preparations (Table 10, Figure 24) from rat small intestine. ARG treatment to 
control rats caused significant decrease in AlkPase, GGTase and LAP in mucosal 
homogenates. ARG treatment also resulted in the decrease of ACPase activity. When 
ARG treatment was given to FO/FXO fed rats normalization of the activities of 
AlkPase. GGTase, LAP and sucrase whereas ACPase was partially restored to control 
values. 
The effect of ARG, FO and FXO diets was also observed on BBM marker enzymes in 
isolated BBMV preparations. The results showed a similar activity pattern of various 
enzymes in the BBMV as observed in mucosal homogenates (Table 10, Figure 24). 
ARG treatment profoundly decreased the activities of all BBM enzymes but sucrase 
which was elevated, FO/FXO caused marked increase in AlkPase and GGTase 
whereas LAP and sucrase activities were significantly normalized by both FO/FXO 
diets. ARG induced decrease in the BBMV and lysosomal marker enzymes was not 
only preserved by FO/FXO diets but the activities were restored to near control 
values. 
O Effect of dietary fish oil and flaxseed oil on ARG induced alterations on marker 
enzymes of BBM and lysosomes in liver homogenates: 
The effect of ARG and FO/FXO diet was also determined on marker enzymes of 
BBM and lysosomes in liver homogenates (Table 9). ARG treatment to rats resulted 
in extensive reduction in the specific activity of alkaline phosphatase (AlkPase), 
GGTase LAP and ACPase in the liver homogenates. The feeding of FO and FXO-diet 
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Table 10: Effect of Fish oil (FO) and Flaxseed oil (FXO) activities of biomarker 
enzymes of BBM in intestinal BBMVs with L-Arginine (ARG) treatment. 
Enzyme 
Groups 
Control 
ARG 
FOARG 
FXOARG 
AlkPase 
(lamols/mg protein/h) 
37.33 ±0.34 
20.11 ±0.13' 
(-46%) 
34.63 ± 0.49' 
(-7%) 
38.78 ±0.98' 
(+4%) 
GGTase 
(|imols/mg protein/h) 
11.24 ±0.54 
8.39±1.3r 
(-25%) 
11.98 ±0.83' 
(+7%) 
12.56 ±0.52' 
(+11%) 
LAP 
(|.imols/mg protein/h) 
33.24 ±0.38 
17.29 ±0.51* 
(-48%) 
34.67 ±0.43' 
(+4%) 
32.01 ±0.61' 
(-4%) 
Sucrase 
(nmols/mg protein/h) 
273.14 ±4.05 
297.55 ±3.36 
(+9%) 
239.63 ±1.93 
(-12%) 
233.19± 1.87 
(-15%) 
Results (specific activities) are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
a Control ea ARG B FOSNT m FXOSNT 
400 n 
.|^  300 -
I 200 H 
Si too H 
0 llll'l I Iffa i'i'i'iC7?aW9f 1 
AlkPase GGTase LAP Sucrase 
Figure 24: Effect of FO and FXO on activities of AlkPase, GGTase and LAP 
in intestinal BBM with L-Arginine (ARG) treatment. 
Above figure is drawn using values from Table 10. Results (^mols/mg 
protein/hour) are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from ARG; 
at p < 0.05 by one way ANOVA. 
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to ARG treated (FOARG/FXOARG) rats not only prevented ARG elicited changes, 
but the activities of GGTase and AlkPase were even increased by FO diet. 
Effect of dietary fish oil and flaxseed oil on ARG induced alterations in 
antioxidant defense parameters in renal cortex and medulla; 
It is evident that reactive oxygen species generated by various toxicants are important 
mediators of cellular injury and pathogenesis of various diseases [Walker 1999]. 
Primary components of oxidative stress and cellular injury response include elevation 
of lipid peroxidation (LPO), depletion of GSH and suppression of antioxidant 
enzymes [Priyamvada et al, 2008, 2010]. To ascertain the role of antioxidant system 
in ARG-induced toxicity, the effect of ARG observed on oxidative stress parameters. 
ARG enhanced lipid peroxidation (LPO) and significantly altered antioxidant 
enzymes both in cortex and medulla, albeit differently (Table 11). LPO measured in 
terms of malodialdehyde (MDA levels) significantly enhanced in the cortex (+43%) 
and medulla (+51%) to similar extent whereas total-SH declined in these tissue (-16% 
to -26%). ARG treatment caused marked increase in superoxide dismutase (SOD, 
+68%)) but decrease in Glutathione peroxidase (GSH-Px, -37%)) activity in the renal 
cortex. In medulla however the activity of SOD (-36%) and GSH-Px (-16%) 
significantly decreased by ARG administration alone. 
The protective effect of both FO and FXO enriched in co-3 fatty acids was determined 
on ARG-induced oxidative stress parameters .The results indicate that FO and FXO 
dietary supplementation was able to ameliorate the ARG induced oxidative damage in 
both renal cortex and medulla. ARG induced increase in LPO and decrease in total-
SH was not observed by feeding FO or FXO diet to ARG-treated rats. The activity of 
GSH-Px and catalase in the cortex and the activity of catalase and GSH-Px in the 
medulla respectively remained significantly higher in FO/FXO + ARG rats compared 
to ARG and/or control rats. The results indicate marked protection by both FO/FXO 
diet against ARG induced oxidative damage to renal tissues. 
Effect of dietary fish oil and flaxseed oil on ARG induced alterations in 
antioxidant defense parameters in rat intestine: 
The effect of ARG, FO and FXO were determined on various antioxidant parameters 
in mucosal homogenates (Table 12). ARG treatment caused marked increase in SOD 
(+35%)) but decrease in catalase (-22%)). These changes were associated with 
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significant increase in lipid peroxidation (+30%) measured in terms of MDA levels 
and decrease in total-SH (-21%). Both FO and FXO-diet partially prevented ARG-
induced alterations in SOD, catalase and GSH-Px activities. ARG induced increase in 
LPO and decreased SH-content were prevented by FO/FXO diet. 
O Effect of dietary fish oil and flaxseed oil on ARG induced alterations in 
antioxidant defense parameters in rat liver: 
The effect of ARG, FO and FXO-diet was determined on Vcirious antioxidant 
parameters in liver homogenates (Table 12). ARG treatment to control rats caused 
marked decrease in catalase (-22%) and GSH-Px (-17%) activities. These changes 
were associated with significant increase in lipid peroxidation (+35%) and decrease in 
total-SH content (-21%)). Both FO/FXO-diets prevented ARG-induced decrease in 
catalase and GSH-Px activities when FO and FXO diets were given in combination 
with ARG treatment. Total-SH and LPO were also normalized to near control values. 
O Effect of dietary fish oil and flaxseed oil on ARG induced alterations in Na-
gradient dependent transport of ^^Pi in BBMV isolated from renal cortex; 
The bulk of filtered Pi in the kidney is reabsorbed by its proximal tubule. The Na-
gradient dependent {Naoutside (Nao)>Nainside (Nai)} transport of Pi in renal proximal 
tubule across its luminal brush border membrane (BBM) is an initial and regulatory 
step. The Pi is transported by secondary active transport mechanism, requires 
expenditure of energy in the form of ATP that is generated by cellular metabolism. 
The uptake of ^^ Pi was percent change from control determined in the presence and 
absence of Na-gradient in the initial uphill phase (30s) and after equilibrium at 
120min in BBM preparations. The rate of concentrative uphill uptake of •'^ Pi in the 
presence of a Na-gradient (NaCl in the medium) was markedly decreased by ARG 
treatment (Table 13). However, the uptake of'''Pi at the equilibrium phase (120min) 
when Nao=Naj was not significantly different between the two groups. Also Na-
independent uptake (in the absence of a Na gradient, when NaCl in the medium was 
replaced by KCl where Ko> Kj) of ^^ Pi at 30s and 120min was also not affected by 
ARG treatment indicating specific alterations only when Na-gradient was present. 
When ARG treatment was extended to FO and FXO feeding rats, ARG induced 
decrease in •'^ Pi transport was not observed. 
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Table 13: Effect of Fish Oil (FO) and Flaxseed oil (FXO) on uptake of 32Pi in brush 
border membrane vesicles (BBMV) from whole cortex with L-Arginine 
(ARG) treatment. 
(A) Na'^ -gradient dependent uptake (Ns 
Group 
Control 
ARG 
FOARG 
FXOARG 
30sec 
1631.09 ± 17.06 
1232.83 ±75.37* 
(-25%) 
1711.64 ±69.79^ 
(+5%) 
1637.20 ±61.29^ 
(NA) 
(B) K'^ -gradient dependent uptake (Ko> 
Group 
Control 
ARG 
FOARG 
FXOARG 
30sec 
191.05 ±6.93 
200.79 ±3.50 
(+5%) 
194.76 ±5.85 
(+2%) 
192.70 ±0.30 
(+1%) 
io>Nai) (pmol/mg protein) 
120min 
334.78 ± 10.89 
397.21 ± 13.02 
(+19%) 
344.81 ±7.99 
(+3%) 
368.22 ±2.41 
(+10%) 
•K|) (pmol/mg protein) 
IZOmin 
323.93 ±2.85 
324.65 ±0.61 
(NA) 
345.11 ±2.55 
(+6%) 
302.28 ±2.83 
(-7%) 
(C) Net Na -^gradient dependent uptake at 30 sec 
Group Na*-gradient dependent uptake K'^ -gradlent dependent uptake Net uptake (Na*-K*) 
Control 1631.09± 17.06 191.05±6.93 1440.04± 13.76 
ARG 1232.83 ±75.37 200.79 ±3.50 1032.04 ± 10.09* 
(-28%) 
FOARG 1711.64 ±69.79 194.76 ±5.85 1516.88 ± 18.93* 
(+5%) 
FXOARG 1637.20±61.29 192.70±0.30 1444.50 ± 14.75* 
(NA) 
Results are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control. 
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Table 14: Effect of Fish oil (FO) and Flaxseed oil (FXO) on tissue nitrite concentrations 
in different tissue homogenates with L-Arginine (ARG) treatment. 
Tissues 
Groups 
Control 
ARG 
FOARG 
FXOARG 
Cortex 
(Nanomols/gm tissue) 
17.23 ±0.56 
21.16±0.64* 
(+23%) 
18.34 ±0.61^ 
(+6%) 
18.57 ±1.03' 
(+8%) 
Medulla 
(Nanomols/gm tissue) 
10.12 ±0.84 
13.68 ±0.53* 
(+35%) 
10.04 ±0.57' 
(NA) 
11.07 ±0.32' 
(+9%) 
Intestine 
(Nanomols/gm tissue) 
35.61 ±1.17 
45.61 ±0.92' 
(+28%) 
38.16 + 0.84' 
(+7%) 
37.43 ±1.62' 
(+5%) 
Liver 
(Nanomols/gm tissue) 
17.81 + 0.27 
21.88 ±0.47' 
(+23%) 
20.08+1.02 
(+13%) 
18.83 + 0.76' 
(+6%) 
Results are Mean ± SEM for five different preparations. 
* Significantly different from control, tsignificantly different from ARG at p < 0.05 
by one way ANOVA. 
Values in parentheses represent percent change from control 
• Control 0 ARG H FOARG S FXOARG 
Z 0 
Cortex Medulla Intestine Liver 
Figure 24: Effect of FO and FXO on tissue nitrite concentration with L-
Arginine (ARG) treatment. 
Above figure is drawn using values from Table 14. Results (nanomols/gm tissue) 
are Mean ± SEM for five different preparations. 
* Significantly different from control, t significantly different from ARG; 
at p < 0.05 by one way ANOVA. 
IS4 
Effect of dietary fish oil and flaxseed oil on tissue nitrite concentration after 
ARG treatment in different rat tissues: 
Nitrite concentration is an important parameter in cases where nitrogen metabolites 
(nitrite, nitrate and NO) are being overproduced. Since nitrite, nitrate and NO are 
recycled baclc and forth, the amount of nitrite in the tissues reflects the amount of all 
three metabolites. 
As expected, exposure of ARG to rats increased the tissue concentrations of nitrite in 
all tissues (Figure 25), the accumulation of nitrite being greater in renal medulla 
(+35%) and intestine (+28%). This can be attributed to the fact that most of the 
ingested nitrate gets converted into nitrite by bacterial action in the gut. Also kidneys 
are the major filtration site for nitrite. When FO/FXO was given in combination with 
ARG. both FO and FXO partially improved the values to near control in renal cortex, 
medulla and intestine, whereas in the liver complete amelioration was observed 
(Table 14). When FO/FXO was given in combination with ARG, ARG-induced 
increase of tissue nitrite concentrations were ameliorated to near control both by FO 
and FXO diet. The results indicate that either the nitrite was not accumulated in the 
tissues or it was degraded and washed out of the body. 
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Discussiow-m 
L-Arginine (ARG) is a semi-essential, proteinogenic amino acid [Rose, 1938] that 
was discovered in mammalian protein by Hedin in 1895]. Since 1886 it has been 
recognized as a naturally occurring molecule [Schulze, 1886]. It is involved in two 
major metabolic pathways, one of them is the urea cycle and the other being nitric 
oxide synthase (NOS) pathway by which ARG is converted to NO and L-citruUine 
[Moncada and Higgs, 2002; Sidney and Morris. 2002]. ARG and NO affect the 
cardiovascular system as endogenous anti-atherogenic molecules that protect the 
endothelium, modulate vasodilatation, and interact with the vascular wall and 
circulating blood cells [Boger et al, 1996; Cooke and Dzau, 1997; Cooke, 2004; Li et 
al.. 2006; Napoli et al., 2006]. Together, they can function in the brain as 
noradrenergic, noncholinergic neuro-transmitters in learning and memory, synaptic 
plasticity, and neuroprotection [Bohme et al., 1993; Paakkari and Lindsberg, 1995]. 
They can influence the immune system too by playing a key role in regulating 
inflanimatory processes [Potenza et al, 2001] and redox stress. They can also 
modulate the metabolism of glucose and insulin activity as natural constituents from 
diets and regulate neurogenesis [Lobgena et al, 2006]. 
Alternatively, L-Arginine may enhance the synthesis of potentially detrimental NO 
from iNOS which countered the neuroprotective effects of iNOS inhibitor in several 
studies [Luiking et al, 2004; Bronte and Zanovello, 2005]. Increased production of 
NO has been described in various human cancers, that might contribute to tumour 
development by favouring neo-angiogenesis, tumour metastasis, resistance to DNA-
damaging drugs, and tumour-related immunosuppression [Bogdan, 2001; Xu et al, 
2000]. Mizinuma et al, (1984) were the first who studied the effect of an excessive 
dose of ARG on different tissues of rats. High doses of ARG were linked with 
pancreatitis along with multi-organ failure [Mizinuma et al, 1984]. The extra 
pancreatic manifestations such as circulatory, pulmonary, renal and hepatic failure 
contributed significantly to the morbidity and mortality of pancreatitis [Steinberg and 
Tenner, 1994; Renner et al, 1985; Karomgani et al. 1992]. It has been reported that 
high doses of ARG caused widespread morphological changes [Kishino, 1984]. The 
liver cells showed slight vacuolar degeneration [Hegyi et al, 2004]. The kidney 
contained eosinophilic compositions in the proximal convoluted tubules [Hegyi et al. 
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2004]. Adipose tissues around the pancreas siiowed fat necrosis [Hegyi et al., 2004]. 
The weight of different organs viz. liver, kidney, spleen and thymus were not changed 
however, the weight of the pancreas was found to be doubled [Hegyi et al., 2004]. 
Motoo et al., (2000) examined the effect of ARG on cellular morphology, PAP 
expression and apoptosis in rat pancreatic acinar cells. The growth of AR-2J cells 
were inhibited in a dose dependent manner. 
ARG-induced acute pancreatitis has been studied in much greater detail than in other 
organs [Hegyi et al., 2004]. It has been shown that oxidative stress development also 
includes remote organs such as liver and kidney during ARG-induced acute 
pancreatitis [Hegyi et al., 2004; Czako et al.. 2000a]. The MDA concentration was 
found to be significantly increased in the liver, kidney along with the pancreas. It was 
associated with significantly reduced endogenous scavengers, Mn'" and Cu, Zn-SOD 
and glutathione peroxidase (GSH-Px) both in the liver and in the kidney [Hegyi et al., 
2004]. Catalase was shown to be significantly increased in the liver whereas 
significantly decreased in the kidney [Hegyi et al, 2004]. The oxidative stress was 
observed concomitant with histological damage to the liver, pancreas and renal 
proximal convoluted tubules [Hegyi et al, 2004]. 
Recently, the use of naturally occurring dietary substances for prevention of various 
chronic diseases and against various toxicities is gaining interest. Omega-3 fatty acid 
rich fish oil and polyphenol rich green tea are shown to have several beneficial health 
effects against various pathologies including cancer, CVD and immune inflammatory 
disorders [Simopoulos, 1991; Higdon and Frei, 2003; Kakar et al. 2008]. Watkins et 
al. (2007) have also suggested the therapeutic use of co-3 PUFA and flavonoids 
against inflammation that is mediated by environmental pollutants. 
In view of the above, the present work was undertaken to test the hypothesis whether 
dietary fish oil and flaxseed oil rich in (o-3 FA would be able to protect against ARG 
induced nephrotoxicity/gastrotoxicity/hepatotoxicity. The effects of ARG treatment 
and dietary FO and FXO were determined on various nephrotoxicity parameters and 
on the enzymes of carbohydrate metabolism, brush border membrane and oxidative 
stress in rat kidney and intestine. 
As can be seen from the "Results", a single dose of ARG produced a typical pattern of 
nephrotoxicity manifested by increased serum creatinine and elevated BUN 
accompanied by polyuria, proteinuria, glucosuria, phosphaturia and decreased 
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creatinine clearance indicating that a significant damage to kidney has occurred by 
ARG exposure. Both FO and FXO-diet given 15 d prior to and during ARG 
administration prevented ARG-induced alterations in various serum/urine parameters. 
ARG-induced increase of Scr/BUN, phospholipidosis, proteinuria and glucosuria 
were all absent in FO/FXO fed ARG treated rats. Thus, the results clearly indicated 
that ARG -induced alterations in serum/urine parameters were prevented similarly by 
both FO and FXO-diets. The preventive effects of FO and FXO-diet on ARG treated 
rats were made possible because of increase in serum Pi, glucose and decrease in 
serum creatinine, BUN by FO/FXO alone. A positive balance of cholesterol and 
phospholipids (essential membrane components) in serum may facilitate the repair 
and regeneration of the membrane as required after ARG exposure. 
The activities of BBM marker enzymes were determined to examine the structural and 
functional damage caused by ARG to BBM integrity and any protection against ARG 
actions exerted by FO/FXO-diets. As shown in the "Results" the activities of AlkPase, 
GGTase and LAP markedly decreased by ARG treatment to control rats in renal 
cortical BBM preparations. However, the activities of AlkPase and GGTase were 
significantly increased by FO/FXO-diet alone. Thus FO/FXO-diets to ARG treated 
rats were able to prevent the decrease in the activities of these enzymes. Dietary fatty 
acids are knovra to be incorporated in the membrane causing changes in the lipid 
composition which in turn affect the biophysical characteristics of the membrane and 
the activities of certain membrane associated enzymes [Stenson et al., 1989; Kaur et 
ai. 1996: Thakkar et al., 2000; Carrillo-Tripp M and Feller, 2005]. Thus by the virtue 
of their influence on membrane physiology, dietary co-3 PUFA might have played an 
important role in reducing the membrane perturbing effects of ARG. A similar 
positive impact of co-3 PUFA against cyclosporine A induced changes in membrane 
structure and function has been reported earlier [Thakkar et al., 2000]. 
The reabsorption of Na^ by renal proximal tubular BBM is considered to be the major 
function of the kidney because the transport of other ions and various solutes depend 
directly or indirectly on Na^ reabsorption [Coux et al., 2001; Khundmiri et ai, 2005]. 
Since these transports depend on the structural integrity of BBM and available energy 
as ATP provided by various metabolic pathways it is imperative that any alterations to 
BBM integrity and metabolic pathways caused by toxic insult or otherwdse would 
determine the rate of renal transport functions [Khundmiri et al., 2004; 2005]. As 
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shown in the "Results" the activities of various enzymes involved in glycolysis, TCA 
cycle, gluconeogenesis and HMP shunt pathway were significantly affected by ARG 
treatment albeit differently. Taken together, ARG significantly increased the activity 
of HK and LDH (glycolysis) whereas the activity of and MDH (TCA cycle) 
significantly decreased. The marked decrease in MDH activity indicates an impaired 
oxidative metabolism of glucose and decreased ATP production and hence depressed 
renal transport function. Although the actual rates of glycolysis and other pathways 
were not determined, the increased activity of LDH along with simultaneous decline 
in TCA cycle enzymes suggest a shift in energy production from mitochondria to 
anaerobic glycolysis due to mitochondrial damage caused by ARG. The decreased 
activities of gluconeogenic enzymes: FBPase and G6Pase may be the result of 
decrease in TCA cycle enzyme activities. This can be further explained by the fact 
that the reduced activities of TCA cycle enzymes especially that of MDH may have 
reduced the producfion of oxaloacetate from malate which is required not only for the 
continuation of TCA cycle but also for gluconeogenesis. The oxidative conversion of 
glucose or glucose-6-phosphate to 6-phosphogluconate by G6PDH of HMP shimt 
pathway, was also lowered in part due to mitochondrial dysfunction by ARG. 
FO/FXO diet normalized the activities of the metabolic enzymes when they were 
given to ARG treated rats prevented ARG -induced decrease of various enzymes 
involved in glucose degradation and production. 
To further correlate BBM integrity and ATP production by metabolic activity of the 
kidne> the results indicate that ARG caused reduction in the enzyme activities of 
oxidative metabolism and BBM whereas FO and FXO-diet increased most of them, 
would lead to decrease/increase production of ATP by ARG and FO/FXO 
respectively. Thus, both situations would affect transport functions of the kidney. 
Indeed. Na-dependent transport of Pi across renal cortical brush border membrane 
was significantly declined by ARG exposure whereas increased by FO/FXO-diets. 
ARG -induced decrease in Pi transport was also prevented by FO/FXO-diets when 
given together (FOARG /FXOARG), indicating a positive correlation between ARG 
and FO/FXO actions on Na-Pi transport. 
It has been reported that some toxicants including certain drugs and heavy metals 
exert their effect by inducing the generafion of ROS/RNS. However, redox stress can 
occur as a result of either increased ROS/RNS generation or decreased antioxidant 
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defense or both. Of them SOD, catalase and GSH-Px constitute the main components 
of the antioxidant defense system. The present results demonstrate that ARG exposure 
causes increase in the activities of SOD and decrease in catalase and GSH-Px activity 
accompanied by increased LPO and decreased total-SH in renal cortex whereas all 
antioxidant enzymes were depressed in renal medulla. 
The feeding of both FO and FXO-diets with ARG treatment prevented ARG -induced 
increase in LPO and decrease in total-SH and antioxidant enzymes activities remained 
normal in FO/FXO-ARG treated compared to control rats. Taken together, the present 
observations clearly demonstrate that FO/FXO-diets were able to prevent many of the 
adverse alterations caused by ARG in metabolic, BBM and antioxidant enzymes in 
the kidney. Dietary FO/FXO have been shown to improve antioxidant defenses in a 
variety of pathophysiologic situations where the oxidant/antioxidant defense 
mechanism are decelerated [Xi and Chen; 2000; Barbosa et al, 2003; Erdogan et al, 
2004; Bhattacharya et al, 2003; 2006; Bhatia et al, 2006; 2007]. Thus the changes in 
the cell antioxidant status and membrane fatty acid composition could significantly 
alter the ability of the cell to cope with ARG-induced toxicity. 
ARG and FO/FXO-diets and their combinations produced similar biochemical effects 
in the intestine and liver as observed in the kidney. The activity of LDH significantly 
increased but MDH, G6Pase, FBPase, G6PDH and ME activities significantly 
decreased by ARG exposure. ARG caused profound decrease in the activities of BBM 
enzymes: AlkPase, GGTase, and LAP in the intestinal/liver homogenates and BBM 
preparations. The feeding of FO/FXO-diet significantly increased the activities of all 
metabolic enzymes which were lowered by ARG exposure. 
The effect of ARG on metabolic enzymes was largely ameliorated by FO and FXO-
diet alike. The activities of BBM enzymes in general remained significantly higher in 
FO/FXO-ARG treated rats compared to control rats. Effect of ARG and FO/FXO was 
also observed on various parameters of oxidative stress in rat intestine/liver. ARG 
caused significant increase in SOD activity but the activities of catalase and GSH-Px 
markedly decreased in both intestine and liver. LPO, an indicator of tissue 
injury/oxidative stress was significantly increased whereas total-SH declined. 
Collectively, these results show that ARG also caused marked oxidative damage to 
intestinal mucosa and liver and that ARG -induced damage to a large extent was 
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reversed by FO and FXO-diets as reflected by the improvement in oxidative stress 
parameters. 
The mechanism by which ARG causes these effects is not fully understood. 
Accumulating evidence suggests that oxygen free radicals [Varga et al, 1997a, b; 
Czako et al, 1998, 2000a, b], NO [Takacs et al, 2002a], inflammatory mediators 
[Takacs et al, 1996, 2002b; Rakonczay et al. 2003; Czako et al, 2000b] all have a 
ke) role in the development of ARG-mediated alterations. In general NO is generated 
from ARG by an enzymatic pathway (NO synthase. NOS) originally demonstrated in 
vascular endothelial cells [Gross and Wolin, 1995]. Under physiological conditions, 
constitutive NOS (eNOS) resuhs in a low level of NO while in different inflammatory 
processes inducible NOS (iNOS) produces larger quantities of NO in various cell 
types. The activity of eNOS was shown to be increased early (24-48 hrs) then 
declined thereafter at 48 hrs [Hegyi et al, 1997] whereas iNOS activity was found to 
be increased after 24 and 48 hrs vs control and remained higher thereafter [Hegyi et 
al, 2004]. It has been suggested, that both the NOS forms play important role in the 
development of ARG-induecd toxic alterations [Hegyi et al, 2004]. It has been 
demonstrated that NO derived fi"om ARG is a potential source of redox stress. It can 
be quickly cleared through reacting with superoxide (O2') to generate peroxynitrite 
(ONOO) while cells are in a pro-oxidative state. As a highly reactive species, ONOO 
can react via homolytic or heterolytic cleavage and, generate secondary constituents 
of nitroxidative stress and highly reactive oxygen/nitrogen species (ROS/RNS) 
including NO:"^ , NO2', and OH radicals. The present results show that ARG caused 
increase in LPO and decrease in SH content, whereas the activities of antioxidant 
defense system e.g. SOD, GSH-Px and catalase were perturbed in the kidney, liver 
and intestine although variably. The results confirmed previous studies which showed 
that ARG caused morphological changes in the liver, kidney and some other tissues 
including pancreas which were demonstrated to be mediated by perturbation in the 
oxidative stress parameters [Hegyi et al, 2004]. In contrast, FO and FXO, major 
source of (o-3 fatty acids by altering membrane fatty acid composition appeared to 
affect membrane organization and ftanctions. Both FO and FXO appear to accelerate 
repair and/or regeneration of injured organelles e.g. mitochondria, peroxisomes and 
increased activity of TCA cycle and BBM as evident by increased activities of the 
enzymes of carbohydrate metabolism. Most importantly, by activating endogenous 
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antioxidant defense mechanism FO and FXO provided protection from ARG induced 
RNOS production. 
We conclude that while ARG elicited deleterious nephrotoxic and other adverse 
effects by causing severe damage to renal mitochondria, brush border membrane and 
other organelles and by suppressing antioxidant defense mechanism, dietary 
supplementation with fish/flaxseed oil enriched in co-3 fatty acids caused 
improvement in nutrition/energy metabolism, BBM integrity, Pi transport capacity 
and antioxidant defenses and thus prevented ARG induced various deleterious effects. 
ARG induced uncontrolled NO production and mediators such as ONOO and other 
RNOS appear to cause most of ARG-induced deleterious effects and FO/FXO elicited 
increased antioxidants counter these alterations. Based on our present observations 
and already known health benefits we propose that dietary fish oil supplementation 
may provide a cushion for a prolonged therapeutic option against ARG induced 
various adverse effects without harmful side effects. 
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SUMMARY & CONCLUSION 
Besides oxygen, carbon and hydrogen, nitrogen is an essential element that constitutes 
life. It is generally consumed as nitrate (N03~) or nitrite (N02~). Changes in patterns 
of agricultural practice, food processing and industrialization have impacted 
accumulation of nitrates/nitrites in the enviromnent. Nitrate is abimdantly present in 
the soil and water [Hill, 1991]. It is a valuable fertilizer and is used extensively in the 
farming practice. Livestock and poultry as well as urban sewage treatment also 
contribute nitrogenous wastes to the soil. Bacteria present in the soil, water, feed and 
foods are capable of utilizing these nitrogenous compounds to synthesize nitrates (and 
nitrites) de novo via heterotrophic nitrification (and nitrate reduction) [Tannenbaum et 
al, 1978]. Nitrates and nitrites, used in combination with salt, serve as important 
antimicrobial agents in meat to inhibit the growth of bacterial spores that cause 
botulism, a deadly food-borne illness. Nitrites are also use as preservatives and for 
flavoring and fixing color in a number of red meat, poultry, and fish products. 
Additionally, nitrites have been employed as a vasodilator, or a circulatory depressant 
to relieve smooth muscle spasm, and an antidote for cyanide poisoning [Nickerson, 
1970]. and potassium nitrate has been used therapeutically as a diuretic agent. Other 
precursors or sources of nitrite include N-containing foods, nitrogen containing 
drugs/chemicals (e.g. nitroglycerin, an anti-microbial agent and coronary dilator; 
sodium nitroprusside, Na2[Fe(CN)6NO], an anti-hypertensive agent and nitric oxide 
(NO) [Chow and Hong, 2002]. Nitric oxide (NO), which is synthesized in vivo from 
L-arginine (ARG), can be oxidized to nitrite or nitrate. NO is also a component of 
cigarette smoke and automobile exhaust. Thus, man and animals are subjected to 
significant nitrate and nitrite levels in foods, feed, soil and water as well as those 
formed in vivo. Nitrites and nitrates formed from nitrogenous sources from 
microorganisms in saliva, intestine, however, are the major source of human exposure 
under normal conditions [White, 1975; Tannenbaum et al, 1978]. 
Nitrates are generally not toxic however, ingestion of large amounts of nitrates was 
found to be associated with methemoglobinemia, anemia, severe gastroenteritis and 
nephritis [DoUahite and Rowe, 1974]. Any toxicity linked with nitrate was found to 
be due to its bioconversion to nitrite by the bacteria in the soil, mouth or stomach 
[Duncan et al, 1995; Lundberg and Govoni, 2004]. The major health concerns with 
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nitrite are the risk of methemoglobinaemia and its potential carcinogenic, mutagenic 
and cytotoxic effects [Ger et al, 1996, Magee and Barnes, 1956; Spencer et al, 2000; 
Sun et al. 2006]. A high dietary intake of nitrite has been implicated as a risk factor 
for human cancer, and formation of nitroso-compounds in the stomach during 
inflammation is correlated with nitrate in food and water [Ames, 1983; Mirvish, 
1995], A number of biochemical changes, functional impairments and 
histipathological lesions have been observed in nitrite-treated rats [Abuharfeil et al, 
2001]. It has now been documented that reactions of H2O2 with nitrite and of 
superoxide with NO have a common intermediate-peroxynitrite (ONOO') 
[Carmichael et al, 1993], which is responsible for nitration of proteins, DNA strand 
breaks and mutations, and with interference of protein functions [Sampson et al, 
1998]. Moreover in acidic conditions, nitrite is spontaneously decomposed to NO that 
can be reconverted back to nitrite [Lundberg et al, 2008]. Sodium nitroprusside 
(SNP) is widely used as an anti-hypertensive agent in clinical practice. SNP has been 
documented to induce genotoxicity [Andreassi et al, 2001], mutagenictiy [Asaka et 
al, 1997; Lin et al, 1998] and apopotosis [Feldman et al, 1997]. Recent studies have 
shown that SNP alters the mitochondrial energy generation processes. It has been 
shown to irreversibly inhibit the respiratory chain [Brown and Borutaite, 2002] but 
stimulates glycolysis [Maletic et al, 2000] thereby decreasing total energy 
production. L-Arginine (ARG) is the substrate for the different nitric oxide synthase 
(NOS) isoforms which are responsible for the production of NO n vivo. ARG itself 
lias very moderate toxicity, whatever harmful effects it manifests is mainly due to the 
overproduction of NO. An excessive dose of ARG was linked with pancreatitis along 
with multi-organ failure [Mizinimia et al, 1984]. It has been reported that high doses 
of ARG causes widespread morphological changes in the liver, kidney and adipose 
tissues [Kishino, 1984; Hegyi et al, 2001]. Nitric oxide is a double-edged sword as it 
can be both cytoprotective and cytotoxic. Produced by mammalian cells at an 
appropriate magnitude and tempo, it serves as a key signaling molecule in 
physiological processes as diverse as host-defense, neuronal commimication, and 
vascular regulation [9-11]. On the other hand, excessive and unregulated NO 
synthesis has been implicated as causal or contributing to pathophysiological 
conditions including many lethal and debilitating human disorders: arthritis, 
atherosclerosis, cancer, diabetes, numerous degenerative neuronal diseases, stroke, 
and myocardial infarction to name a few [Culotta and Koshland, 1992, Gross and 
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Wolin, 1995]. Recently both nitrates and nitrites are recognized as key oxidation 
products of NO, which can be generated in the tissues by a number of enzymatic and 
non-enzymatic reactions [Lundberg et al, 2008 review]. Therefore, they should now 
be viewed as storage pools for NO-like bioactivity, thereby complementing the NO 
synthase (NOS)-dependent pathway. The recognition of this mammalian nitrogen 
cycle (nitrate-nitrite-NO) has led researchers to explore the role of nitrate and nitrite 
in physiological and pathophysiological processes where NO is known to play a key 
role. 
The last two decades have witnessed a major drift in the interests of the scientific 
community towards providing better means to containing the health risks of the 
human race. The century old chemotherapies against various disorders have never 
been a success, albeit not a total failure. Such therapies have a major drawback of side 
effects that give rise to unseen disorders that emerge as a new challenge. From ancient 
times, the physicians and scholars in Asia have understood that food has both 
preventive and therapeutic value and is an integral part of human health. The concept 
of chemo-prevention of certain diseases using naturally occurring substances that can 
be included in the diet consumed by human populations is gaining attention. Of late, 
renewed interest and vigor has been showered on the role of omega fatty acids. Fish 
oil enriched in co-3 PUFA (EPA and DHA) provide one such dietary source of 
biologically active components that has been shown to be co-preventative and co-
therapeutic in a wide variety of ailments [Doughman et al, 2007]. Early clues to the 
possible importance of unsaturated fatty acids especially polyunsaturated fatty acids 
(PUFA) came from studies showing that young humans and experimental animals 
experienced impaired growth when all fatty acids were removed from the diet. Small 
amounts of co-3 (a-linolenic acid) or co-6 (linoleic acid) fatty acids prevented that 
impaired growth and thus were termed as "essential" [Burr and Burr, 1930]. Highly 
unsaturated/polyunsaturated FA (HUFA/PUFA) were relatively found to be several-
fold more effective [Turpeinen, 1937]. 
Further studies have revealed that both co-3 and co-6 PUFA have numerous health 
benefits. However, co-3 PUFA especially from fish/marine foods were found to be 
more effective in lowering incidence of various pathologies compared to co-6 PUFA 
rich diets [Simopoulos, 2001]. This stems from the observations of the different 
prevalence of coronary heart disease and other chronic diseases (including psoriasis, 
16S 
SiMnmaty ^ Conclutvon/ 
bronchial asthma, diabetes mellitus and thyrotoxicosis) in the Greenland Inuit 
(Eskimo) population relative to Western populations [Kromann and Green, 1980], (o-3 
PUFA (e.g. EPA and DHA) from marine fish and mammals were indicated as the 
main dietary factor responsible for such differences [Dyerberg et al, 1975; Bang et 
ciL. 1976]. The consumption of fish has now been linked with the rate of depression 
among various populations. In countries where people eat the least fish the rate of 
depression is highest, and vice versa [Hibbeln, 1998; Small, 2002]. This correlation 
holds true across the world. The most dramatic change in what we eat has happened in 
the past century, with industrialization and development of the food industry, the 
intake of saturated fat, trans fat and especially co-6 enriched refined oils have 
enormously increased whereas the consumption of co-3 PUFA has considerably 
declined. These dietary imbalances in fat intake, in fact, are prime cause of modem 
sufferings like cancer, hypertension, diabetes, depression, cardiovascular and renal 
disorders. 
Role of fish oil/o)-3 PUFA has been extensively investigated and has received a great 
deal of attention in recent times as therapeutic options in a variety of clinical 
situations ranging from CVD to hyperlipidemia, cancer, inflammatory and immune 
disorders, respiratory diseases, depression and diabetes [De Caterina et al, 1994; 
Kakar et al. 2008]. Lately, o)-3 PUFA from certain plants/seeds e.g. walnut, canola 
and most notably from flaxseed (linseed) showed many similar health benefits as 
demonstrated by (0-3 PUFA fi-om fish/fish oil [Nannicini et al, 2006; Vijaimohan et 
al. 2006]. 
Although (0-3 PUFA have been shown as deterrents for environmental pollutants, 
studies on their possible beneficial effects against drug/chemical induced 
nephrotoxicity and gastrointesfinal toxicity are very limited [Watkins et al, 2007; 
Priyamvada et al, 2008, 2010]. Considering profound beneficial health effects of co-3 
PUFA from marine or plant foods against various pathologies the present work 
embodied in this thesis was undertaken to study the detailed mechanisms of NO 
donors/metabolites induced nephrotoxic alterations and possible mechanism of 
protection/prevention of co-3 fatty acids enriched fish oil (FO) and/or flaxseed oil 
(FXO) in the diets against NO donors/metabolites induced nephropathies. Useful 
sources of NO for study in animal models are its essential amino acid substrate L-
arginine and pharmacological donors like sodium nitroprusside (SNP). To study the 
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role of NO metabolites, sodium nitrite (SNT) was used. In extension, the effects of 
NO donors/metabolites and FO/FXO were also studied in small intestine and liver, 
which are primary targets of toxic insult. In view of numerous beneficial health 
effects of co-3 PUFA "we hypothesized that: dietary FO and FXO enriched in a)-3 
PUFA would be able to prevent/reduce NO donors/metabolites induced nephrotoxic 
and other adverse effects in the rat kidney, intestine and liver." 
To address this hypothesis the present work was undertaken to study the detailed 
biochemical events/cellular response/mechanism of NO donors/metabolites induced 
nephrotoxic and other adverse effects in rat kidney, intestine and liver. The effects of 
dietary (0-3 PUFA was also determined to observe any protection provided by them 
against NO donors/metabolites nephrotoxicity. The following parameters were 
determined: 
(a) Certain biochemical parameters in serum/urine. 
(b) The activities of certain enzymes of carbohydrate metabolism involved in 
glycolysis, TCA cycle, gluconeogenesis and HMP-shunt pathway in renal cortex 
and medulla, small intestine and liver. 
(c) The activities of BBM and lysosomal marker enzymes in renal cortical and 
mucosal homogenates and BBM marker enzymes in isolated BBM preparations 
from renal cortex and intestinal mucosa. 
(d) The transport of ^^ Pi in renal cortical BBM. 
(e) The enzymatic and non-enzymatic parameters of antioxidant defense system in 
renal cortex and medulla, small intestine and liver. 
# THE RESULTS OBTAINED ARE SUMMARIZED AS FOLLOWS; 
O PART I: EFFECT OF FISH OIL (FO) AND FLAXSEED OIL (FXO) ON 
SODIUM NITRITE (SNT) INDUCED NEPHROTOXIC AND OTHER 
ADVERSE EFFECTS 
(a) Serum/Urine Parameters: 
SNT treatment to control rats resulted in significant increase in serum creatinine (Scr) 
and blood urea nitrogen (BUN), but decrease in cholesterol, glucose, phospholipids 
and inorganic phosphate (Pi) as compared to control rats. These changes where 
associated with profound phosphaturia, proteinuria and glucosuria, accompanied by 
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decrease in creatinine clearance. Feeding of FO or FXO diet to SNT administered rats 
resulted in significant reversal of various SNT elicited deleterious effects on serum 
and urine parameters. 
(b) Enzymes of carbohydrate metabolism'. 
(i) SNT treatment to rats significantly increased the activity of lactate dehydrogenase 
(LDH) but decreased malate dehydrogenase (MDH), hexokinase (HK); glucose-6-
phosphatase (G6Pase) and fructose-1, 6-bisphosphatase (FBPase) activities in the 
renal cortex. When SNT treatment was extended to FO and FXO-fed rats, SNT-
induced alterations in metabolic enzyme activities were not only prevented by FO and 
FXO diets, but G6Pase remained significantly higher in FOSNT and FXOSNT 
compared to control as well as SNT rats in the renal cortex. 
SNT treatment to control rats significantly increased G6PDH but decreased ME 
activity. SNT elicited increase of G6PDH activity was normalized to near control 
values by both FO and FXO diets. SNT induced ME activity decrease was arrested by 
both FO and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by SNT treatment (Table 3a) as in the cortical homogenates. 
Feeding of FO and FXO to SNT treated rats prevented SNT induced alterations in 
various enzyme activities. Similar to cortex, G6PDH activity increased whereas ME 
activity decreased by SNT in the medulla (Table 3b). FO and FXO diet to SNT treated 
rats decreased G6PDH activity and increased ME activity. 
(iii) The effect of SNT and dietary oils was also determined on the enzymes of 
carbohydrate metabolism in mucosal homogenates from different experimental rats. 
SNT treatment to rats caused significant increase in LDH (+40%) and hexokinase 
(HK) but decrease in MDH activities. SNT caused significant decrease in 
gluconeogenic enzymes, G6Pase and FBPase in the intestine. The activities of LDH, 
G6Pase and to some extent FBPase remained significantly higher after SNT treatment 
to FO and FXO-fed rats compared to control rats reversing the SNT-induced decrease 
in G6Pase and FBPase activities. SNT-induced decline in MDH activity was also 
restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+34%) but that of ME decreased (-21%) by SNT treatment compared to control rats. 
However, when SNT treatment was given to FO/FXO diet fed rats, SNT induced 
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increased in G6PDH and decrease in ME activities were not observed indicating that 
both FO and FXO diet significantly prevented the alterations caused by SNT. 
(iv) SNT treatment significantly increased the activities of LDH (+62%), HK (+43%) 
and G6PDH (+30%) whereas decreased G6Pase, FBPase and ME activities in the 
liver. When SNT treatment was extended to FO-fed rats, SNT-induced decrease of 
metabolic enzyme activities was prevented by FO and FXO alike except HK and 
MDH. whose activities remained significantly higher than control by FXO. 
{c) Marker enzymes of BBM and lysosomes: 
(i) The activites of alkaline phosphatase (AlkPase), y-glutamyl transpeptidase 
(GGTase) and leucine aminopeptidase (LAP) and acid phosphatase were determined 
under different experimental conditions in the homogenates of renal cortex and 
medulla. SNT treatment to control rats caused significant reduction in the specific 
activities of AlkPase (-35%), GGTase (-57%) and LAP (-52%) in cortical 
homogenate. The prior feeding of FO or FXO diet with SNT treatment prevented SNT 
elicited decrease in BBM enzyme activities. The activity of acid phosphatase 
(ACPase) was also decreased (-45%) by SNT in cortical homogenates and FO/FXO 
diet was able to prevent the decrease in enzyme activity in a similar manner. The 
consumption of FO/FXO in combination with SNT treatment resulted in the reversal 
of SNT induced decrease in AlkPase (-19%), GGTase (-33%) and LAP (-42%) in the 
medulla. The activity of ACPase was not affected by SNT and SNT+FO. However it 
was found to be lower in SNT+FXO rats (-18%) compared with the control rats. 
(ii) The effect of SNT, FO and FXO on BBM marker enzymes was further analyzed 
in BBMV preparations isolated from the renal cortex. The data shows a similar 
activity pattern of BBM enzymes as observed in cortical homogenates. However the 
magnitude of the effects was much more pronounced in BBMV than in cortical 
homogenates. Activities of AlkPase (-67%), GGTase (-53%) and LAP (-51%) 
profoundly declined by SNT treatment as compared to control rats. Fish oil (FO) and 
flaxseed oil (FXO) dietary supplementation similar to the effect in the homogenates 
appeared to lower the severity of the SNT treatment. SNT-induced decrease in BBM 
enzyme activities was significantly prevented by dietary FO and to greater extent by 
FXO diet. 
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(iii) SNT treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. SNT treatment also resulted in the decrease of 
ACPase activity. When SNT treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. 
The effect of SNT, FO and FXO diets was also observed on BBM marker enzymes in 
isolated BBMV preparations. The results showed a similar activity pattern of various 
enzymes in the BBMV as observed in mucosal homogenates. SNT treatment 
profoundly decreased the activities of all BBM enzymes but sucrase which was 
elevated, FO/FXO caused marked increase in AlkPase and GGTase whereas LAP and 
sucrase activities were significantly normalized by both FO/FXO diets. SNT induced 
decrease in the BBMV and lysosomal marker enzymes was not only preserved by 
FO/FXO diets but the activities were restored to near control values. 
(iv) The effect of SNT and FO/FXO diet was also determined on marker enzymes of 
BBM and lysosomes in liver homogenates. SNT treatment to rats resulted in extensive 
reduction in the specific activity of alkaline phosphatase (AlkPase) whereas other 
enzymes were not altered significantly in the liver homogenates. The feeding of FO 
and FXO-diet to SNT treated (FOSNT/FXOSNT) rats not only prevented SNT 
elicited changes, but the activities of GGTase, AlkPase and LAP were even increased 
by FO/FXO diet. 
(d) Enzymatic and non-enzvmatic antioxidant defense parameters: 
(i) SNT enhanced lipid peroxidation (LPO) and significantly altered antioxidant 
enzymes both in cortex and medulla, albeit differently. LPO measured in terms of 
malodialdehyde (MDA levels) significantly enhanced in the cortex (+46%) and 
medulla (+40%) to similar extent whereas total-SH declined in these tissue (-29% to -
37%). SNT treatment caused marked increase in superoxide dismutase (SOD, +58%) 
and Glutathione peroxidase (GSH-Px, +30%) activities but decrease in catalase (-
16%) activity in the renal cortex. In medulla however the activity of SOD (-58%) and 
catalase (-28%) significantly decresed but in the activitiy of GSH-Px (+45%) was 
significantly increased by SNT administration alone. FO and FXO dietary 
supplementation was able to ameliorate the SNT induced oxidative damage in both 
renal cortex and medulla. 
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(ii) The effect of SNT, FO and FXO were determined on various antioxidant 
parameters in mucosal homogenates. SNT treatment caused marked increase in SOD 
(+160%), catalase (+55%) and GSH-Px (+28%). These changes were associated with 
significant increase in lipid peroxidation (+87%) measured in terms of MDA levels 
and decrease in total-SH (-21%)). Both FO and FXO-diet partially prevented SNT-
induced increase in SOD, catalase and GSH-Px activities. SNT induced increase in 
LPO and decreased SH-content were prevented by FO/FXO diet. 
(iii) The effect of SNT, FO and FXO-diet was determined on various antioxidant 
parameters in liver homogenates. SNT treatment to control rats caused marked 
increase in SOD (+34%)) and GSH-Px (+55%)) activities but decrease in catalase (-
20%). These changes were associated with significant increase in lipid peroxidation 
(+30%) and decrease in total-SH content (-37%). Both FO/FXO-diets prevented SNT-
induced increase in SOD and GSH-Px activities whereas catalase was significantly 
lowered by FO and FXO diet were given in combination with SNT treatment. Total-
SH and LPO were also normalized to near control values. 
(e) Na*- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ''^ Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by SNT treatment. However, the uptake of 
'^ Pi at the equilibrium phase (120min) when Nap=Nai was not significantly different 
between the two groups. Also Na-independent uptake (in the absence of a Na 
uradient. when NaCl in the medium was replaced by KCl where Ko> Ki) of ""Pi at 30s 
and 120min was also not affected by SNT treatment indicating specific alterations 
only when Na-gradient was present. When SNT treatment was extended to FO and 
FXO feeding rats, SNT induced decrease in ^^ Pi transport was not observed. 
(f) Tissue concentration of nitrite: 
Exposure of SNT to rats increased the tissue concentrations of nitrite in all tissues, the 
accumulation of nitrite being greater in renal cortex (+78%)) and intestine (+52%)). 
When FO/FXO was given in combination with SNT, both FO and FXO partially 
improved the values to near control in renal cortex, medulla and intestine, whereas in 
the liver complete amelioration was observed (Table 14). 
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ftf Interpretation; In general, SNT caused severe adverse effects on various 
serum/urine parameters and on the enzymes of carbohydrate metabolism, BBM and 
antioxidant defense system in rat kidney and intestine. FO and/or FXO diet similarly 
protected against GM-induced nephrotoxic and other adverse effects most likely due 
to their intrinsic biochemical and antioxidant properties. 
O PART II; EFFECT OF FISH OIL (FO) AND FLAXSEED OIL (FXO) ON 
SODIUM NITROPRUSSIDE (SNP) INDUCED NEPHROTOXIC AND OTHER 
ADVERSE EFFECTS 
(a) Setunt/urine parameters: 
SNP treatment to control rats resulted in significant increase in serum creatinine (Scr), 
blood urea nitrogen (BUN), cholesterol, glucose and phospholipids but decrease in 
inorganic phosphate (Pi) compared to control rats. These changes where associated 
with profound phosphaturia, proteinuria and glucosuria accompanied by decrease in 
creatinine clearance (Table 2). Feeding of FO or FXO diet to SNP administered 
(FOSNP and FXOSNP) rats resulted in significant reversal of various SNP elicited 
deleterious effects on serum and urine parameters. 
(b) Enzymes of carbohydrate metabolism: 
(i) SNP increased the activity of lactate dehydrogenase (LDH) and hexokinase (HK) 
but decreased malate dehydrogenase (MDH), glucose-6-phosphatase (G6Pase) and 
fructose-1. 6-bisphosphatase (FBPase) activities in the renal cortex. When SNP 
treatment was extended to FO and FXO-fed rats, SNP-induced alterations in 
metabolic enzyme activities were prevented by FO and FXO diets alike. SNP 
treatment to control rats significantly increased G6PDH but decreased ME activity. 
SNP elicited increase of G6PDH activity was normalized to near control values by 
both FO and FXO diets. SNP induced ME activity decrease was arrested by both FO 
and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by SNP treatment as in the cortical homogenates. Feeding of 
FO and FXO to SNP treated rats prevented SNP induced alterations in various 
enzyme activities. Similar to cortex, G6PDH activity increased whereas ME activity 
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decreased by SNP in the medulla (Table 4). FO and FXO diet to SNP treated rats 
decreased G6PDH activity and increased ME activity. 
(iii) SNP treatment to control rats caused significant increase in LDH (+29%) and 
hexokinase (HK) but decrease in MDH activities. SNP caused significant decrease in 
gluconeogenic enzymes, G6Pase and FBPase in the intestine. The activities of LDH, 
G6Pase and to some extent FBPase remained significantly higher after SNP treatment 
to FO and FXO-fed rats compared to control rats reversing the SNP-induced decrease 
in G6Pase and FBPase activities. SNP-induced decline in MDH activity was also 
restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+29%) but that of ME decreased (-19%) by SNP treatment compared to control rats. 
However, when SNP treatment was given to FO/FXO diet fed rats, SNP induced 
increased in G6PDH and decrease in ME activities were not observed indicating that 
both FO and FXO diet significantly prevented the alterations caused by SNP. 
(iv) SNP treatment significantly increased the activities of LDH (+35%) and HK 
(+59%) whereas decreased G6Pase, FBPase, ME and G6PDH activities in the liver. 
When SNP treatment was extended to FO-fed rats, SNP-induced decrease of 
metabolic enzyme activities was prevented by FO and FXO alike except HK and 
MDH. whose activities remained significantly higher than control by FXO. 
(c) Marker enzymes of BBM and Ivsosomes: 
(i) SNP treatment to control rats caused significant reduction in the specific activities 
of GGTase (-24%) and LAP (-56%) in cortical homogenates. The prior feeding of FO 
or FXO diet with SNP treatment prevented SNP elicited decrease in BBM enzyme 
activities. The activity of acid phosphatase (ACPase) was increased (+31%) by SNP 
in cortical homogenates and FO/FXO diet was able to restore the enzyme activity in a 
similar manner. The activites of BBM enzymes similar to the cortex were also 
lowered in the medulla by SNP administration although to a lower extent. The 
consumption of FO/FXO in combination with SNP treatment resulted in the reversal 
of SNP induced decrease in GGTase (-29%)) and LAP (-48%)) in the medulla. The 
activity of ACPase was increased (+46%)) by SNP. 
(ii) Activities of AlkPase (-25%), GGTase (-13%) and LAP (-43%) profoundly 
declined by SNP treatment as compared to control rats in renal BBM. Fish oil (FO) 
and flaxseed oil (FXO) dietary supplementation similar to the effect in the 
173 
Sicnunaty ^ Concluttotv 
homogenates appeared to lower the severity of the SNP treatment. SNP-induced 
decrease in BBM enzyme activities was significantly prevented by dietary FO and to 
greater extent by FXO diet. 
(iii) SNP treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. SNP treatment also resulted in the decrease of 
ACPase activity. When SNP treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. SNP treatment profoundly decreased the activities of all 
BBM enzymes, FO/FXO caused significant normalization in the values of AlkPase, 
GGTase and sucrase. SNP induced decrease in the BBMV and lysosomal marker 
enzymes was not only preserved by FO/FXO diets but the activities were restored to 
near control values. 
(iv) SNP treatment to rats resulted in extensive reduction in the specific activity of 
GGTase and LAP whereas AlkPase and ACPase where increased in the liver 
homogenates. The feeding of FO and FXO-diet to SNP treated (FOSNP/FXOSNP) 
rats prevented SNP elicited changes. 
(d) Enzymatic and non-enzvmatic antioxidant defense parameters: 
(i) SNP enlianced lipid peroxidation (LPO) and significantly altered antioxidant 
enzymes both in cortex and medulla, albeit differently. LPO measured in terms of 
malodialdehyde (MDA levels) significantly enhanced in the cortex (+42%) and 
medulla (+75%) to similar extent whereas total-SH declined in these tissue (-22% to 
-37%). SNP treatment caused marked increase in superoxide dismutase (SOD, +40%) 
but decrease in Glutathione peroxidase (GSH-Px, -29%) and catalase (-18%) activities 
in the renal cortex. In medulla however the activity of SOD (-87%), catalase (-35%) 
and GSH-Px (-42%) significantly decreased by SNP administration alone. SNP 
induced increase in LPO and decrease in total-SH was not observed by feeding FO or 
FXO diet to SNP-treated rats. The activity of catalase and GSH-Px in the cortex and 
medulla remained significantly higher in FO/FXO + SNP rats compared to SNP rats. 
(ii) SNP treatment caused marked increase in SOD (+46%)) but decrease in catalase 
(-36%) and GSH-Px (-39%). These changes were associated with significant increase 
in lipid peroxidation (+60%) measured in terms of MDA levels and decrease in total-
SH (-23%). Both FO and FXO-diet partially prevented SNP-induced alteration in 
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SOD, catalase and GSH-Px activities. SNP induced increase in LPO and decreased 
SH-content were prevented by FO/FXO diet. 
(iii) SNP treatment to control rats caused marked decrease in SOD (-21%) and GSH-
Px (-43%) activities. These changes were associated with significant increase in lipid 
peroxidation (+34%) and decrease in total-SH content (-40%)). Both FO/FXO-diets 
prevented SNP-induced increase in SOD and GSH-Px activities whereas catalase was 
significantly elevated by FO and FXO diet when given in combination with SNP 
treatment. Total-SH and LPO were also normalized to near control values. 
(e) No"- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by SNP treatment (Table 13). However, the 
uptake of ^^ Pi at the equilibrium phase (120min) when Nao=Nai was not significantly 
different between the two groups. When SNP treatment was extended to FO and FXO 
feeding rats, SNP induced decrease in ^^ Pi transport was not observed. 
(f) Tissue concentration of nitrite: 
Nitrite is the predominant metabolite of nitric oxide in vivo therefore. The effect of 
SNP, FO and FXO on tissue accumulation of nitrite was determined by the Griess 
reagent assay as described in methods. SNP significantly increased nitrite 
accumulation in all tissues however the effect was maximum in renal medulla. Both 
FO and FXO reduced the amount of nitrite in rat tissues. 
fy- Interpretation; SNP treatment caused severe damage to the kidney and intestine 
as reflected by increase in serum creatinine and BUN and decrease in biomarker 
BBM enzymes. There appeared to be a shift from aerobic to anaerobic metabolism 
most likely due to SNP induced mitochondrial damage. SNP also increased oxidative 
stress as indicated by increased LPO and decreased total-SH levels associated with 
imbalances in the activities of antioxidant enzymes. FO/FXO-diet prevented/retarded 
SNP-induced alterations in various biochemical parameters and enzyme activities 
most likely due to their incorporation in cellular membranes and antioxidant 
properties. 
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O PART III; EFFECT OF FISH OIL (FO) AND FLAXSEED OIL (FXO) ON L-
ARGININE (ARG) INDUCED NEPHROTOXIC AND OTHER ADVERSE 
EFFECTS 
(a) SerunvVrine Parameters: 
ARG treatment to control rats resulted in significant increase in serum creatinine 
(Scr). blood urea nitrogen (BUN), glucose and phospholipids but decrease in 
inorganic phosphate (Pi) compared to control rats. These changes where associated 
with profound phosphaturia, proteinuria and glucosuria accompanied by decrease in 
creatinine clearance. Feeding of FO or FXO diet to ARG administered (FOARG and 
FXOARG) rats resulted in significant reversal of various ARG elicited deleterious 
effects on serum and urine parameters. 
(b) Enzymes of carbohydrate metabolism: 
(i) ARG treatment to control rats significantly increased the activity of lactate 
dehydrogenase (LDH) and hexokinase (HK) but decreased malate dehydrogenase 
(MDH), giucose-6-phosphatase (G6Pase) and fructose-1, 6-bisphosphatase (FBPase) 
activities in the renal cortex (Table 3, 4). When ARG treatment was extended to FO 
and FXO-fed rats, ARG-induced alterations in metabolic enzyme activities were 
prevented by FO and FXO diets. ARG treatment to control rats significantly increased 
G6PDH but decreased ME activity. ARG elicited increase of G6PDH activity was 
normalized to near control values by both FO and FXO diets. ARG induced ME 
activity decrease was arrested by both FO and FXO diet. 
(ii) The activities of LDH, MDH, HK, G6Pase and FBPase in medullary homogenates 
were similarly affected by ARG treatment as in the cortical homogenates. Feeding of 
FO and FXO to ARG treated rats prevented ARG induced alterations in various 
enzyme activities. Similar to cortex, G6PDH activity increased whereas ME activity 
decreased by ARG in the medulla. FO and FXO diet to ARG treated rats decreased 
G6PDH activity and increased ME activity 
(iii) ARG treatment to control rats caused significant increase in LDH (+26%) but 
decrease in MDH activities. ARG caused significant decrease in gluconeogenic 
enzyme, G6Pase in the intestine. The activity of G6Pase remained significantly higher 
after ARG treatment to FO and FXO-fed rats compared to control rats reversing the 
ARG-induced decrease in its activity. ARG-induced decline in MDH activity was also 
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restored by both FO and FXO-diets. The activity of G6PDH significantly increased 
(+24%) but that of ME decreased (-39%) by ARG treatment compared to control rats. 
However, when ARG treatment was given to FO/FXO diet fed rats, ARG induced 
increased in G6PDH and decrease in ME activities were not observed. 
(iv) ARG treatment significantly increased the activities of LDH (+41%), HK (+35%) 
and G6PDH (+50%) whereas decreased G6Pase, MDH and ME activities in the liver 
(Table 5. 6). When ARG treatment was extended to FO-fed rats, ARG-induced 
decrease of metabolic enzyme activities was prevented by FO and FXO. 
(c) Marker enzymes ofBBMand Ivsosomes: 
(i) ARG treatment to control rats caused significant reduction in the specific activities 
of AlkPase (-28%), GGTase (-27%) and LAP (-29%) in cortical homogenate. The 
prior feeding of FO or FXO diet with ARG treatment prevented ARG elicited ecrease 
in BBM enzyme activities. As can be seen from the data ARG induced decrease in 
BBM enzyme activities were similarly prevented by FO or FXO diet. The activity of 
acid phosphatase (ACPase) was also decreased (-17%) by ARG in cortical 
homogenates and FO/FXO diet was able to prevent the decrease in enzyme activity in 
a similar manner. The activities of BBM enzymes similar to the cortex were also 
lowered in the medulla by ARG administration (Table 7). The consumption of 
FO/FXO in combination with ARG treatment resulted in the reversal of ARG induced 
decrease in GGTase (-22%) and LAP (-40%) in the medulla. The activity of ACPase 
was also lowered by ARG (-16%). However it was found to be higher in ARG+FO 
rats (+19%) compared with the control rats. 
(ii) Activities of AlkPase (-47%), GGTase (-45%) and LAP (-40%) profoundly 
declined by ARG treatment as compared to control rats in renal BBM. Fish oil (FO) 
and flaxseed oil (FXO) dietary supplementation similar to the effect in the 
homogenates appeared to lower the severity of the ARG treatment. 
(iii) ARG treatment to control rats caused significant decrease in AlkPase, GGTase 
and LAP in mucosal homogenates. ARG treatment also resulted in the decrease of 
ACPase activity. When ARG treatment was given to FO/FXO fed rats normalization 
of the activities of AlkPase, GGTase, LAP and sucrase whereas ACPase was partially 
restored to control values. 
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ARG treatment profoundly decreased the activities of all BBM enzymes but sucrase 
which was elevated in intestinal BBM, FO/FXO caused marked increase in AlkPase 
and GGTase whereas LAP and sucrase activities were significantly normalized by 
both FO/FXO diets. ARG induced decrease in the BBMV and lysosomal marker 
enzymes was not only preserved by FO/FXO diets but the activities were restored to 
near control values. 
(iv) ARG treatment to rats resulted in extensive reduction in the specific activity of 
alkaline phosphatase (AlkPase), GGTase LAP and ACPase in the liver homogenates. 
The feeding of FO and FXO-diet to ARG treated (FOARG/FXOARG) rats not only 
prevented ARG elicited changes, but the activities of GGTase and AlkPase were even 
increased by FO diet. 
(d) Enzymatic and non-enzvmatic antioxidant defense parameters: 
(i) To ascertain the role of antioxidant system in ARG-induced toxicity, the effect of 
ARG observed on oxidative stress parameters. ARG enhanced lipid peroxidation 
(LPO) and significantly altered antioxidant enzymes both in cortex and medulla, 
albeit differently. LPO measured in terms of malodialdehyde (MDA levels) 
significantly enhanced in the cortex (+43%) and medulla (+51%) to similar extent 
whereas total-SH declined in these tissue (-16% to -26%)). ARG treatment caused 
marked increase in superoxide dismutase (SOD. +68%) but decrease in Glutathione 
peroxidase (GSH-Px, -37%) activity in the renal cortex. In medulla however the 
activity of SOD (-36%) and GSH-Px (-16%) significantly decreased by ARG 
administration alone. ARG induced increase in LPO and decrease in total-SH was not 
observed by feeding FO or FXO diet to ARG-treated rats. The activity of GSH-Px and 
catalase in the cortex and the activity of catalase and GSH-Px in the medulla 
respectively remained significantly higher in FO/FXO + ARG rats compared to ARG 
and/or control rats. 
(ii) ARG treatment caused marked increase in SOD (+35%) but decrease in catalase (-
22%). Tliese changes were associated with significant increase in lipid peroxidation 
(+30%) measured in terms of MDA levels and decrease in total-SH (-21%)). Both FO 
and FXO-diet partially prevented ARG-induced increase in SOD, catalase and GSH-
Px activities. ARG induced increase in LPO and decreased SH-content were 
prevented by FO/FXO diet. 
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(iii) ARG treatment to control rats caused marked decrease in catalase (-22%) and 
GSH-Px (-17%) activities. These changes were associated with significant increase in 
lipid peroxidation (+35%)) and decrease in total-SH content (-21%)). Both FO/FXO-
diets prevented ARG-induced decrease in catalase and GSH-Px activities when FO 
and FXO diets were given in combination with ARG treatment. Total-SH and LPO 
were also nonnalized to near control values. 
(e) Na*- dependent transport of^^Pi in the BBMV isolated from renal cortex: 
The rate of concentrative uphill uptake of ^^ Pi in the presence of a Na-gradient (NaCl 
in the medium) was markedly decreased by ARG treatment. However, the uptake of 
^^ Pi at the equilibrium phase (120min) when Nao=Naj was not significantly different 
between the two groups. Also Na-independent uptake (in the absence of a Na 
gradient, when NaCl in the medium was replaced by KCl where Ko> Kj) of Pi at 30s 
and 120min was also not affected by ARG treatment indicating specific alterations 
only when Na-gradient was present. When ARG treatment was extended to FO and 
FXO feeding rats, ARG induced decrease in "Pi transport was not observed. 
(f) Tissue concentration of nitrite: 
ARG administration to rats increased the tissue concentrations of nitrite in all tissues, 
the accumulation of nitrite being greater in renal medulla (+35%) and intestine 
(+28%). When FO/FXO was given in combination with ARG, both FO and FXO 
partially improved the values to near control in renal cortex, medulla and intestine, 
whereas in the liver complete amelioration was observed. 
fy' Interpretation; In general, ARG caused severe adverse effects on various 
serum/urine parameters and on the enzymes of carbohydrate metabolism, BBM and 
antioxidant defense system in rat kidney and intestine. FO and/or FXO-diet similarly 
protected against ARG-induced nephrotoxic and other adverse effects most likely due 
to their intrinsic biochemical and antioxidant properties. 
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O CONCLUSION: 
In conclusion the results of the present studies demonstrate that SNT/SNP/ARG 
elicited deleterious nephrotoxic effects by causing major damage to mitochondria, 
lysosomes and in particular to BBM of renal proximal tubule, intestinal mucosa and 
liver as reflected by significant decrease in the activities of their specific biomarker 
enzymes, confirming some of the previous morphologic and biochemical observations 
that showed these organelles as prime NO donors/metabolites targets. NO 
donors/metabolites seem to enhance glycolytic enzyme LDH in various tissues in 
order to increase energy dependence on glycolysis due to mitochondrial damage and 
depressed TCA cycle enzymes. Gluconeogenic enzymes also appeared to decrease 
also due to mitochondrial dysfunction as oxalate produced by MDH is not available. 
Serum Pi and renal Pi transport was also decreased suggesting a decrease in metabolic 
activity. These nephrotoxic and other adverse effects appeared to be mediated in part 
due to NO donors/metabolites elicited oxidative/nitrosative damage. In agreement 
with previous studies except for few direct effects, SNT/SNP/ARG appear to cause 
many of these deleterious effects either by conversion to NO or by its uncontrolled 
excessive production, as supported by increased tissue levels of nitrite as NO is 
rapidly converted to nitrite. Dietary co-3 PUFA enriched fish oil and flaxseed oil to a 
larger extent prevented NO donors/metabolites induced nephrotoxicity parameters by 
enhancing nutrition/energy metabolism and Pi transport capacity, by strengthening 
antioxidant defense mechanism and by altering membrane 
organization/fluidity/permeability, co-3 PUFA enriched FO/FXO diets leads to an 
enhancement in the metabolic processes. This enhancement leads to increase in the 
demand of Pi, which in turn leads to increased utilization, as Pi is required in the 
synthesis of membranes such as endoplasmic reticulum, mitochondria and plasma 
membrane in order to support higher metabolic activities. The results also suggest that 
w-3 PUFA strengthen the biological antioxidant defense system thereby reducing 
oxidative/nitrosative damage induced by NO donors/metabolites. 
It is apparent that a)-3 PUFA is a source of wide range of nutraceuticals that are 
digested, absorbed and metabolized and that they exert their effects at the cellular 
level. Fish/flaxseed oil enriched in ©-3 PUFA provide a dietary source of biologically 
active components that has been shown to be co-preventative and co-therapeutic in a 
wide variety of ailments. Based on our present observations and already known 
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numerous health benefits, we propose that co-3 PUFA enriched FO/FXO may provide 
a cushion for a prolonged therapeutic option against drug/chemical induced 
nephropathy without harmful side effects. Similar protective effects of FO and FXO 
provide a much needed relief for millions of vegetarians who do not eat fish/fish oil 
for religious or other reasons. 
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